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Abstract 
Raman micro-spectroscopy presents a highly sensitive, non-invasive, and rapid way to 
collect biochemical information from cells and tissues. The resulting Raman spectrum 
is a chemical ‘fingerprint’ containing a wealth of molecular level information which 
has been used to characterize, monitor, compare and confirm biological processes 
from the cellular to tissue levels. The work presented in this thesis utilizes Raman 
spectroscopy to test live in vitro cellular models, classify human tissues of interest, and 
determine the biomolecular differences in tissue samples which are diseased or 
undergoing therapeutic treatment. Additionally new ways of visualizing and 
interpreting multivariate analytical results are proposed and demonstrated to ease 
the determination of the biomolecular features which are most important when 
comparing sample groups. 
 
A persistent challenge in the interpretation of information rich biological Raman 
spectra includes the multitude of signals from lipids, proteins, carbohydrates, nucleic 
acids, and minerals found in a limited spectral range and in some instances 
overlapping significantly. Partial Least Squares – Discriminant Analysis (PLS-DA) 
Variable Importance Projection (VIP) scores were presented as heat maps overlaying 
difference spectra to ease the visualization of significant biochemical bond changes 
between sample groups and their trends. The advantages of applying PLS-DA VIP 
scores in this way are demonstrated in well studied and known system including a 
cultured cellular model incorporating fixation methods and a human tissue 
comparison between healthy and osteoporotic bone. PLS-DA VIP score plots were 
additionally utilized to characterize and compare the biolomecular environments 
surrounding the recently described microscopic mineral inclusions in human aortic 
valves and aortae. The PLS-DA VIP score plots exposed the chemical differences in 
these systems through highlighting the corresponding spectral bands in an easy to 
read and interpret way.  
 
Raman micro-spectroscopy was also applied to investigate an in vitro ‘calcified’ 
porcine aortic valvular interstitial cell model. This model system was probed for the 
first time using the combination of Raman micro-spectroscopy and complimentary 
gold standard biological techniques to determine the protein and potential mineral 
content within these nodular, cellular systems. The ‘calcified’ porcine aortic valvular 
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cell nodules showed no evidence of mineral inclusion. These nodules did exhibit a 
heavy extracellular matrix production including the production of collagen I.  
The porcine aortic valvular cell nodules acting as a model system for diseased aortic 
valve tissue requires not only the characterization of the cell nodule in vitro but also 
the characterization of the human disease spectrum which the model is suggested to 
replicate. The discovery and characterisation of microscopic mineral spherical 
inclusions (50nm-200µm) located in both valvular and vascular tissues leads to an 
interesting question on the introduction and role of microscopic mineral deposits in 
cardiovascular disease.  Here Raman micro-spectroscopy was utilized to investigate 
the organic matrix surrounding these microscopic mineral deposits to determine if 
any colocalised protein changes exist. Protein and specifically collagen changes are 
demonstrated between tissues with and without the spherical mineral deposits 
despite being macroscopically indistinguishable. 
 
Raman spectroscopy was also utilized to provide direct insights into tissue constituent 
and structural changes on the molecular level in heat-induced tissue fusion via radio-
frequency (RF) energy. This type of tissue fusion has gained wide acceptance clinically 
and is presented here as the first optical-Raman-spectroscopy study on tissue fusion 
samples in vitro. This study exposed spectroscopic evidence for the loss of distinct 
collagen fibres rich tissue layers as well as the denaturing and restructuring of 
collagen crosslinks post RF fusion.  
 
Raman spectroscopy is a demonstrated, powerful, biomolecular imaging technique 
which benefits from advancements in mathematical analytical techniques as well as its 
own application in biological investigations. This thesis explores the application of 
Raman spectroscopy in combination with powerful analytical techniques to further 
characterize and compare biological systems of interest. 
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1 Introduction  
Medical science research continues to strive to understand, unravel, alter, mimic, 
utilize, replicate, control, repair, and/or completely replace biological systems of 
interest. For these complex investigations a wide variety of techniques have been 
developed and applied to explore these intricate systems, each with its advantages 
and disadvantages. From the atomic to the tissue level, each contributing viewpoint is 
aiding our understanding of biological systems. 
1.1.1 Aims 
The focus of this thesis is to interrogate biological systems of interest at the molecular 
level to furnish new information on these systems. This effort incorporates utilizing 
Raman micro-spectroscopy and complimentary techniques to unearth bio-molecular 
information from relevant samples as well as exploring analytical tools to aid the 
biological interpretation of such data. The exploration and demonstration of analytical 
tools which both takes advantage of sophisticated statistical techniques yet allows for 
an ‘easy to read’ visualization of spectral ranges of interest is one of the aims in this 
thesis. For this purpose Partial Least Squares – Discriminant Analysis (PLS-DA) 
Variable Importance Projection (VIP) score plots were presented as heat maps 
overlaying difference spectra distinguishing spectral ranges of interest. These spectral 
ranges can then be further investigated to help determine the molecular changes 
distinguishing sample groups. These PLS-DA VIP plots were incorporated in several 
studies in this thesis to demonstrate the potential for this technique and to utilize this 
tool for studies at the cellular and tissue level. 
 
A central aim in this work includes the interrogation of cardiovascular calcification 
with some focus on aortic valve calcification. Here an in vitro ‘calcified’ porcine aortic 
valvular interstitial cell system was probed to determine the presence (if any) of the 
calcified content, the nature of this calcification and further expose the molecular 
components of the nodules this cellular system forms. 
 
Human cardiovascular tissue was also examined in a variety of states along the 
calcification spectrum to explore the molecular differences between tissues with and 
without calcification present. Following the discovery and characterization of 
microscopic spherical mineral inclusions located in both valvular and vascular tissues 
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we aimed to determine if any changes in the organic matrix surrounding these 
microscopic mineral inclusions were occurring and if so aimed to identify some of 
these changes. 
 
Finally heat induced tissue fusion via radio-frequency energy for use in surgical 
procedures was investigated to determine the changes within the molecular 
constituents of fused tissue which provide the strong seal associated with this 
technique. Specifically the molecular bond changes which occur during tissue fusion 
were of interest in hopes to further characterize the changes in fused tissue as well as 
identify, if possible, any changes associated with the tissue fusion.  
 
This introduction chapter details the fundamentals of Raman spectroscopy, its 
incorporation into the study of the biological systems and the analytical techniques 
applied in this thesis. Additionally presented is an introduction into cardiovascular 
calcification, and specifically aortic valve calcification, as cardiovascular pathology 
was a central focus for chapters 3 and 4. 
1.2 Raman Spectroscopy 
1.2.1 Characteristics of the Raman Process 
Vibrational Raman spectroscopy is an optical scattering process based on the 
interaction of light and matter as first experimentally discovered and described by C.V. 
Raman in 1928 [1]. Motivated by Arthur Compton’s observation that X-rays could lose 
energy when scattered in-elastically by electrons (also known as the ‘Compton effect’), 
Raman and Krishnan hypothesized that a similar energy transfer should take place 
when ‘normal’ light is scattered by atoms or molecules. The experimental evidence 
and discovery of this effect that bears his name along with his research on the 
diffusion of gases won Sir C.V. Raman the noble prize in physics in 1930 [2]. 
 
When a beam of monochromatic light (e.g. a laser beam) illuminates a substance the 
majority of this light is transmitted, some is absorbed and a small percentage is 
scattered. An isolated atom scatters light due to the electric field of the incident light 
forcing the electrons in the atom to oscillate back and forth about their equilibrium 
position. The laws of electromagnetism then state when a charge changes its velocity 
it emits radiation and this emission is uniform in all directions in the plane 
perpendicular to the oscillation with a decreasing amplitude as the viewing angle 
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shifts away from the oscillation plane. Of this scattered light the majority is Rayleigh 
scattering (also known as elastic scattering) meaning the photons experience a 
directional change only and are essentially of the same frequency. Inelastic scattering 
occurs when the light emitted not only changes direction but also wavelength and is 
called Raman scattering.  
 
Moving to polyatomic systems, the vibrational scattering process is often described as 
a two-photon process where the illuminated molecule goes through a process from an 
initial quantum state to an intermediate ‘virtual’ state and lastly to a final quantum 
state and emits a photon. The virtual state is not a stable, stationary energy state of 
the molecule but rather a distortion of the electron distribution of the chemical bond. 
Due to the instability of the virtual state the molecule immediately relaxes back to an 
electronic state by emitting a photon. For the majority of these interactions the 
molecule relaxes back to its initial quantum state and the emitted photon is equivalent 
in energy to the incident photon. This elastic interaction is again called Rayleigh 
scattering. For a minority of these interactions an energy transfer occurs and some of 
incident light energy is transferred to the molecule (or vice versa) during the 
electronic oscillation process. This means the emitted photon is now of a shifted 
energy level and the amount of the energy transferred corresponds to the specific 
vibrational energy of the chemical bonds in the molecule. In summary, in this two 
photon process, if the molecule excited did not gain or lose energy Rayleigh scattering 
occurred. If the molecule gained or lost energy, Raman scattering occurred. If the 
molecule gained energy Stokes Raman scattering occurred and if the molecule lost 
energy, anti-Stokes Raman scatter occurred. These processes are shown below, where 
Ea is the energy level of the molecular bond before the interaction with the incident 
photon and Eb is the energy level of the bond after the secondary photon is emitted. 
This effect is often summarized using energy level diagrams as displayed in Figure 1-1. 
 
The energy of a photon is expressed as E = hv, where E is the energy of a photon, h is 
planck’s constant and v is the frequency of the radiation.   
Ea = Eb  Rayleigh scattering  
(excitation: ΔEi=hvo relaxation: ΔEf=-hvo) 
Ea < Eb  Stokes Raman scattering  
(excitation: ΔEi=hvo relaxation: ΔEf=-h(vo-vv) scattered energy: ΔEv=hvv ) 
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Ea > Eb  Anti-Stokes Raman scattering  
(excitation: ΔEi=hvo relaxation: ΔEf=-h(vo+vv) scattered energy: ΔEv=hvv ) 
 
Figure 1-1 Energy level diagram showing Rayleigh, Stokes, and anti-Stokes 
Raman scattering. The arrows represent the shift in energy levels during 
excitation (arrows pointing upward) to relaxation and emission of the 
secondary photon (downward pointing arrow). 
Raman inactive or forbidden molecular vibrations will not generate Raman scattering. 
Molecular vibrations which do generate Raman scattering are called Raman active or 
allowed and require a change in the polarizability of the stimulated bond during a 
vibration. Generally speaking, when the excitation of the molecular vibration produces 
a change in the polarizability of the electron cloud of the molecule, this vibration will 
be Raman active. When looking at poly atomic systems the total number of vibrational 
modes found in a poly atomic molecular systems of ‘N’ atoms is equal to 3N-1.  
 
The work presented in this thesis is based on observations of Stokes Raman scattering 
and specifically non-resonance Stokes Raman scattering. The distinction being the 
excitation energy used in these investigations were typically much smaller than the 
energy of the first electronic state of the molecule thus the molecule has not jumped 
electronic states due to its interaction with the incident photon (shown in the left 
most example of Figure 1-1). For resonance stokes scattering the intensity of the 
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Raman scatter light may be much larger however the selection rules are different. 
Although this is a very interesting tool and area of research, it is outside the scope of 
this work. 
 
Raman micro-spectroscopy was utilized in the following chapters to investigate 
polyatomic molecular systems, where each bond is characterized as a band of 
frequencies due to the variable modes of oscillation caused by the influence of the 
surrounding environment on the bond’s energy absorption. Raman spectra are shown 
as a plot of scattered intensity (arbitrary units often abbreviated as ‘arb units’) as a 
function of the energy difference between the incident and scattered photons (often 
shown in this thesis as ‘Raman Shift (cm-1)’). Frequencies contributed from the 
multiple bonds within the samples construct the vibrational spectrum presenting a 
chemical fingerprint of the sample. With micro-spectroscopy the composition was 
characterized under a microscopic sampling region through a microscope objective in 
a system described further in this chapter [3]. 
 
Specifically the work in this thesis utilizes spontaneous, non-resonate, CCD-based, 
dispersive Raman micro-spectroscopy. This form of Raman spectroscopy benefits 
from using relatively inexpensive excitation lasers, compactness, robustness, mobility 
and a lower technical complexity. There are many other forms of Raman spectroscopy 
which are briefly described here however are not further detailed as they are 
independently large areas of research and outside the scope of this work. Resonance 
Raman scattering (RRS) gives a greater specificity than normal spontaneous Raman 
scattering however as visible or ultraviolet excitation is required to achieve 
resonance, the fluorescence interference and spectral degradation of the same hinders 
RRS in biological studies [4]. Surface-enhanced Raman spectroscopy (SERS) 
demonstrates an increase in the Raman scattering cross section by the presence of 
metal colloids (often Au, Ag, or Cu) or a roughened metal surface. The chemical and 
electromagnetic effects contributing to SERS is not yet fully understood and the 
inclusion metal colloids or a roughened surface makes it an invasive or contact 
technique [5,6].  Coherent anti-Stokes Raman scattering (CARS) is a nonlinear optical 
process using multiple lasers to excite scattering from higher order vibrational modes 
and produces a significant signal enhancement. The limitation of CARS includes a 
much increased technical complexity and a somewhat limited spectral and chemical 
resolution [7,8].  FT-Raman spectroscopy provides a Fourier transform of the time-
domain interferogram to produce a frequency-domain Raman spectrum and 
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ultimately provides signal enhancement through suppression of any fluorescence 
background encountered with visible wavelength excitation. The limitations of FT-
Raman include a typically longer collection time which greatly affects live cell or tissue 
studies. The advantages and disadvantages of these systems are evolving with 
technological and analytical developments which are not discussed further in this text; 
however advancements in each separate family of Raman spectroscopy may translate 
into the type of Raman spectroscopy utilized here and vice versa. 
1.2.2 Raman Spectroscopy of Biological Samples 
Raman spectroscopy is applicable for hydrated samples as (polar) water molecules 
scatter Raman signals weakly, thereby making it useful for gaining bio-molecular 
insight into cellular systems. Additionally the Raman spectral peaks are sharp and 
relatively distinct for several bonds of interest in cellular, extracellular matrix (ECM), 
and mineral environments. The Raman spectra are so intensely information rich that 
it is also difficult to differentiate each component fully due to overlapping vibrations. 
Thus the band assignments of individual vibrations must be done with great care. The 
use of peak assignment tables consisting of the most common and well defined 
vibrations in biological Raman spectra is essential. Looking further than individual 
band assignments, the focus of the following investigations were not of one particular 
molecule but rather an entire cell or tissue region and thus a collection of changes in 
the Raman spectra were of interest and the trends in these changes. This leads to the 
use of multivariate statistics which takes into consideration multiple bands and their 
discrepancies. This is described in more detail below in the Data Collection and 
Analysis section and in chapter 2. 
 
Raman spectroscopy is extremely versatile in nature and this enables it to be used in a 
variety of configurations, ranging from fiber optical probes to microscope-based 
measurements. This allows the user to tailor measurement collection parameters to 
the constraints of each system of interest. Examples include in vitro studies of cell 
culture systems to in vivo studies using high throughput fiber optic probes to capture a 
wealth of biomolecular information rapidly [9-18]. The main system used in this 
thesis is fully described in this chapter and its configuration remained relatively 
conserved for more accurate cross comparisons of spectra collected. Each 
modification to the Raman system may introduce spectral changes that may be 
adjusted for in spectral pre-processing (described further in this chapter). For the 
investigations presented in this thesis the Raman spectroscopy instrumental system 
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was only maintained and not modified during the course of a study, any alterations to 
the instrument occurred in-between studies as necessary. 
1.2.3 Raman Spectroscopy of Soft Tissues 
Raman spectroscopy and in particular micro-Raman spectroscopy has been applied to 
multiple biological investigations ranging from single cells to whole tissue mapping 
and found significant importance in the fields of medicine, pharmacology and biology. 
There are several novel biomedical applications of optical spectroscopy, such as 
fluorescence, reflectance and Raman spectroscopy with Raman spectroscopy 
providing the most detailed information about the chemical composition of the tissue 
under study [19,20]. Since progression of diseases are accompanied by a chemical 
change, Raman spectroscopy has been found valuable in providing information on  
low level biochemical changes that occur at the cellular or extracellular level including 
detailed information on proteins, DNA, and lipids.   
 
In 1970 Lord and Yu reported one of the first structurally interpretable laser excited 
Raman spectrum of a native protein, specifically from a lysosome[21]. Numerous 
studies have taken advantage of laser excitement and biological compatibility of 
Raman spectroscopy showcasing it’s ability for not only protein but also 
phospholipids [22] and DNA [23] investigations. Through these studies a large 
database of molecular fingerprint spectral assignments has accumulated and the 
reader is referred to Movasaghi et al.’s summary of the most widely used peak 
frequencies and their assignments [24]. In the following chapters the Raman peaks of 
interest to that particular study will be introduced and defined including the peak’s 
assignments details within each chapter. A list of Raman spectroscopic peaks used to 
identify various tissue environments in this thesis can be found in appendix A along 
with some references reporting those peak assignments. There have been many 
studies establishing and utilizing the peaks listed in appendix A and the references are 
some of and not all of the studies which have been used to support them. 
1.2.4 Raman Spectroscopy of Mineralized Tissues 
Raman spectroscopy has been used to investigate the formation and mineralization of 
bone nodules in vitro previously and has distinct spectral regions correlating to both 
the organic and inorganic components of bone tissue as shown in Figure 1-2. It is has 
evolved into a powerful tool for analyzing the inorganic mineral structures in 
biological tissues due to the high sensitivity to changes in the crystallinity and 
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molecular substitution of biological apatite [12,25-28].  The spectral bands 
predominantly used in the investigation of mineralization in this thesis are shown in 
Table 1-1 with their corresponding bond assignments and Raman peak intensity as 
described.
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Figure 1-2 Raman spectrum collected from a bone sample with inorganic (mineral) peaks labeled in red and organic (protein) peaks 
labeled in blue. Some information reproduced from [29]. 
 
 
 
 30 
Table 1-1 Bone mineral and protein Raman spectral peaks and/or bands and 
assignments. Some information reproduced from [25,29,30] 
 
 
These bands have been previously used to investigate the molecular content in bone 
and revealed information on the crystallinity (related to the full width half maximum 
(FWHM) of apatite phosphate peak), type-B carbonate substitution (ratio of type-B 
carbonate area/ apatite phosphate area), and degree of mineralization of the collagen 
matrix (ratio of apatite phosphate peak area to amide I area) in mineralized studies 
[28,31,32].  Due to the overlapping peaks and the parameter preferences of various 
research groups the assignment and measurement of mineral components such as 
carbonate is not always agreed upon. The methods used in this thesis are detailed in 
each chapter and when possible are performed in the manner which provided a close 
approximation to known weight contributions in samples. An example is the 
approximation of carbonate and a study by Awonusi et al. who compared a series of 
apatites with known varying carbonate levels to the Raman spectra and univariate 
analysis of those samples [33].   
 
In addition to the information gained from the univariate analysis of Raman spectral 
bands and peaks of interest, multivariate analysis is available to determine the main 
components contributing to the differences between each experimental groups [12]. 
The multivariate statistical techniques used in this thesis are described in detail later 
in this chapter. 
1.2.5 Raman Spectroscopy System Used 
A Raman spectrometer allows for the observation of Raman scattered light. The key 
components of a Raman spectrometer include an excitation source, sampling 
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apparatus, filter(s) to reject elastically scattered light, a dispersion element and a 
detector. The Raman system used predominately in the following chapters was a 
modified Renishaw InVia system (Renishaw, U.K.). A schematic of this system is 
presented in Figure 1-3. 
 
 
Figure 1-3 Schematic diagram of the modified Renishaw InVia, CCD-based 
Raman micro-spectroscopy system used in this thesis with the main system 
components as labeled.  
 
The excitation source was a Renishaw 785 nm (near infrared) diode line focus laser 
(Renishaw, U.K.) with a 300 mW power and approximately 120mW power at the 
sample. For sampling microscopic regions of interest, the spectrometer was connected 
to a Leica DM-LM (Leica, Germany) microscope fitted with a heated motorized stage 
(Prior Scientific, U.K.). Various objectives were used for different applications and 
specifics on the types of objects will detail in the individual chapters. The collection 
optics includes a holographic notch filter (HNF) which is a laser rejection filter used to 
filter out Rayleigh scatter light. The remaining predominately Raman scattered light is 
then passed focused through a 50µm spectrometer entrance slit to a diffraction 
grating (1200 lines/mm). This light is then detected by a multichannel (e.g. 1040 x 
256 pixels) thermo-electrically (Peltier cooled to -70°C), deep depletion, charged 
coupled device (CCD). The detected photons are then displayed as a spectrum on the 
integrated computer as (arbitrary) counts plotted against their shift from the incident 
irradiation (thus the Raman shift). 
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1.3 Data Collection and Analysis 
For each investigation minor modification to the system may have been incorporated 
and will be described in the methods section of that chapter. All experiments were 
performed on an anti-vibrational optics table in a cool, dark, access limited room.  
 
Prior to data collection the wavelength axis was calibrated to the strong and sharp 
silicon peak at 520.5 cm-1 using a sample supplied by Renishaw. 
 
Raman spectroscopy measurement factors which were considered in every 
investigation were the Raman shift range, energy and power of the incident beam, 
signal integration time per accumulation and the number of accumulations per 
spectrum. Typically Raman spectra were collected over the biological finger print 
region (500 cm-1 – 1900 cm-1). In hydrated samples and living cells in culture, 
typically the maximum laser power was utilized (300 mW at source, 120 at sample) 
as near infrared radiation at this wavelength (785 nm), power and beam geometry 
(line laser with elliptical focal spot size 10 x 20 x 40 µm axial resolution, depending 
on the objective used) have been previously shown to not disrupt the sample and 
produce information rich spectra. With dehydrated samples a power reduction was 
sometimes applied to reduce any risk of burning. Signal integration time per 
accumulation and the number of accumulations per collected spectrum depended 
greatly on the experimental conditions and samples. With each biological sample 
particular constraints were considered (temporal, spatial, thermal, and sensitivity 
considerations) to ensure a non-invasive invigoration of the sample while yielding a 
high enough signal to noise Raman spectrum for data analysis. Details of the selected 
measurement parameters are found in each chapter. 
1.3.1 Chemometrics 
Each collected Raman spectrum is a signature containing chemical signatures 
describing the normal vibrational molecular modes within the sampled region. 
Translation of the collected Raman spectra into chemical information and further to 
biologically relevant chemical information requires multiples stages of analysis. The 
analytical process includes signal processing (synonymous with preprocessing), the 
comparison of specific peaks (univariate analysis), and the semi-quantitative and 
qualitative multivariate analysis of more than one peak of interest (and often the 
entire spectrum). The high dimension and complexity of the Raman spectral dataset 
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collected in biological investigations requires a diverse range of high power analytical 
techniques to enable identification of key trends. The preprocessing is often required 
to ensure robust and reliable multivariate analysis by removing unwanted parts of the 
signal (noise, background, cosmic rays, etc.) and to correct spectra for instrumental or 
experimental errors. Thus the combination of preprocessing methods may differ in 
each investigation as do the univariate and multivariate analysis. Within each study 
however the preprocessing methods are held constant as to generate a standardized 
data set in which the individual spectra are then directly comparable. 
 
In each of the following chapters the preprocessing and applied analytical technics are 
further specified. For the preprocessing of the Raman spectra however the following 
techniques were often utilized and are described further here. 
1.3.2 Baseline and Background Correction 
Background correction greatly improves the qualitative interpretation of spectral data 
through the removal of Raman spectral features what are not informative on the 
sample of interest. These spectral features are often appear from the luminescence 
process (such as fluorescence), contamination light (e.g. sunlight, monitors, blackbody 
radiation, chemiluminescence), and/or the Raman scattering from the laser lights 
interaction with substrates, optics, and/or impurities within the sample. All 
background subtracted implemented in this thesis is automated rather than using 
user-defined curves. 
 
The predominant background and baseline correction techniques utilized include 
application of a Savitsky-Golay filter to compute 2nd derivative Raman spectra [34], 
polynomial baseline correction, and extended multiplicative scatter correction 
(EMSC). The polynomial baseline correction was based on a modpoly algorithm 
described by Lieber and Mahadevan-Jansen and modeled the broad-band signal with a 
4th or 5th order polynomial (with 1000 iterations) to eliminate background effects[35]. 
EMSC is a development of multiplicative scatter correction which is based on the 
assumption that the wavelength of the scatter light is different to the absorption of the 
sample and EMSC further considers the non-linearity of the scattering signals [36]. 
1.3.3 Smoothing 
The signal to noise ratio (SNR) can be variable due to the Raman scattering being a 
low occurring phenomenon and the added constraints of imaging biological systems 
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and their relatively low scattering cross sections. To correct for some of the noise a 
Savitsky-Golay polynomial smoothing function was utilized in some of the studies 
presented here.  
1.3.4 Normalisation 
Raman spectral intensity can vary based on factors independent of the sample. These 
variations are introduced via changes in the irradiation laser power, optical 
component aging and degradation, sample fluorescence variance between sample 
groups, optical property variation between sample groups and treatments (opacity, 
absorptivity, refractive index, etc.). Background and baseline correction relieve some 
of these intensity variations however further normalization techniques are required 
before further analytical techniques are applied. Normalisation techniques applied in 
this thesis include. 
1.3.5 Univariate Analysis 
Univariate analysis is the selection, characterisation and comparison of individual 
peaks of interest in the collected Raman spectrum. Often these are vibrational modes 
of a molecule of interest which is either strong, sharp and with relatively little overlap 
as in the case with the 960 cm-1 peak (as seen in Figure 1-1), or the characterisation of 
the peak has shown to be reflective of the compound of interest despite its location 
with overlapping peaks as was shown for the 1070 cm-1 carbonate peak with its peak 
height and area strongly correlating with the weight percent carbonate found in 
apatite[33]. 
 
To characterise molecular species of interest through univariate peak analysis two 
predominate techniques were used. The first was a curve fitting tool found in the 
WiRE 3.2 software (Renishaw, U.K.) and includes a user interface where the user 
selects the start and end wavenumbers of the curve (or curves) of interest and 
selecting the height on the selected spectrum. A mixed 50% Lorentzian-Gaussian 
curve will show as a default and the width is then adjustable. After a fit is determined 
where the ratio of Lorentzian-Gaussian fit is adjusted to best fit the signal selected the 
included option of baseline correction with a straight line passing through the end 
points of the Raman shift range of interest is available. As described here, this is a very 
individually intensive process and may be highly subjective. This technique was used 
for initial analysis during spectral collection and when multiple peaks of interest occur 
in the same Raman shift range. With the ability to fit multiple curves, of mixed 
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Lorentzian-Gaussian fits in a selected range to best fit the signal, the level of input may 
allow for a better extraction of a singular peak of interest rather than an automated 
method. When a peak of interest is sharp and less sensitive to overlapping peaks, an 
automated method (in house written script) was used where the Raman shift range 
was selected and all the spectra any selected data set were then subjected to a integral 
function over that selected range to determine the peak area and the full width half 
maximum (FWHM) could also be determined. 
1.3.6 Multivariate Analysis 
Multivariate analysis is critical for the understanding of molecular trends in high-
dimensional spectral data. Raman spectra are information rich and often the 
determination of multiple peak changes, and their relationship to each other are 
essential to gaining a full picture of the different molecular environments of 
experimental groups. These techniques include unsupervised and supervised 
techniques. Supervised techniques allow for the inclusion of labeled sample groups in 
the analysis. 
1.3.7 Principal Component Analysis 
Principal component analysis (PCA) is an unsupervised linear mathematical transform 
which enables the classification of datasets into distinct classes. The multivariate data 
collected is transformed into a smaller subset of derived variables so that each 
spectrum is a linear combination of orthogonal basis functions, called principal 
components (PC). These new variables represent the important variations found in 
the entire dataset in a more compact way. PCA analysis provides PCs and scores. The 
PCs contain spectral features showing the main molecular variation found between 
spectra in the dataset and the scores show the contribution of the PCs to the original 
dataset. PC1 captures the greatest variance, followed by PC2, etc. This also allows for 
dimensionality reduction by expressing the data in terms of a smaller number of PCs 
and compression can be achieved by retaining only the PCS of interest and discarding 
the PCs accounting for noise (higher order PCs).  
 
PCA scores are often plotted against one another to produce PC-score plots and may 
be analysed to indicate if spectra are related. The grouping or clustering of spectra 
may suggest systematic differences between sample groups of interest. If grouping 
occurs, the examination of the PCs which are responsible for the grouping and 
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discrimination between sample groups often elude to the biochemical species of 
importance in sample segregation. 
1.3.8 Partial Least Squares Discriminant Analysis (PLS-DA) 
In many of the investigations presented in this thesis, PCA was used initially to 
determine if any grouping occurred using the unsupervised technique. Although some 
rough grouping emerged, PCA was not sufficient for identification of important 
spectral variables in the investigations presented in this thesis and thus only used as 
noise reduction technique. Due to PCA’s rotational freedom which always expresses 
the greatest variance, the differences interesting to the investigation are sometime not 
the greatest differences. An easy and efficient way to maximize variation between 
samples is to use Partial Least Squares Discriminant Analysis (PLS-DA). Partial least 
squares regression has become a standard tool in chemometrics and used in 
chemistry and engineering and more fully described by Wold et. al [37]. PLS-DA is a 
predicative technique and allows for use of a priori knowledge to provide 
bioinformatics clues for the identification of spectral variables most effective in 
discriminating between different experimental groups. PLS as a discrimination tool 
was explored by Barker and Rayens in which they exposed it was preferable over PCA 
when discrimination was the goal and dimension reduction was needed [38]. This 
method of supervised classification has given very good results for relatively complex 
problems sets including spectra which were very similar in studies including 
discriminating isogenic cancer cells with different metastatic properties [39] as well 
as other Raman based problems [40,41]. PLS-DA also has the advantage of dealing 
with challenges biological datasets often confront in multivariate statistical modeling 
such multicollinearity [42] however consideration must be taken to avoid data over 
fitting.   
 
‘With four parameters I can fit an elephant, and with five I can make him wiggle his 
trunk.’ – John von Neumann 
 
Data over fitting causes a statistical model too closely fits a limited set of data points 
and starts to describe random error or noise instead of the fundamental underlying 
relationships. Data over fitting often occurs in models which are complex and much 
greater number of predictors (parameters) relative to the number of observations. 
This can ultimately cause a poor predictive performance as the model will exaggerate 
minor fluctuations in the data.  
 37 
 
Multicollinearity occurs when high correlations among the independent/predictor 
variables are strong. As a result multiple predictors often convey the same 
information (redundant) and can skew their significance leading to unreliable and 
unstable estimates of regression coefficients. Multicollinearity can misleadingly inflate 
the standard errors making some variables statistically insignificant when they are 
significant. 
1.3.9 N-FINDR 
Spectral un-mixing methods are a relatively new addition to the micro spectroscopic 
imaging. This analytical approach originates from the area of remote sensing and 
mainly developed for usage in arial reflection spectroscopy. Spectral un-mixing was 
applied to Raman data by the Diem group [43] in 2008 and previously used in FT-IR 
imaging. The N-FINDR spectral un-mixing algorithm searches the original input 
spectra, from the non-dimension reduced input matrix, for the most extreme spectra 
present and exposes these as endmembers. These endmembers are then identified 
based on their spectral features as pure contributing component of the tissue and can 
be used to build maps with each map pixel (a spectrum) being comprised of the 
endmembers selected. A more detailed description of N-FINDR and its comparative 
advantages to both clustering and other spectral un-mixing methods can be found in a 
paper by Hedegaard et al. [44] and is presented in chapter 5. 
1.3.10  Computational Considerations 
All of the Raman data preprocessing and analysis was performed in the Matlab 
environment (The Mathworks, USA) using in house written scripts and the 
multivariate statistical analysis toolbox, PLS-toolbox (Eigenvector Research Inc., USA) 
unless otherwise stated. Many of the techniques described here and in further 
chapters were initially developed for analytical chemistry applications in various 
other sciences. Their adaptation to and constrains within use here are best described 
in various other texts. 
1.4 Cardiovascular Calcification 
Cardiovascular disease is a global concern involving several diseases which combined 
are responsible for taking more than 17 million lives in 2008 [45]. Cardiovascular 
calcification refers to the pathological deposition of calcium phosphate in blood 
vessels, myocardium, and cardiac valves [46]. Initially cardiovascular calcification was 
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thought of as a passive, degenerative and inevitable process with precipitation of 
calcium in microenvironments of high phosphate. Additionally calcification was 
thought to be uncommon in the coronary arteries until in the 1990’s the 
understanding of the mechanisms behind and the frequencies of calcification in the 
cardiovascular system changed dramatically. Calcification was found to be occurring 
in a vast majority of significant cardiovascular lesions and in 90% of patients with 
coronary artery diseases. Osteogenic morphogens were found in calcifying blood 
vessels and subsequent work showed the presence of bone matrix in cardiovascular 
tissue in a subset of patients with severe aortic valve stenosis. This information and 
other findings combined established the ‘osteogenic hypothesis’ of cardiovascular 
tissue [47-50]. The ‘osteogenic hypothesis’ suggests valvular and vascular calcification 
is an active, regulated process with similarities to bone mineralization. Recently our 
group reported a presence of spherical particles in cardiovascular disease lesions 
which are composed of highly crystalline hydroxyapatite that crystallographically and 
structurally differs from bone mineral [51]. This raises an exciting new era for the 
field of cardiovascular calcification and is further discussed in chapter 4. 
  
The importance of researching cardiovascular calcification grows as life expectancy 
continues to increase and age is strongly associated with increases in calcium 
accumulations in the aortic valve, coronary arteries and the aorta [49].  Initially the 
aim of these studies was to further understand the microenvironments in aortic valve 
calcification and an in-depth introduction can be found in the following sections. It is 
important to note however, the finding of a common mineral structure reported by 
our group may bridge current separation between vascular and aortic valve 
calcification [51] and thus chapter 4 investigates both. 
1.4.1 Aortic Valve Calcification – Clinical Importance 
The aortic valve maintains healthy heart function by ensuring unidirectional flow 
throughout the cardiac cycle. This thin tissue valve opens and closes approximately 40 
million times a year and three billion over the average lifetime.  Aortic Valve 
calcification, when causing aortic sclerosis, presents the second most common 
indication for cardiac surgery and carries an 80% 5-year risk of progression to heart 
failure, valve replacement or death [52,53].  With surgery being the prevailing 
treatment option for patients with moderate to severe aortic valve calcification [54] 
pharmaceutical alternatives are desperately needed yet remain elusive.  With the 
aortic valve being relatively inaccessible and a poor candidate for in vivo monitoring, 
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the vast majority of human disease progression has been described from observations 
of the valves after removal from the patient. 
    
Animal models are being used in research and potential in vitro models are being 
explored.  Of all the potential options, in vitro models are the most attractive for 
investigating molecular mechanisms of disease onset and pharmaceutical treatment 
potential, however these model systems need to be carefully characterized and 
compared before utilization [54]. 
1.4.2 The Aortic Valve – Structure and Function 
The typical aortic valve is tricuspid and responsible for mediating the unidirectional 
flow of blood from the left ventricle of the heart to the aorta for transport of 
oxygenated blood to the entire body (Figure 1-4 A). Coaptation of the three cusps 
ensures a complete closure of the valve during diastole and therefore prevents 
regurgitation of blood from the aorta to the left ventricle.  During systole, the cusps 
open so they are parallel to the blood flow and are flexible enough to deform with 
little obstruction to the passing oxygenated blood (Figure 1-4 D). Thereby there is a 
great dependency on the valve tissue’s mobility, pliability and structural integrity 
when performing its essential functions. 
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Figure 1-4 The human aortic valve and its cusps. A. Drawing of the human heart 
as a cross section cut in the coronal plane.  The tricuspid aortic valve is 
highlighted with the three leaflets in white and the sinus directly above them 
with coronary artery exits also displayed. B. Histological cross section of an 
aortic valve cusp in typical systole configuration showing the three distinct 
layers, f- fibrosa, s- spongiosa, v – ventricularis using a Movat Pentachrome stain 
(collagen – yellow, elastin – black), 100x magnification. C.  Diagram of cusps 
showing location of belly, commissure, nodulus, and regions of coaptation. D. 
Outflow perspective of aortic valve during systole (right) and diastole (left). E. 
Cross section of the valve leaflets showing the architecture and configuration of 
the collagen and elastin during systole (right) and diastole (left). Some 
information reproduced from [55-57] 
Each cusp is attached to the aortic wall in a semilunar fashion, with adjacent cusps 
coming together at commissures at the aorta (Figure 1-4 C).  The cusps individually 
descend into the basal attachment to the aortic wall and the adjacent aortic root is 
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shaped as a dilated pocket called the sinuses of Valsalva, which bulges with each 
ejection of blood.  The middle of the free edge of each cusp contains a fibrous mound 
called the nodule of Arantius, (Figure 1-4 C).  This fibrous mound is where each cusp 
meets in the center of the valve and it helps ensure the cusps can withstand the 
pressure gradient between the aorta and left ventricle.  The cusps are described in 
relation to the coronary artery which extends from it or lack there-of, namely: left, 
right, and non -coronary cusps.  
  
Aortic valve leaflets consist of four layers with varying, distinct extracellular matrices.  
They are the ventricularis (closest to the left ventricular chamber), spongiosa 
(middle), fibrosa (most apparent layer at the aortic side) and arterialis (at aortic 
surface below basement membrane and endothelial cells) (Figure 1-4 B). These layers 
vary in thickness as the valve extends from the annulus to the free margin of each 
cusp.  
 
The ventricularis comprises of elastic collagenous fibers and elastin fibers aligned in 
the longitudinal direction (parallel to blood flow).  This layer provides the tensile 
recoil necessary to retain the folded shape of the cusp.  The spongiosa is located near 
the base of each cusp and is a very loose and watery connective tissue of varying 
thickness. This layer is mostly proteoglycans and water as to damper vibrations of the 
fibrosa when the leaflets close and this layer adds considerable plasticity.  The 
spongiosa does contain some fibers and cells which are typically oriented radially.  
The fibrosa is a very dense series of parallel tendinous cords (more towards the free 
end of the leaflet) and in rigid sheets of tissue component collagenous fibers.  These 
cords/fibers run circumferentially.  This is the mechanically strongest part of the 
leaflet and provides the principle support of diastolic pressure.  The arterialis is a thin 
layer at the aortic surface which consists of small elastic collagenous fibers which are 
relatively (in comparison to the fibrosa) loosely arranged. 
 
The percentage of each type of collagen identified in the valve is ~74% collagen type I, 
~24% type II, and ~2% type V.  Collagen is principally responsible for structure and 
mechanical strength, while the elastin of the valves have been described as providing 
the extensibility.  Human valves are approximately 11% elastin (Dry weight ratio) and 
together with collagen, these two comprise of approximately 80% of the total valvular 
protein.  The glycosaminoglycans are the ground substance for which the other 
components are laid upon [58]. 
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The two predominate types of cells which populate the aortic valve are endothelial 
cells and valvular interstitial cells (VICs).   VICs are a mixed cell population which will 
be described in more detail later.  The valve cusps are sufficiently thin to be nourished 
by diffusion from the blood bathing them however some valves may contain 
vasculature, especially towards the base, therefore smooth muscle cells may also be 
present in arterioles and venules and not just as subpopulations of VICs.  The blood 
contacting surface of the valves is populated with endothelial cells which are 
continuous with the lining of the vessels and the sinuses and with the endocardium 
[58].  VICs populate the body of the leaflets in all the layers [58].   Additionally nerves 
have been identified within some valves [59], however their function role has not yet 
been clarified. 
1.4.3 Valvular Disease Progression / Potential Initiating Factors 
In diseased valves the normally efficient thin tissue transforms to become rigid, 
thickened and in some cases cusps fuse together.  This disrupts the primary function 
of ensuring uni-directional flow and places an incredible burden on the left ventricular 
muscle.  Clinically there are 4 stages in this progression, 1 – healthy, 2- moderate, 3 – 
mild and 4 - severe.  Patients with severe aortic calcification, who do not undergo 
surgery, have a life expectancy of under 5 years [53].  Various mechanisms have been 
proposed to lead to aortic valve calcification, including osteogenic differentiation of 
VICs, cellular apoptosis related calcification and necrosis-related calcium deposition 
[60-63].  Different hypotheses also exist as to the specific biomolecular and/or 
mechanical initiating factors.  
 
Wound repair is thought to be a critical step in initiating the pathogenesis of several 
valvular  and vascular pathological conditions [58].  Injury may be mechanically 
induced during medical procedures or a more complex phenomenon with no external 
factors clearly defined.  In any case this injury denudes the endothelial cells which 
results in a local area of VICs in a void of the potentially critical regulatory signals 
typically from the endothelium [63].  This instigates the initiation of the repair 
process.   Artificial organ bath maintained tissue models suggest the removal of the 
endothelial cells causes elongated cells to close over the wound edge growing parallel 
to the edge and overlapping each other without reestablishment of the monolayer.  
These cells also continuously express proliferative proteins.  A porcine mitral valve 
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study results suggested the VICs populating areas towards the ventricle were more 
proliferative than the VICs at the atrial side under the same stimulation [64].  
 
Intrusive angiogenesis due to the down regulation of chondromodulin-I, an 
angiogenesis inhibitor protein found in the avasular tissues cartilage and the eyes [54] 
is another potential initiating culprit.  Hakuno et al. [54] reveled expression of 
chondromodulin-I at the mRNA and protein levels in all four cardiac valves (aortic, 
mitral, pulmonary and tricuspid valves) indicating a VICs mediated regulation of 
angiogenesis.  This indicates chondromodulin-I is secreted from cultured VICs to 
potentially inhibit vascular endothelial tube formation and migration. 
 
Similar initial pathological ignitions may exist between atherosclerosis and aortic 
valve calcification.  This relationship was suggested as observed similarities between 
the two emerged including local inflammation, lipid infiltration and phenotypic 
alterations progressing towards a more osteoblastic phenotype [65,66]. 
1.4.4 Current Treatment Options for Aortic Valve Calcifications 
Current treatment options for aortic valve calcification are almost exclusively surgical.  
If the patient is a candidate for replacement, the surgeon and patient may choose 
between different replacement valves which generally fall into two categories: 
biological (sometimes referred to as tissue / bioprosthetic) and mechanical valves.  
The type of valve replacement has to be carefully selected as it is the patient’s specific 
risk factors which will determine the best option.  Advantages and disadvantages to 
available options are described in Table 1-2. 
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Table 1-2 Comparison of replacement heart valve options. Note: Subsets of each 
type including tissue types and design do exist beyond this simple classification. 
Reproduced with information from [67]. 
 
 
Current surgical options are suitable for a majority of patients as conventional valve 
technology is very mature with a well-defined performance. As surgical approaches 
and techniques improve the surgical outcomes are as well. Very often the main 
consideration is durability, as the replacement should ideally outlive the patient as 
reoccurring surgeries are associated with higher complication risks. The population in 
the most need of a better replacement is pediatrics. Children are less tolerant of 
prosthetic devices and as a minority of the commercial market (less than 10% of the 
adult market) their commercial demand renders pediatric specific research less than 
viable [68].  
1.4.5 Obstacles Facing Improved Options for Aortic Valve 
Calcification 
The development of better treatment options, including pharmaceutical intervention 
at early stages, improved bioprosthetic valves, and ultimately the potential of a tissue 
engineered valve is highly dependent on the better understanding of the complex 
environment at the cellular level.  The aortic valve is not accessible for non-invasive 
monitoring of pharmacological agents, animal models are expensive with their 
relevance questionable, and a proven in vitro model remains elusive.  Understanding 
the basic nature of the cells which populate and maintain the valves is important for 
the development of new treatment or replacement options.  Additionally the VICs’ 
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ability to change phenotypes and begin the pathogenic process is still a mysterious 
phenomenon which creates a limiting step towards developing a trustworthy model. 
1.4.6 Valvular Interstitial Cells – An Introduction 
Valvular Interstitial Cells (VICs) are the prevalent cell type in the aortic valve which 
are believed to be critical in maintaining function [69] and have been proposed as the 
cells involved in the pathogenic calcification[58,70].  This mixed cell population 
contains myofibroblasts (when activated), fibroblasts, smooth muscle cells and a 
population of valvular progenitor cells.  VICs heterogeneity in relation to different 
locations within the valve remains unknown. 
 
Myofibroblasts are mesenchymal cells which possess the phenotypic markers of both 
muscle and non-muscle cells [71].  During the process of ‘activation’ in some tissues, 
fibroblasts respond to wound healing by trans-differentiating into myofibroblasts.  
The myocardium reportedly contains cells which undergo this activation and 
therefore might act as contributing source [72]. 
   
VICs are strongly attached to and synthesize the extracellular matrices [58].  They 
express matrix degrading enzymes and their inhibitors which exposes their ability to 
respond to and control the remodeling of the collagen and other matrix components 
[73].  VICs in healthy valves are predominately quiescent with low levels of α-smooth 
muscle actin (SMA) and low levels of matrix metalloproteinases (MMPs).  These cells 
are however very plastic and readily respond to a number of stimuli (biomolecular 
and mechanical) by altering their phenotype.  These changes may involve the 
necessary remodeling of the extracellular matrix, in response to injury or deviation 
into a pathological phenotype. 
 
Activation and the variable responses of VICs has eluded to a spectrum of described 
VICs phenotypes [74].  The various types of VICs and some of their stimulatory 
mechanisms are expressed in Figure 1-5.  These various VICs phenotypes are listed 
with their location and function in Table 1-3. 
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Figure 1-5 Heart valve interstitial cell phenotypes mapped into five variable 
classifications in which VICs transition between each due to external stimuli. 
Reproduced with information from [55,74]. 
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Table 1-3 General categories of heart valve interstitial cells phenotypes, location 
within the body and function. Reproduced with information from  [55,74]. 
 
 
Valvular progenitor cells have been identified in adult human pulmonary valves [75] 
and in abundance in porcine valves [76].   This progenitor cell population has also 
demonstrated increased angiogenic activity in calcified aortic valves in comparison to 
healthy valves [77].  This population of cells presents a potential obstacle to efforts of 
controlling consistently primary VICs phenotype in culture as it is extremely 
responsive. 
 
Porcine aortic valves are commonly used in efforts to unravel the molecular pathways 
leading to pathogenesis.  The VICs isolated from them are readily available, 
inexpensive and robust when grown in vitro.  They form ‘calcified nodules’ which have 
been heavily researched, including investigations on the pharmacological effects on 
nodule formation and growth being reported. However no direct information relating 
to, much less defining, the relationship between these nodules and human aortic 
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pathogenesis has been reported.  Additionally, porcine aortic valves thicken in vivo 
however are not reported to calcify. 
 
Porcine VICs possess the ability to contract when exposed to non-receptor mediated 
and receptor-mediated stimuli [72,78].  In these experiments porcine cusp tissues of 
all four valves were carefully removed from fresh hearts and maintained in an organ 
bath.  One end of each tissue section was attached to a strain gauge and the other to a 
static steel rod and lengths of cotton string.    After the tissue stabilized, it was 
preloaded with tension of 3mN and allowed to relax.  The tissue was then challenged 
with 90 mmol/L KCL and increasing concentrations of endothelin-1.  All cusp tissue 
demonstrated a contractile response to the KCl and an increasing response to 
endothelin-1 [74].  Previously tissue valves had been shown to be responsive to both 
adrenaline and angiotensin-II stimulation [79].  Cells from porcine aortic valves 
contracted in response to angiotensin II, bradykinin, potassium chloride, carbachol, 
adrenaline and endothelin.  They were also shown to relax in response to 
isoproterenol [80]. 
 
Some recent studies have exposed areas in which complication may arise in efforts to 
replicate valve function in vitro.  Isolated and cultured VICs proving unreliable as far 
as phenotypic expression is just one of those challenges.  In culture there remains a 
limit to the ability to manipulate VICs into normal healthy function such as 
extracellular protein maintenance.  For example, elastin has been described as the 
most difficult component of the valvular ECM to produce in an in vitro environment 
[81].  Knowing elastin has a critical role in the native valve has lead researchers to 
investigate systems which specifically produce elastin. 
1.4.7 Valvular Interstitial Cells in Culture 
In culture VICs are elongated and form an orthogonal pattern during overgrowth and 
closely resemble fibroblasts post confluence [82,83].  If culture continues cells will pile 
in ridges reminiscent of smooth muscle cells however lacking the ‘hill and valley 
pattern’ [82,84].  In about 20% of cultures of mitral valve VICs a selection of 
‘cobblestone-type’ cells which are non-endothelial cell islands with a cuboidal 
morphology will spontaneously grow into confluence and stray distinctly from the 
fibroblastic morphology [85].  Cultured VICs showed serum dependent growth rates 
and are extremely responsive to media supplements [80]. VICs, both in vitro and in 
vivo have the ability to communicate to one another.  Functional gap junctions and 
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adherens junctions have been identified indicating a communication and tight 
bonding respectively[58]. 
 
Some but not all aortic VICs in culture have previously stained positive for alpha 
smooth muscle actin (SMA) along the long axis of the cell and throughout the cellular 
processes [80].  In valve tissue sections the regions closest to the ventricular side of 
the leaflet stained the most prominently for SMA however SMA was seen throughout.   
This is an example of a myofibroblastic feature similar to smooth muscle cells [58]. 
 
Human VICs have been shown to express a variety of thin and thick filament 
contractile protein genes which are typical of both cardiac and skeletal muscle.  
Expression of the non-muscle transcripts appear to be favored in contrast to the 
muscle-specific isoforms associated with myocytes [72].  The same study results 
indicated myogenin regulates the expression of some or all the skeletal muscle 
contractile protein genes in the human heart.  
 
VICs have been found to be very responsive and their quiescent state is described as a 
period in which the cells are awaiting signals for activation [58,69].  These responses 
in culture are thought to be indicative of a communication with the endothelium lining 
the valves which provide soluble growth factors that are mitogenic to the interstitial 
cells and between the VICs themselves.  Additionally mechanical and flow stimuli are 
initiated responses and phenotypic changes. 
 
Several attempts to inhibit nodule formation / osteogenic expression have been 
demonstrated by using in vitro models of calcification.  Atrovastatin was shown to 
inhibit expression of alkaline phosphatase and osteocalcin in human VICs [60].  
Additionally, in vivo studies have been discovered and used to research 
pharmacological intervention.  In an in vivo study on hypercholesterolaemic rabbit 
aortic valves, atorvastatin treatment was associated with the reduction of calcification 
[86]. 
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2 Improving Spectral Interpretation of Differences in 
Raman Spectra of Cells and Tissue Using PLS-DA 
VIP Scores 
 
2.1 Abstract 
In-vitro Raman spectroscopy used for non-invasive, non-destructive characterization 
of single cells and tissues have proven to be a powerful tool for understanding the 
complex biochemical processes within biological systems. It enables the comparison 
of a wide range of in-vitro model systems by discriminating experimental groups 
based on their biomolecular differences through the comparison of information rich 
spectra. However, one persistent challenge in Raman spectroscopy has been the highly 
complex structure of cell and tissue spectra, which comprise signals from lipids, 
proteins, carbohydrates and nucleic acids, and which may overlap significantly.  This 
leads to difficulty in clearly identifying which molecular components are responsible 
for the changes seen between sample groups. To address this problem, Partial Least 
Squares – Discriminant Analysis (PLS-DA) Variable Importance Projection (VIP) 
scores as heat maps combined with group difference spectra were applied as a 
technique to highlight the significant biochemical changes between sample groups. To 
illustrate the advantages of this method we compared two biological systems. The first 
demonstrates the ability of Raman spectroscopy to analyze single cells involving 
cultured HeLa cells in their live, fixed, fixed and ethanol dehydrated, and fixed, 
dehydrated and rehydrated states.  Fixation, ethanol dehydration and rehydration are 
known to induce molecular changes in the lipids and proteins within each cell and 
here the PLS-DA VIP scores plots expose these known differences.  Secondly unaltered 
human tissues comparing healthy bone tissue to osteoporotic bone tissue was 
investigated. Osteoporotic bone is known to have subtle differences in the mineral and 
organic matrix composition when compared to healthy bone and again the differences 
are shown clearly in the PLS-DA VIP score plots. These two contrasting biological 
studies act as model systems for illustrating the use of VIP score heat maps to 
highlight statistically significant biochemical changes of the difference spectra and 
thus important changes between experimental groups of interest. 
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2.2 Introduction 
Raman micro-spectroscopy has been utilized successfully to characterize and compare 
a wide variety of biological samples ranging from single cells to whole tissues both in 
vitro and in vivo [39,87-89].  Raman spectroscopy has proven to be an ideal tool for the 
non-invasive measurement of lipids, proteins, carbohydrates, nucleic acids, and 
mineral in both living and fixed systems [12,90,91], allowing for characterization and 
comparison of biologically interesting samples without altering them. A more 
complete description of the non-invasive advantages of Raman spectroscopy can be 
found in the introduction. 
 
Previous studies have demonstrated the benefits of applying multivariate analysis 
methods for the analysis of Raman spectra taken from biological systems 
[12,44,92,93].  This allows for the comparison of changes on a whole spectrum basis, 
instead of individual peaks and their corresponding bonds.  Examples include but are 
not limited to discriminating isogenic cancer cells [39], circulating tumor cells [90], the 
in vitro calcification of different cell types  [12], cell activity studies [91], and cell 
differentiation [94].  Methods previously used for the classification of biological 
Raman spectra include unsupervised methods such as cluster analysis and principal 
component analysis (PCA).  Additionally a wide range of supervised methods have 
been applied including Linear Discriminant Analysis (LDA), Partial Least Squares – 
Discriminant Analysis (PLS-DA), Support Vector Machines and Neural Networks 
[39,95-99].  These tools have also been used in other spectroscopy techniques 
including NMR and mass spectroscopy for the analysis of various data types including 
metabolomics data [100,101]. In order to fully utilize the power of these multivariate 
analytical techniques in biological systems, the experimental design must ensure the 
requirements for each technique are met and the interpretations of the results are 
translatable into biologically meaningful parameters. 
 
Ultimately the analysis of the Raman spectra, whether simple or complex, often strives 
to reveal the molecular level differences between experimental groups of interest.  
Complications in both the analysis and interpretation may arise from multiple 
overlapping Raman bands found in the same spectral range.  Despite Raman 
spectroscopy’s relatively narrow spectral peaks and bands, overlapping Raman 
signals make it difficult to discern whether the differences between sample groups 
originate from changes in minerals, lipids, proteins, carbohydrates or nucleic acids, or 
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if there are combined effects which act together to discriminate the groups of interest. 
Thus a focal area of development for Raman spectroscopy entails combining 
sophisticated statistical techniques to better visualize and often simplify the spectral 
differences of interest and their possible combined meaning for the investigation. 
 
To improve the interpretation of the resulting Raman spectra, we apply here PLS-DA 
Variable Importance Projection (VIP) scores to highlight the spectral and thus 
molecular changes which significantly discriminate between sample groups.  
Overlaying the difference spectrum between groups with a heat map defined by the 
VIP scores clearly highlights both the bands which contribute the most to the model’s 
ability to distinguish between experimental groups and the trends of those changes. 
This also highlights the most statistically significant molecular changes between trial 
groups.  
 
To illustrate the advantages of combining PLS-DA VIP score heat maps in conjunction 
with difference spectra to expose the critical molecular changes in biological systems, 
this method was applied to study single cell spectra of HeLa cells in their live, fixed, 
dehydrated and rehydrated state.  In addition this method was used to compare 
spectra obtained from unaltered fresh human bone from two patients, one healthy and 
one suffering from osteoporosis. 
2.3 Materials and Methods 
2.3.1 HeLa Cell Culture 
HeLa cells were cultured in DMEM Glutamax medium supplemented with 1% (v/v) 
antibiotic–antimycotic, 10% (v/v) fetal bovine serum (FBS) (all, Invitrogen, U.K.).  All 
HeLa cells were cultured on MgF2 glass slides (Global Optics, U.K.) and seeded at 1x104 
cells/cm2.  Prior to cell seeding, MgF2 glass slides were incubated in 100% FBS (same 
as used for the culture medium) for six hours at 37 °C.  Raman spectral collection was 
then performed after two days. All cells were maintained in 37 °C with 5% CO2, and at 
95% relative humidity. 
2.3.2 Fixation, Dehydration, and Rehydration of HeLa Cells and 
Raman Imagining Conditions 
Live HeLa cell Raman imaging was performed after two days in culture and for a 
maximum duration of 30 minutes after removal from the incubator. Live cells were 
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imaged at a maintained 37°C in PBS in with the cells on the MgF2 glass slides 
contained in a glass petri dish. Post Raman imagining HeLa cultures were fixed in 
3.7% (v/v) formaldehyde (FA) for 40 minutes at 4°C and rinsed three times in 
phosphate buffered saline (PBS) and kept in PBS at room temperature for subsequent 
Raman imaging of fixed cells. 
 
Cells were then dehydrated in an increasing graded ethanol series from 25%, 50%, 
70%, 90% and 100% (twice) (v/v) series for 5 minutes in each solution and 
subsequently placed in a desiccator. Raman spectra were then collected on the dried 
cells at room temperature (cells on the MgF2 glass slides were imaged while placed 
onto a glass slide). 
 
Lastly cells were re-hydrated by submerging the dried and fixed HeLa cells on MgF2 
substrates in PBS for 30 minutes before Raman imaging. Raman imaging was collected 
with the cells on their MgF2 in PBS, in a glass petri dish, at room temperature. 
2.3.3 Human Bone Tissue Isolation and Raman Imaging Conditions 
Human bone tissue was obtained from Charing Cross Hospital (London, U.K.). Cortical 
bone from the femurs of two patients, one male (73 years old) and one female (72 
years old) undergoing hip replacements are included in this study.  The female patient 
was diagnosed with osteoporosis.  Directly after removal from the patient the fresh 
bone tissue was placed into a sterile container and washed with PBS at room 
temperature before testing.  Raman imaging started within one hour after removal 
from the patient and completed within five hours with sterile PBS washes at 30 
minute intervals to help prevent drying and contamination. 
2.3.4 Raman Spectroscopy 
Raman spectra were measured with a Renishaw InVia (Renishaw, U.K.) spectrometer 
connected to a Leica (Leica, Germany) microscope as previously described in the 
introduction and previous publications [6]. Briefly, the spectrometer uses a high 
power 785 nm diode spot laser (~30 mW at sample; Renishaw, U.K.) with a focal size 
of approximately 10 x 20 x 40 µm for excitation. The laser was focused on individual 
cells by a 60× (NA = 1.0) long working distance (2 mm) water immersion objective 
(Nikon, U.K.) or a 100× (NA = 0.9) objective (Leica, U.K.). A heated stage was used to 
37°C for live cell imaging (Linkam, U.K.). 
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For all samples the spectral range selected consisted of the biological fingerprint 
region (620–1720 cm−1) recorded at a resolution of ~1–2 cm−1, with 3 accumulations 
of spectra each with a 5 second integration time. One spectral collection was taken 
from each individual cell. Backscattered radiation was collected by the same objective 
then passed through a 785 nm edge filter to block Rayleigh scattering and reflected 
laser light, before being directed through a 50 µm slit into the spectrometer equipped 
with a 1200 lines/mm grating, and finally detected by a deep-depletion charge-
coupled device detector.  
 
A total of 2080 spectra were collected from single HeLa cells consisting of 384 from 
live cells, 714 from fixed cells, 338 from dehydrated cells and 644 from dehydrated 
cells. These cell spectra were collected from three independent batches of cultured 
HeLa cells. A total of 110 spectra were collected from fresh human bone with 59 
spectra from the normal bone sample and 51 spectra from the osteoporotic bone 
sample. 
2.4 Data Analysis 
All data analysis was performed in MatLab R2011a (The Mathworks, Natick, MA, 
U.S.A.) with in house written scripts, many in courtesy of Dr. Martin AB Hedegaard,  in 
combination with the PLS_toolbox 7.0 (Eigenvector Research, U.S.A.). 
Spectra for the HeLa cell study were background corrected by subtracting the 
spectrum of PBS and substrate (collected in the same conditions) for the hydrated 
samples and the background of the substrate only from the dehydrated samples.  All 
spectra were normalized using extended multiplicative signal correction (EMSC) 
[36,102]and smoothed using a Savitsky-Golay filter (five points, second-order 
polynomial) [34]. 
 
Spectra from the bone tissue samples were normalized using EMSC and used no 
background correction as all spectra were measured in comparable conditions and the 
tissue thickness was greater than the penetration depth of the focused radiation 
volume.  
 
The peak labels found in the Raman spectra presented in this chapter are 
representative of the peaks found in literature and may be slightly shifted from the 
precise peak positions found in the spectral means displayed. 
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For classification we applied Partial Least Squares – Discriminant Analysis (PLS-DA).  
PLS-DA uses the properties of normal PLS regression to rotate a principal component 
analysis (PCA) model to best explain the differences between groups.  Using the model 
to predict a matrix of zeros and ones depending on the experimental group allows for 
a rotation of a PCA model so it best discriminates based on group variances.  
To highlight the variables which contribute the most to the discrimination, we 
calculate the Variable Importance Projection (VIP) score. The VIP score works as a 
summary of the importance of the projection when finding the latent variables [103-
105]. Assuming a single response y and p predictors the PLS model can be expressed 
as 
 
         
 
       
 
Where X is an (n × p) matrix of predictors, T (n × h) is the projection of X (the X score), 
P (p × h) is an orthogonal loading matrix, and E (n × 1) n is an error term assumed to 
be independent identically distributed random normal variables (alias residuals). y (n 
× 1) is a single response array, b (h × 1) is the loadings response vector and regression 
coefficients for T, and f (n × 1) represents the residual.  
 
Using this definition the VIP score for the j’th variable can be calculated as 
 
      √ ∑                       ∑        
 
   
 
   
 
 
where wjk is the j-th element of vector wk and 
 
            
   
    
 
Also described in more detail by Chong and Jun [103]. The VIP score of a predictor 
was first fully published in 1993 by Wold et al. [106]. 
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A PLS-DA model including VIP scores was calculated for each of the following four 
comparison cases: live vs. fixed HeLa cells, fixed vs. dehydrated HeLa cells, dehydrated 
vs. rehydrated HeLa cells and normal bone vs. osteoporotic bone.  Each model was 
cross validated using a leave out random subsets with 10 data splits.  For each model 
the average and difference spectra were calculated to analyse the spectral differences. 
The difference spectra were then overlaid with a heat map of the VIP score for each 
model (method originally proposed by Dr. Martin AB Hedgaard). 
2.5 Results 
2.5.1 Case 1: HeLa Cells 
Raman spectra were collected from HeLa cells after 2 days of culture on the MgF2 
substrates and were of the same morphology of previously reported HeLa cells.  Single 
HeLa cells were selected for Raman imaging as the HeLa cells were not confluent at 
the time of testing. Figure 2-1 shows the mean Raman spectrum of a) live cells, b) 
fixed cells, c) dehydrated cells and d) rehydrated cells. All spectra contain bands 
expected from single cells including the RNA/DNA bands (669, 785, 811, 828, 1093, 
1257, 1320, 1375 and 1575cm-1), Amino Acids bands (Phe: 622, 1002, 1032, 1602 cm-
1, Tyr: 645, Trp: 760, 1554 cm-1, Pro: 937cm-1), lipid bands (877, 1095, 1124, 1255cm-
1) and the Amide III and Amide I bands at 1337 and 1655 cm-1 respectively (more 
detail on band assignments, peak strength and shape information, where appropriate, 
can be found in Appendix 1). There are significant visual differences in the average 
spectrum in the amino acid Phenylalanine (Phe) band at 1002 cm-1 for the dehydrated 
cells in Figure 2-1c and some changes in the shape of the Amide I band when 
compared to the three other HeLa cell experimental groups. 
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Figure 2-1 The mean spectrum of each HeLa cell sample groups: a) live, b) fixed, 
c) ethanol dehydrated, and d) rehydrated form. Visual changes can be seen in 
the Amide I band at 1655cm-1 and the intensity of the phenylalanine (Phe) band 
at 1002 cm-1. 
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A PLS-DA model was employed to compare live vs. fixed, fixed vs. dehydrated and 
dehydrated vs. rehydrated HeLa cells with the resulting model details shown in Table 
2-1. For each model the VIP scores were calculated and plotted as a heat map on the 
background of the difference spectra shown in Figure 2-2 showing the average 
difference spectra between a) live-fixed, b) fixed-dehydrated and c) dehydrated-
rehydrated.   The more intense the green band, the more significant the selected 
Raman spectral band range is in the PLS-DA model’s ability to distinguish between the 
groups. 
Table 2-1 PLS-DA model details from HeLa cell experimental group 
comparisons. 
 Model Components Sensitivity Selectivity 
Live vs. Fixed 3 0.911 0.959 
Fixed vs. Dehydrated 2 1.00 1.00 
Dehydrated vs. Rehydrated 2 1.00 1.00 
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Figure 2-2 Difference spectra overlaid by VIP scores for a) live-fixed, b) fixed-
dehydrated and c) dehydrated-rehydrated. The brightness of the green 
background indicates the value of the VIP scores with the greater the colour 
intensity corresponding to a higher VIP score and thereby a greater significance 
of those bands to the PLS-DA models as shown in Table 2-1. 
Features highlighted in Figure 2-2a between live and fixed cells are mostly related to 
phospholipids (720, 1092cm-1) and lipids (877, 935, 983, 1335 and 1370cm-1).  It is 
important to note that the most statistically significant changes highlighted by the VIP 
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scores are not necessarily the largest variations in the difference spectrum (this is 
further discussed in the discussion).  Differences between fixed and ethanol 
dehydrated cells are also distinctly visible in Figure 2-2b with the most significant 
differences being related to unfolding of proteins, visible by the large shift in the 
Amide I band at 1630-1696cm-1 and the exposure of phenylalanine due to break up in 
α-helixes and β-sheets resulting in higher intensities of the 622, 645, 1002 and 
1032cm-1 bands.  In addition there are visible changes in DNA related vibrations at 
780 and 828 cm-1 and a decrease in lipid content 877, 1227 and 1430cm-1.  
Rehydrating the cells in PBS refolds the proteins to a certain degree reversing these 
changes as seen in Figure 2-2c, however this reversal does not return proteins to their 
fully native state and leaves visible changes in the live and fixed cell spectra. 
2.5.2 Case 2: Bone Samples 
The average spectra of the two sample groups are visible in Figure 2-3 with spectrum 
a) representing osteoporosis bone and spectrum b) representing normal bone. Raman 
bands observed in both average spectra include Amino Acids (Phe: 622, 645, 1002, 
1032 cm-1, Trp: 756 cm-1, Pro: 815 cm-1), Minerals (Hydroxyapatite-: 962 cm-1 
carbonate ions CO3: 1073 cm-1) and the Amide III and Amide I at 1245-1305 and 1660 
cm-1 respectively as well as CH2 bending modes at 1453 cm-1. 
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Figure 2-3 Mean Raman spectrum of a) human osteoporotic bone spectra and b) 
human normal bone spectra. The spectra show nearly no visible changes but are 
differences were distinguishable by the PLS-DA model as seen in Table 2-2. 
Similar to the case of the HeLa cells, a PLS-DA model and its VIP scores were 
performed with the resulting model details presented in Table 2-2.  The difference 
spectrum overlaid with the VIP scores can be seen in Figure 2-4.  
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Table 2-2 PLS-DA model information comparing osteoporotic bone and healthy 
bone 
 
Model Components Sensitivity Selectivity 
Normal vs. Osteoporosis 5 0.941 0.983 
 
 
1 
0 
 
Figure 2-4 Difference spectra of osteoporotic and normal bone spectra overlaid 
with VIP scores. The brightness of the green background indicate the value of 
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the VIP scores and thereby the significance of those bands to the PLS-DA model 
given in Table 2-2. 
 
Figure 2-4 highlights a number of bands that are statically important as determined by 
the PLS-DA model.  The most significant change is in the band shape of the distinct 
mineral peak at 965 cm-1 followed by significant changes in lipid content highlighted 
by variance in the 1412 and 1443 cm-1 band.  
 
In addition there are also visible changes in amino acid signals (Phe: 1004 cm-1, Trp : 
755, 1360 cm-1 Pro/Trp/Tyr: 852 cm-1) and in the amide III region at 1235-1265 cm-1.  
Again this example shows that the largest differences in the difference spectrum are 
not necessarily the most important in discriminating between sample groups. 
2.6 Discussion 
Unveiling the biological significance behind changes in information rich Raman 
spectra collected from biological samples can be challenging due to the complex 
nature of the molecular bonds identified by Raman spectroscopy. This translation 
however, is critical in applying this powerful non-invasive tool to biological 
investigations. Raman spectra collected from biological samples include signals from 
lipids, proteins, carbohydrates and minerals and details of their environmental 
influence on each other.  
 
Introduced here is a novel way of using PLS-DA VIP scores to visually highlight the 
significant differences between biological Raman datasets. The usefulness of this 
analysis is presented using two very different biological systems, one comparing 
cultured HeLa single cells in their live, fixed, fixed and ethanol dehydrated and fixed, 
dehydrated and rehydrated forms, and the other comparing normal and osteoporotic 
human bone tissue.  
 
The PLS-DA VIP scores highlighted Raman spectral ranges, which distinguished 
between HeLa cells depending on their experimental state.  When comparing live 
HeLa cells to fixed HeLa cells, changes in spectral bands corresponding to differences 
in lipid composition (877, 935, 983, 1335 and 1370cm-1) due to the crosslinking of 
phospholipids (720, 1092cm-1) and however no significant change in protein structure 
was resolved by Raman spectroscopy.  It is well reported in previous studies on 
formaldehyde fixation that proteins are well preserved in the fixation process and 
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lipids may be altered or lost [107,108].  In the cases of fixed HeLa cells vs. dehydrated 
HeLa cells and dehydrated HeLa cells vs. rehydrated HeLa cells, the main changes in 
the molecular structure are due to the unfolding and refolding of proteins resulting in 
exposure of phenylalanine and breaking and reformation of β-sheets and α-helices.  
Although fixation preserves protein structure, dehydration and rehydration do have 
an effect on protein structure as seen in our results. The VIP scores highlight the 
statistically important differences quickly and clearly identify specific bands and 
peaks of significance.  
 
In the study comparing human osteoporotic bone vs. healthy bone, the changes 
observed when comparing these bone samples were mostly in the mineral 
composition where the osteoporotic bone shifts towards lower wavenumbers 
suggesting a slightly more amorphous structure, which may be due to both 
osteoporosis and a general trend of bone compositional differences between male and 
female patients [109].  In addition the most significant bands highlighted are related 
to protein composition with changes in Phe: 1004 cm-1, Trp : 755, 1360 cm-1 
Pro/Trp/Tyr: 852 cm-1) and in the amide III region at 1235-1265 cm-1.  Protein 
changes observed in the distinction between osteoporotic bone and healthy bone may 
be due to the protein changes previously demonstrated to occur in osteoporotic bone 
microstructure.  It has been shown that the quality of collagen within the bone matrix 
changes with age and osteoporosis.  Oxlund et al. suggested a reduction of the 
concentration of collagen reducible cross-links in osteoporotic bone however not 
necessarily a change in the amount of collagen [109]. The model’s ability to 
distinguish between the osteoporotic bone and healthy bone may not be exclusively 
caused by osteoporosis, as this could be due to multiple factors such as age, bone 
remodelling, and/or sex differences [110,111]. As these changes are well reported in 
literature, the comparison shown here is a proof of concept for the combination of 
PLS-DA VIP scores overlay on difference spectra and for the ability to apply this 
analysis in conjunction with the non-invasive imaging power of Raman spectroscopy. 
To fully distinguish molecular environments between osteoporotic and healthy bone 
samples in a Raman study, more samples, control measures and spectral pre-
processing would ideally be incorporated. 
 
In all cases the absolute intensity of the difference spectra is not necessarily indicative 
of the importance of those bands as a distinguishing factor between groups. Due to the 
semi-quantitative nature of Raman spectroscopy, the difference spectra are best 
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utilised as indicators of potential trends molecular distinction between sample groups 
describe peak shifts or band shape changes. Combined with PLS-DA VIP score plots, 
Raman spectral band ranges of interest are identified and the band shape or position 
changes eluded to by the difference spectrum exposes the nature of the change which 
differentiates trial groups. 
2.7 Conclusions 
In conclusion, PLS-DA VIP scores was applied to highlight significant chemical 
differences in biological spectra in two separate investigations, one comparing single 
cells tested in their live, fixed, fixed and dehydrated versus fixed, dehydrated and 
rehydrated forms respectively and the other comparing human osteoporotic bone and 
healthy bone. Applying PLS-DA VIP scores was critical and presented a visually 
accessible method to highlight the biomolecular bonds which distinguish one sample 
group from another in the in vitro cellular study and suggested the possibility of 
distinction between experimental groups in the human tissue study (more samples 
are required to confirm the differences highlighted). This visualisation helped in 
translating the changes observed to the biological differences between the sample 
groups. This new analytical tool may find great applications across a wide breath of 
future Raman spectroscopic studies of biosystems. 
2.8 Future Work 
The statistical algorithms used in this study have been applied to other biologically 
relevant studies which produce high dimensional data. Many of these studies include 
the ‘omics-type data (genomics, proteomics, metabolomics, etc.) where a limited 
amount of samples are being analysed with thousands of features under 
consideration. This complicates analysis and gives rise to known issues such as data 
over-fitting and multicollinearity [42]. PLS regression is a predictive technique which 
allows for the modelling of multiples responses while dealing with multicollinearity. 
PLS VIP scores have been applied to studies where there are many more features than 
observations and the objective is to determine which variables are important. An 
example study can be found in Xia and Wishart’s study providing comprehensive 
analysis of quantitative metabolomics data and ranking compound of interest based 
on their VIP scores [101]. It is advantageous to use these methods not only because 
they confront issues commonly found in biologically relevant studies, but also because 
the analysis is then interpretable to members of different disciplines. The VIP score 
heat map plots shown in this study introduce another way to visualise this 
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information providing an overview of all spectral regions and not just those with the 
highest VIP scores. In future studies with larger datasets it would be very interesting 
to see how the VIP scores evolve and which factors remain, gain, or lose importance. 
 
This study applied PLS-DA VIP scores to two bio-spectroscopic datasets to highlight 
the possible advantages of both using the VIP scores and applying them displaying the 
variables highlighted in a heat map fashion. The tissue data used here was from two 
patients, one with osteoporosis and one without. The limited number of patients in 
this dataset leads to limitations in the confidence of these results. There are many 
factors which could alter the bone composition of one individual versus another and 
more patients would be hugely advantageous in confirming the application of these 
statistical techniques. In chapter 4 these techniques were used on cardiovascular 
tissue in a study incorporating more donors. 
 
Further studies using larger datasets of live cells in vitro may allow for threshold 
limits to be set. Limits could be applied to determine if a peak or band is significantly 
changing in the system in relationship to the experimental factors or because the 
peaks/bands shift significantly independent of experimental factors. This study used 
experimental conditions with known consequences as fixation and dehydration of 
biological tissues and cells has been widely studied. In future further studies where 
the differences are not as widely reported, limits and thresholds could be very 
significant in determining analytical results. 
 
Raman spectroscopy can expose critical differences in protein, DNA, lipids and 
biological mineralisation. The rich data collected from Raman gives it great potential 
with the obstacles of finding appropriate analytical techniques to harness the high 
dimensional datasets. Studies such as the one presented here offer tools to ease the 
translation of complex analysis into biologically relevant results and can be applied to 
many future investigations. 
 67 
3 Characterization of Porcine Aortic Valvular 
Interstitial Cell ‘Calcified’ Nodules 
3.1 Abstract 
Valve interstitial cells populate aortic valve cusps and have been implicated in aortic 
valve calcification. This study focused on investigating a common in vitro model for 
aortic valve calcification by characterizing nodule formation in porcine aortic valve 
interstitial cells (PAVICs) cultured in osteogenic medium (OST) supplemented with 
transforming growth factor beta 1 (TGF-β1). Using a combination of materials science 
and biological techniques, the relevance of PAVICs nodules in modeling the 
mineralised material found in calcified aortic valve disease was studied. PAVICs were 
grown in OST medium supplemented with TGF-β1 (OST+TGF-β1) or basal (CTL) 
medium for up to 21 days. Murine calvarial osteoblasts (MOBs) were grown in OST 
medium for 28 days as a known in vitro mineralizing model for comparison. Cultured 
PAVICs grown in OST+TGF-β1 produced nodular structures staining positive for 
calcium content. Micro-Raman spectroscopy allowed live, non-invasive imaging that 
showed an absence of mineralized material within these nodules, which was readily 
identified in nodules formed by MOBs and in diseased human aortic valves. Gene 
expression analysis, immunostaining, and transmission electron microscopy imaging 
revealed that PAVICs grown in OST+TGF-β1 medium produced abundant collagen rich 
extracellular matrix via the up regulation of the gene for Type I Collagen.  PAVICs, 
nevertheless, did not appear to further transdifferentiate to osteoblasts.  ‘Calcified’ 
nodules formed from PAVICs do not mineralize after 21 days in culture. PAVICs 
nodules do however, express a myofibroblast-like phenotype and produce a collagen-
rich extracellular matrix. This study clarifies further the role of PAVICs as a model of 
calcification of the human aortic valve highlighting a significant consideration when 
investigating the mineralizing stage of aortic valve calcification. 
3.2 Introduction 
The aortic valve performs a number of sophisticated functions including critical 
regulation of unidirectional oxygenated blood flow from the heart to the rest of the 
body [112,113]. The maintenance of these continuous functions is highly dependent 
on the unique structure of the valve at the tissue, cellular and molecular levels [114]. 
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Aortic valve calcification, a disruption to the intricate structure of the valve through 
the accumulation of mineral deposits in the valve tissue cusps, leads to considerable 
morbidity and mortality globally. The disease increases in prevalence with age [115], 
and will continue to increase as the world’s population ages [116]. Currently, there is 
no proven pharmacotherapy to prevent or manage aortic valve calcification 
progression. The treatment of choice for aortic valve calcification, therefore, is to 
surgically repair or replace valves with bioprosthetic or mechanical alternatives [117-
119] and is associated with many complications including progressive calcification of 
the replacement valve. Pharmacotherapies that prevent native and prosthetic valve 
calcification remain elusive, partially due to a lack of understanding of the 
pathophysiological mechanisms that regulate disease progression and the lack of a 
proven in vitro disease model [114,120,121]. 
 
Valvular Interstitial Cells (VICs) are the most abundant cell type in the aortic valve and 
play a vital role in maintaining valve function [69]. VICs comprise of a heterogeneous 
population of cells consisting of embryonic progenitor, endothelial/mesenchymal, 
progenitor, quiescent (fibroblasts), activated (myofibroblasts) and osteoblastic 
phenotypes [58,69,74,79], which are thought to play a role, either alone or 
collectively, in the process of calcification [58,122]. Several studies have suggested 
that VICs may transdifferentiate to bone-forming cells and directly mediate the 
formation of calcified mineral deposits, in a process analogous to bone formation 
[115,117,123]. Additionally VICs have been implicated in a dystrophic calcification 
through VICs activation in combination with apoptotic events resulting in calcium salt 
deposition [124].  
 
VICs derived from porcine tissue (PAVICs) are often used as a model for aortic valve 
research, as the fast-growing, relatively inexpensive and readily available cells can be 
cultured in vitro [82]. PAVICs have been reported to be a particularly valuable model 
in aortic valve calcification studies, as distinct cellular nodules spontaneously form in 
culture in the presence of control medium and osteogenic medium supplemented with 
transforming growth factor beta 1 (TGF-β1) [82,124].  TGF-β1 has been implicated in 
the pathobiology of aortic valve stenosis and shown to co-localize with calcification in 
diseased aortic tissue cusps [124,125]. Cellular nodules formed in the presence of 
TGF-β1 in vitro have been referred to in the literature as ‘calcifying nodules’ 
[124,126]. Nevertheless, a relationship between in vitro nodule formation and 
pathological aortic valve calcification has not been clearly established, and the cellular 
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composition and nature of the material that comprises these nodules has yet to be 
determined. The hard material that accumulates within human calcified valves has 
been identified as a mixture of calcium phosphate phases [127-129], thus similar 
mineral species should be identifiable in a cell-mediated model of aortic valve 
calcification. The calcified material found in diseased human valves has been 
suggested to be a result of an osteoblast like mineralization process and/or via a 
dystrophic calcification mechanism [48,123]. 
 
This chapter describes the characterisation of PAVICs in vitro nodules grown in 
osteogenic (OST) medium supplemented with TGF-β1 (OST+ TGF-β1) through a series 
of biological and materials-based characterization of the internally produced 
extracellular matrix (ECM). This information was used to compare these materials to 
those found within nodules formed by mineralizing murine calvarial osteoblasts 
(MOBs) and to PAVICs maintained in basal (CTL) medium. To do this, a myriad of 
techniques were utilized including a combination of gene expression, 
immunohistochemistry, histochemical staining, scanning electron microscopy (SEM), 
transmission electron microscopy (TEM), and live cell bio-molecular analysis with 
micro-Raman spectroscopy. Raman spectroscopy is a rapid, non-invasive technique 
based on light scattering which reveals the molecular fingerprint of a sample without 
dyes or labels. Micro-Raman spectroscopy additionally enables a more specific 
visualization of calcium salt deposition when compared to traditionally used Alizarin 
Red S and detects the presence of any calcium phosphate inclusion within the PAVICs 
nodules regardless of an osteoblast-like or dystrophic deposition [130,131]. The  
results presented in this chapter suggest that PAVIC nodules grown in OST+TGF-β1 
for up to 21 days show no evidence of calcium phosphate formation and showed no 
indication of undergoing an osteoblastic differentiation, however these nodules do 
produce an abundant ECM which is predominately collagen including type I collagen. 
3.3 Methods and Materials 
This study was reviewed and approved by the North London Research Ethics 
Committee (reference # 10/H0724/18), registered with the Royal Brompton & 
Harefield NHS Foundation Trust and performed in accordance with the requirements 
of the research governance framework.   
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3.3.1 VICs Isolation 
Whole hearts from 18 to 24 month old pigs were obtained from an abattoir (Cheale 
Meats, Essex, U.K.). Aortic valve cusps were removed within 12 hours of slaughter and 
PAVICs were isolated through two collagenase digestions as previously described 
[82]. Some PAVICs utilised were isolated by Ismail El-Hamamsy. 
3.3.2 Cell Culture and Tissue Collection and Preparation 
PAVICs were cultured in CTL medium consisting of high glucose Dulbecco’s Modified 
Eagles Medium (DMEM) supplemented with 1% (v/v) antibiotic–antimycotic, 10% 
(v/v) fetal bovine serum (FBS), and 2 mM L-Glutamine (All Invitrogen). OST+TGF-β1 
medium consisted of CTL medium supplemented with 10 mM β-glycerophosphate, 10-
7M dexamethasone, 10-6M ascorbic acid, and 10 ng/mL TGF-β1 (all Sigma-Aldrich). 
Media was replenished every three days.  CTL+TGF-β1 medium consisted of CTL 
medium supplemented with 10 ng/mL TGF-β1. OST medium consisted of CTL medium 
supplemented with 10 mM β-glycerophosphate, 10-7M dexamethasone, and 10-6M 
ascorbic acid. MgF2 coverslips (micro-Raman spectroscopy), glass cover slips 
(histology) and tissue culture plastic were seeded with 5 x104 cells/cm2 at passages 
four or five. Prior to cell seeding, MgF2 and glass cover slips were incubated in FBS for 
6 hours.   
 
MOBs were enzymatically derived from the calvaria of neonatal mouse pups as 
previously described [132] and performed by Dr. Eileen Gentleman. To form 
mineralized nodules, cells were cultured in alpha minimum essential medium 
(Invitrogen) supplemented with 15% (v/v) FBS, 2mM L-glutamine, 10mM β-
glycerophosphate, 50µg/ml ascorbic acid and 10-6 M dexamethasone from day 14. All 
MOBs were at passages two to four during testing. 
 
Calcified human aortic valves were obtained from the Royal Brompton Hospital, 
London, U.K. A total of four patients were included in this investigation at ages 51, 55, 
63 and 81 years old.  After collection each cusp was isolated, fixed in 4% (w/v) 
formaldehyde (FA) for 48 hours at 4°C and then rinsed in phosphate buffered saline 
(PBS). The cusps were then dehydrated in a graded ethanol series and calcified tissue 
was isolated for testing.  Raman spectra were collected from dry isolated human aortic 
valve cusp calcified tissue at room temperature with 3 accumulations of 5 second 
scans covering the Raman shifts range of 618-1728cm-1. 
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3.3.3 PAVICs Nodule Cross Section Preparation for Histology 
After 7, 14 and 21 days, cultures were fixed in 4% (w/v) formaldehyde (FA) for 20 
minutes at room temperature and then rinsed in phosphate buffered saline (PBS). For 
histological sectioning, cells were carefully scraped from the culture surface using a 
rubber policeman and re-suspended in a 1% (w/v) agarose (Sigma) in PBS using the 
method described by Gruber et al. [133]. Agarose gels containing VICs were again 
fixed in 4% (w/v) FA for 1 hour, dehydrated in a graded ethanol series and embedded 
in paraffin. 5μm sections were collected on glass slides and prepared for staining. 
3.3.4 Modified Verhoeff van Gieson for Detection of Collagen, 
Elastin, Muscle and Cell Nuclei 
Samples were stained using an elastin stain kit (Sigma) which utilizes the modified 
Verhoeff van Gieson method to stain elastic fibres blue-black to black, collagen pink to 
red, muscle yellow and nuclei blue to purple. Sections from blood vessels of adult mice 
were used for a positive control. 
3.3.5 Immunoperoxidase for Detection of Smooth Muscle Alpha 
Actin (aSMA) 
Prior to immunoperoxidase staining, sections were dewaxed, rehydrated in nanopure 
distilled water (dH2O) and washed in PBS for 5 minutes. Slides were immersed in 
0.1M citrate buffer (pH 6) and microwaved for 10 minutes before being immersed in 
peroxide (0.01% w/v) in PBS for 10 minutes. Sections were then washed 3 times for 5 
minutes each in PBS and blocked with 3% (w/v) bovine serum albumin (BSA) in PBS 
for 30 minutes. Sections were incubated separately for 1 hour with primary antibodies 
(Sigma). 
 
Sections were incubated with biotinylated goat anti-mouse immunoglobulins (GAM 
IgG-Vector laboratories) for 1 hour, washed 3 times in PBS and then incubated for 1 
hour with Avidin-Biotin Complex (ABC-Vector laboratories). Reactivity was detected 
using diaminobenzidine tetrahydrochloride (DAB tablets- Sigma) (25mg/ml) and 
hydrogen peroxide (0.01% w/v). Sections were then counter stained with 
haematoxylin. 
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3.3.6 Immunostaining for aSMA and DNA 
Sections were dewaxed and rehydrated in dH20. Antigen retrieval was carried out by 
immersing slides in 0.1M citrate buffer (pH 6), placing in a microwave for 10 minutes, 
incubating in citrate buffer for a further 20 minutes, and rinsing with tap water. To 
reduce non-specific binding, slides were incubated with 3% (w/v) BSA for 30 minutes. 
Specimens were then incubated with a smooth muscle alpha actin (αSMA) antibody 
(DAKO) for 1 hour at room temperature. Negative controls were incubated with 3% 
(w/v) BSA in PBS. After thorough washing, sections were incubated with goat anti 
mouse (IgG) Alexa Fluor 594 (Invitrogen) for 1 hour. After washing twice with PBS, 
cells were stained with DAPI and specimens mounted using Permafluor (Beckman 
Coulter). 
3.3.7 Alizarin Red S Staining for Calcium Detection 
Cultures were fixed in 2% (v/v) FA for 10 minutes, washed in dH20 and stained for 10 
min in 2% (w/v) Alizarin Red S (ARS) (Sigma) in dH2O, rinsed again, air dried, 
mounted on glass slides using DPX mounting medium and viewed using bright field 
microscopy. 
3.3.8 Gene Expression Analysis for Collagen I and BGLAP 
Gene expression analysis was performed after 7, 14 and 21 days in culture by 
Francesca Colazzo. RNA was extracted using the QIAGEN Mini extraction kit according 
to the manufacturer’s instructions. Reverse transcription (RT) and real-time 
polymerase chain reaction (PCR) was performed as described [126]. TaqMan assays 
were purchased for type 1 collagen (COL1A1) and bone gamma-carboxyglutamate 
protein (BGLAP) (Ss03373340_m1, Ss03373655_s1) respectively; (Applied 
Biosystems). Target gene data were normalized against 18S ribosomal RNA levels 
(Cat. No. 4310893E; Applied Biosystems) and analyzed using the comparative cycle 
threshold (Ct) method. 
3.3.9 Scanning Electron Microscopy (SEM) 
Cultures were fixed in 4% (v/v) FA in PBS for 45 minutes at 4°C and dehydrated in a 
graded ethanol series, followed by critical-point drying with hexamethyldisilazane 
(Sigma). Samples were sputter-coated with gold and viewed using a Leo 1525 Gemini 
scanning electron microscope with an EDX detector (Carl Zeiss SMT Ltd.) operated at 
15 kV. 
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3.3.10 Transmission Electron Microscopy (TEM) 
TEM sample preparation and imaging was performed by Suwimon Boonrungsiman. 
Cultures were fixed in 4% (v/v) glutaraldehyde in 0.1 M PIPES buffer (pH 7.4) at 4˚C 
for 2 hours and then fixed in 1% (w/v) osmium tetroxide in 0.1M PIPES buffer at room 
temperature for 1 hour.  The samples were then dehydrated using a graded ethanol 
series from 50%, 70%, 90% and 100 % (v/v), followed by immersion in acetronitrile. 
The nodules were then progressively infiltrated with a Quetol based resin (12.6g 
Quetol, 15.5g Nonenyl succinic anhydride (NSA), 6.5g Methyl nadic anhydride (MNA) 
and 0.6g Benzyl dimethylamine (BDMA)) with ratio of 1:1, 3:1 (resin: acetonitrile) and 
pure resin for 2 hours, overnight and 4 days, respectively. Pure resin was changed 
every 24 hours. Embedded samples were polymerized at 60˚C for 24 hours. 70 nm 
thick sections were cut onto a water bath via ultramicrotomy. The sections were 
collected immediately on bare 300 mesh copper TEM grids; selected sections were 
post-stained with uranyl acetate and lead citrate. TEM was performed on the Joel 
2000 operated at 120 kV. 
3.3.11 Raman Spectroscopy 
Live cell spectra were collected with a 785nm laser, using a Renishaw InVia 
spectrometer connected to a Leica microscope as previously described [12]. Briefly, 
spectra were collected from live cell cultures maintained at 37°C in PBS supplemented 
with Mg and Ca. Spectra were collected over 5 accumulations of 3 second scans 
covering the Raman shifts range of 800-1800cm-1. Samples were kept outside the 
incubator during testing for no longer than 30 minutes. 
 
Raman spectra were pre-processed for background removal (baseline subtraction 
using weighted least squares) and multiplicative scattering correction [134,135]. 
Interval partial least squares discriminate analysis (iPLS-DA) was applied to 
determine if a model could distinguish between treatment groups [136]. This model 
was derived using 194 total spectra collected from PAVICs nodules grown for 21 days 
in CTL or OST+TGF-β1 media. 
 
For mapping of PAVICs nodules, cultures were fixed in 4% (v/v) FA in PBS for 45 
minutes at 4°C and dehydrated in a graded ethanol series. Raman spectra were 
collected using a 532nm laser, on a Renishaw InVia spectrometer connected to a Leica 
microscope using a 60x (NA=1.0) long working distance (2mm) water immersion 
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objective (Nikon, U.K.). Spectra were collected using 1 accumulation of 10 seconds 
covering the Raman shifts range of 670-1500cm-1. 
 
Raman spectra of human valves were processed and analysed with software 
developed internally, including scripts written by Dr. Martin AB Hedegaard, for use 
with Matlab (The Mathworks) environment and with the multivariate statistical 
analysis PLS toolbox (Eigenvector Research) as described in chapter 1.  Raman spectra 
were intensity-corrected for instrument response; background signals were 
subtracted using the Modpoly algorithm (5th order polynomial, 1000 iterations) and 
lightly smoothed using a 5-point Savitsky-Golay filter (2nd order polynomial) as 
previously described [29]. 
 
3.3.12 Statistical Methods 
All continuous data are presented as mean ± one standard deviation.  For RT-PCR, all 
data were compared using the Mann-Whitney test for statistical significance.  p-values 
< 0.05 were considered significant. 
3.4 Results 
3.4.1 PAVICs Grown in OST+TGF-β1 Media Form Nodular Structures 
and Stain Positive for ARS 
VICs cultured in CTL and OST+TGF-β1 media for 21 days produced distinct, dense 
nodules approximately 50-200 µm in diameter (Figure 3-1A and D, respectively) with 
nodule formation occurring as early as day 4 in culture. Whilst nodules formed in CTL 
medium were visibly distinguishable from the surrounding monolayer, those formed 
in OST+TGF-β1 medium were more raised from the culture surface and appeared 
more compact. Nodules were similar in gross appearance to those formed from MOBs 
(Figure 3-1G). Nodules formed from PAVICs grown in OST+TGF-β1 media stained 
positively for ARS, a calcium stain, after 21 days in culture (Figure 3-1E).  Nodules 
formed in CTL medium did not stain positively for ARS (Figure 3-1B), whilst MOBs 
nodules did (Figure 3-1H). SEM images demonstrated that nodules formed from 
PAVICs cultured in OST+TGF-β1 medium produced distinct three-dimensional 
morphologies (Figure 3-1F), whereas nodules formed in CTL medium appeared as 
dense areas of cell growth with a less raised profile from the cell monolayer (Figure 
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3-1C). Nodules formed from MOBs had similar three-dimensional morphologies to 
those observed in the PAVICs cultures grown in OST+TGF-β1 medium (Figure 3-1I). 
 
 
Figure 3-1 Phase contrast and SEM images of cultured PAVICs and MOBs. A,D,G - 
Phase contrast images of cultured PAVICs grown in CTL medium for 21 days, 
PAVICs grown in OST+TGF-β1 medium for 21 days, and MOBs grown in OST 
medium for 21 days respectively (scale = 100 µm).  B,E,H - Alizarin Red S 
staining negative for PAVICs grown in CTL medium for 21 days, positive for 
PAVICs grown in OST+TGF-β1 medium for 21 days, and positive for MOBs grown 
in OST medium respectively (scale = 100 µm). C,F,I - SEM images of cultured 
PAVICs grown in CTL medium for 21 days, PAVICs grown in OST+TGF-β1 
medium for 21 days, and MOBs grown in OST medium for 21 days respectively 
(scale = 50 µm). 
3.4.2 PAVICs Grown in OST+TGF-β1 Medium Show an Increase in 
Type I Collagen Expression 
PAVICs grown in OST+TGF-β1 media showed a significantly higher expression of 
collagen type I after 14 and 21 days in culture compared to the expression levels after 
7 days (p<0.05) and to PAVICs cultured in CTL medium at the same time points 
(p<0.05, Figure 3-2a). PAVICs grown in CTL medium also showed no changes in type I 
collagen expression at any of the three time points examined.   
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BGLAP (osteocalcin) was stably expressed in PAVICs grown in OST+TGF- β1 or CTL 
media, however, its expression was significantly lower (p<0.05) in cells cultured in 
OST+TGF-β1 medium when compared to cells grown in CTL medium after 7, 14 and 
21 days, (Figure 3-2B). 
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Figure 3-2 Gene expression and staining of PAVICs nodules. A - Gene expression 
of collagen I (* = p < 0.05, ** = p< 0.0001, *** = p< 0.05;**** = p< 0.001) and B - 
Osteocalcin (bone gamma-carboxyglutamate protein (BGLAP)) (*= p < 0.05; ** = 
p< 0.001; *** = p< 0.0001) comparing PAVICs  expression at day 7 (D7), day 14 
(D14), and day 21 (D21) in both OST+TGF-β1 and CTL media.  C – Cross sectional 
plane of cultured nodules used for the D,E,F,G,H, and I.  D,E - Modified Verhoeff 
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van Gieson stain [purple – cell nuclei, pink – collagen, black-elastin] of a cross 
section of PAVICs cultured in CTL media for 21 days and PAVICs cultured in 
OST+TGF-β1 media for 21 days respectively (scale = 50 µm). F,G - Peroxidase 
stain with Sirius red staining [brown - αSMA , red – collagen] for PAVICs grown 
in CTL medium for 21 days and  PAVICs grown in OST+TGF-β1 medium for 21 
days respectively (scale = 50 µm) H,I - Fluorescence staining  [red - αSMA, blue - 
cell nuclei] of  a PAVICs nodule cultured for 21 days in CTL medium and a  
PAVICs nodule cultured in OST+TGF-β1 medium for 21 days respectively (scale 
= 50 µm). 
 
3.4.3 OST+TGF-β1 Medium Induces αSMA Expression and Collagen 
Deposition in PAVICs 
PAVICs cultured nodules were cross-sectioned for staining with a graphic showing the 
selected sectioned plane shown in Figure 3-2C. Modified Verhoeff van Gieson staining 
and sirius red identified collagen in PAVICs nodules formed in OST+TGF-β1 medium 
(Figure 3-2E and G, respectively). This was in contrast to nodules spontaneously 
formed in CTL medium where no collagen deposition was visualized in either the 
monolayer or nodule cross sections (Figure 3-2D,F). No elastin was observed in 
PAVICs cultures treated with either CTL or OST+TGF-β1 media. αSMA was present in 
CTL and OST+TGF-β1 derived nodules and monolayers, however, was not expressed 
homogeneously throughout the nodules, but rather only in the outermost layers in 
OST+TGF-β1 nodules (Figure 3-2G,I) and one side of the CTL nodules (Figure 3-2H). 
3.4.4 TEM of OST+TGF-β1 PAVICs Nodule Cross Sections Show 
Abundant ECM and No Evidence of Mineralization 
TEM images of PAVICs nodule cross sections showed layered cellular aggregates 
similar to those identified by histology. PAVICs nodules grown in OST+TGF-β1 
medium contained a proteinaceous ECM which was apparent throughout the nodules 
and surrounding cells (Figure 3-3A). The proteinaceous ECM appeared disorganized 
and contained fibrous proteins with a banded appearance (approximately 65nm in 
periodicity) indicative of mammalian collagen, specifically type I collagen [137-139]. 
PAVICs nodules formed in CTL medium displayed a rough membrane and contained 
little to no proteinaceous ECM between cells (Figure 3-3B). Electron dense mineral 
deposits were not evident in any PAVICs cross sections. 
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Figure 3-3 Transmission Electron Micrographs of cultured PAVICs grown in A - 
CTL medium and B - OST+TGF-β1 medium (VIC – valvular interstitial cell, ECM – 
extracellular matrix) (scale = 2µm). 
 
3.4.5 Raman Spectroscopy Exposes High Protein Content in 
OST+TGF-β1 PAVICs Nodules Without Any Mineral Presence 
Inorganic peaks indicative of mineralization were not present in CTL (day 21), 
CTL+TGF-β1 (day 14), OST (day 14) or OST+TGF-β1 (day 21) treated PAVIC nodules. 
In contrast the 960 cm-1 and 1070 cm-1 mineral peaks identifying the phosphate PO4 
bonds and type B carbonate substitution CO3 bonds, respectively, are clearly seen in 
the spectrum collected from an MOB nodule (Figure 3-4A). Raman maps spanning 
entire PAVICs nodules grown in CTL (day 21), CTL+TGF-β1 (day 14), OST (day 14) or 
OST+TGF-β1 (day 21) demonstrated a clear absence of mineral throughout the entire 
area of the nodules imaged as demonstrated in the representative Raman spectrum 
from each group (Figure 3-5D). The collected Raman maps were successful in imaging 
the organic area of the nodules through mapping of the phenylalanine peak (Figure 
3-5B) when compared to the white light micrograph (Figure 3-5A). No mineral 
content was visible in maps of these nodules as demonstrated by a representative 
Raman map in Figure 3-5C. Mineral bands were present in spectra collected from 
 80 
calcified human aortic valve tissue as seen in the representative mean spectrum 
(Figure 3-6). 
 
 
Figure 3-4 Raman spectra and PLS-DA model of cultured PAVICs. A - Raman 
spectra comparing a representative MOBs mineralized nodule spectrum (black), 
PAVICs grown in CTL media mean spectrum (dark grey), and PAVICs cultured in 
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OST+TGF-β1 medium mean spectrum (shaded box over entire spectrum).  
Vertical shaded areas highlight the 960cm-1 apatite peak and the 1070 cm-1 
carbonate peak spectral range.  B - Higher magnification of the PAVICs mean 
spectrum grown in CTL (dark grey) and in OST+TGF-β1 medium (light grey).  
The red spectrum is the difference between the two PAVICs mean spectra.  
Shaded red bands highlight spectral ranges which discriminate between groups.  
C - Scatter plot showing group separation between PAVICs grown in CTL 
medium (red triangles) vs. PAVICs grown in OST+TGF-β1 medium (green 
circles).  D - Latent variables loadings used in the interval partial least squares 
discriminant analysis (iPLS-DA) model, bands highlighted are spectral ranges 
which contributed to the distinction between groups. 
 
 
Figure 3-5 Raman mapping of cultured PAVICs nodules.  A - White light 
micrograph of PAVICs grown in CTL+ TGF-β1 (scale = 20µm).  B - Overlay of a 
Raman map (step size 1 µm in the x and y direction) of the phenylalanine peak 
onto the white light micrograph in A, showing the cellular presence as seen 
within the collected Raman spectra (scale = 20µm).  C - Overlay of the apatite 
peak Raman map onto the white light micrograph in A showing no mineral was 
detected in any of the mapped area (scale = 20µm).   D - Representative Raman 
spectra from Raman maps of PAVICs nodules grown CTL medium for 21 days, 
OST+TGF-β1 medium for 21 days, OST medium for 14 days and CTL+TGF-β1 for 
14 days.  The phenylalanine (1003cm-1), amide III (1214-1270cm-1), and CH2 
bending (1445cm-1) peaks clearly identified cellular areas within the Raman 
maps.  The absence of mineral peak, including the 960cm-1 apatite and 1070cm-1 
carbonate peak show that there is no mineral presence within these nodules, 
and mineral associated peaks were not seen in any spectra collected from the 
PAVICs. 
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Figure 3-6 Mean Raman spectrum of 128 spectra collected from independent 
locations within calcified human aortic valve tissue (isolated from 4 separate 
donors).  The grey bands highlight the mineral peaks present within the 
collected spectra at 960cm-1 (apatite) and 1070cm-1 (carbonate peak). 
 
The difference spectrum between CTL and OST+TGF-β1 (red spectrum in Figure 3-4B) 
reveals that protein bonds contributed the majority of the difference between the 
groups. Specifically, bands at 855, 874, 1043 and 1245-1270 cm-1 corresponding to C-
C stretch proline, C-C stretch hydroxyproline, proline and Amide III, respectively, are 
notable. The hydroxyproline and two proline peaks identified in these spectra are 
specifically Raman collagen assignments [140] confirming a collagen presence within 
the PAVICs grown in OST+TGF-β1 medium. 
 
The unsupervised technique of principal component analysis (PCA) was performed 
and although some experimental grouping was observed there was not sufficient 
information to distinguish experimental groups confidently from one another. For this 
reason supervised techniques were incorporated to discriminate between the 
experimental groups. 
 
The iPLS-DA model derived from spectra collected from PAVICs nodules grown in CTL 
or OST+TGF-β1 media for 21 days identified three latent variables which differentiate 
between the two groups with an equal sensitivity and specificity of 0.979. A clear 
division emerged between PAVICs grown in CTL and OST+TGF-β1 media, as is evident 
in the scatter plot which identifies the loadings of each collected spectra (Figure 3-4C). 
The latent variables used in the iPLS-DA model are also shown in Figure 3-4D. These 
variable loadings show spectral regions which varied between the experimental 
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groups. The latent variables are shown with highlighted bands indicating spectral 
regions which highly contributed to the differentiation between experimental groups.  
Specifically, bands at 855, 874, 1032, 1206, 1247 and 1665cm-1 are collagen 
assignment groups. Table 3-1 lists all bands (mineral and organic) highlighted in both 
the univariate and multivariate Raman analysis with their corresponding assignments. 
Table 3-1 Raman bands contributing to univariate and multivariate distinction 
between PAVICs grown in OST+TGF-β1 media, CTL media and MOBs mineralized 
nodules.  Inorganic peaks are in shaded rows. Stars indicate collagen 
assignments. 
 
 
3.5 Discussion 
The underlying mechanism of heart valve calcification has been likened to that of bone 
formation and/or a dystrophic process which includes the deposition of 
hydroxyapatite mineral [48,115,127,141]; nevertheless the process which mediates 
the formation of calcified lesions on aortic valve cusps remains uncertain and under 
investigation. Researchers have speculated that valve calcification involves a 
transdifferentiation of VICs into osteoblasts, which then mediate bone-like mineral 
formation within the valve tissue, starting in the collagen rich fibrosa layer 
[117,141,142]. The implication of such an osteoblast-like mineralization process has 
prompted the development of calcified in vitro models to examine the disease process. 
Easily cultured and fast-growing PAVICs are often used as a simplified model for 
aortic valve calcification [82], however, their efficacy in representing the disease and 
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ability to yield disease like materials has yet to be established. This study aimed to 
characterize the ‘calcified’ OST+TGF-β1 PAVICs nodule composition, compare them to 
those created by a confirmed mineralizing culture model (MOBs), and report any 
calcium phosphate deposition within the PAVICs nodules. 
 
It was observed that PAVICs grown in OST+TGF-β1 medium formed nodular 
structures which stained positively for ARS, as has been previously described 
[124,143]. Such nodules were notable for their distinct three-dimensional 
morphologies that are reminiscent of nodules formed from MOBs, which also stained 
positively for ARS. Nevertheless, when examining the ultrastructure of such nodules 
by TEM, no electron-dense mineral deposits were observed, as were readily 
identifiable  and described in the previously published report of nodules formed from 
MOBs [12]. Furthermore, Raman spectroscopy measurements clearly showed an 
absence of mineralization in the OST+TGF-β1 PAVICs, whilst MOBs nodules 
demonstrated distinct mineral peaks, indicative of phosphate and type-B carbonate-
substitution. These results suggest PAVICs ‘calcified’ nodules do not form mineral 
deposits when cultured under the conditions tested here and that ARS staining is a 
poor method to identify and confirm mineral deposits in PAVICs cultures. 
 
Numerous studies have suggested that PAVICs and human aortic VICs may 
differentiate to osteoblast-like cells during calcified valve disease progression 
[60,62,76]. A study by Chen et al. demonstrated mesenchymal and osteogenic 
progenitor cells exist within the primary PAVICs mixed cell population. Their results 
further exposed that PAVICs have the ability to transdifferentiate into myofibrogenic, 
adipogenic, osteogenic and chodrogenic lineages in vitro and thus potentially in vivo 
[76]. To probe PAVICs nodules’ potential for osteoblastic differentiation, the 
expression of two genes: type I collagen (COL1A1) and osteocalcin (BGLAP) were 
examined. Calcified human aortic VICs have been reported to show an increase in 
osteocalcin RNA expression (a late marker for bone differentiation) [123].  This study 
noted an up regulation of type I collagen in OST+TGF-β1 grown PAVICs, BGLAP 
expression remained stable in PAVICs grown in OST+TGF-β1 and this level of 
expression was significantly lower than expression levels in CTL PAVICs for the same 
time points. This suggests that PAVICs grown in OST+TGF-β1 for up to 21 days were 
not differentiating into osteoblasts. A previous study demonstrated PAVICs grown in 
mineralization medium for up to eight days did not display the same level of increased 
alkaline phosphatase (an early mineralization marker) as osteoblasts in culture [144].  
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The lack of osteoblastic differentiation in this study may be attributed to a wide range 
of factors including their growth on stiff tissue culture plastic/glass substrates and/or 
the inclusion of TGF-β1 within some of the tested conditions [62] and is discussed 
further in the future works section of this chapter. It is important to state this work 
does not suggest osteoblastic differentiation is not possible in other culture 
conditions. 
 
In this study the OST media was supplemented with TGF-β1 due to its demonstrated 
physiological importance in tissue calcification.  Studies have shown qualitatively 
higher levels of TGF-β1 in the ECM that co-localized with areas of calcification in 
diseased human aortic valves [124,125].  Additionally, the inflammatory response has 
been implicated as an important contributing factor in disease onset, which suggests a 
local availability of TGF-β1 [117,145] may increase during the initial stages of disease 
progression.  Nevertheless, the connection between TGF-β1 use in this in vitro system 
and disease progression remains unclear.  Osman et al. showed that supplementation 
of human VIC cultures with members of the TGF-β family (including TGF-β1) 
prompted the cells to adopt a more osteoblast-like phenotype by inducing the 
secretion of proinflammatory cytokines which may play an important role in 
pathological valvular calcification [60].  The results found in this study show that 
PAVICs grown in OST+TGF-β1 medium show no evidence of osteoblastic 
transdifferentiation and thus these ‘calcified nodules’ have yet to demonstrate their 
relationship to calcified aortic valve disease progression.  The absence of mineral 
within PAVICs nodules grown in CTL+TGF-β1 and OST medium suggests the lack of 
mineralization is not due to solely osteogenic supplementation or the additional TGF-
β1 supplementation. 
 
TEM and histological staining demonstrated that PAVICs nodules grown in OST+TGF-
β1 were marked by an abundant proteinaceous ECM, which contained collagen 
without a specific arrangement or orientation. Collagen production is mediated by 
VICs in vivo as part of normal valve maintenance, however, disruption of this carefully 
regulated process has also been associated with calcified aortic valve disease 
progression [146]. Valvular fibrosis and over-activated VICs have been implicated in 
the early stages of calcified valve pathobiology [146], including a suggestion of 
calcified aortic valve stenosis being more appropriately viewed as a fibrocalcific 
disease [147]. This study confirms TGF-β1 supplementation likely promotes and/or 
maintains an activated myofibroblastic phenotype in cultured PAVICs and their 
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production of ECM components. The relationship, if one exists, between in vitro 
PAVIC-mediated ECM production and the fibrotic stage of aortic valve calcification, 
however, has yet to be established and described. 
 
PAVICs-mediated production of fibrous ECM was additionally explored using Raman 
spectroscopy. Like the histological analyses, Raman spectroscopy further identified 
the abundant proteinaceous content of PAVICs nodules cultured in OST+TGF-β1 
medium. The derived PLS-DA model successfully distinguished between the two 
experimental PAVICs systems based on the ECM produced by PAVICs grown in 
OST+TGF-β1 medium. This model also clearly indicated the collagen content within 
the nodules was a heavy contributor to the model variables, and thus suggested 
collagen as a distinguishing element between the experimental groups. Taken 
together, these results suggest Raman spectroscopy may be an effective method to 
successfully and non-invasively monitor ECM production in live PAVIC systems in 
vitro. 
 
Cross sections of OST+TGF-β1 PAVICs nodules presented positive expression of αSMA, 
as did monolayers of PAVICs grown in CTL medium, implicating a myofibroblastic 
phenotype [148]. These results show that the cells at the centre of these nodules are 
not αSMA positive and thus may have a different phenotype or be undergoing 
apoptosis, as has been previously suggested [143].  TGF-β1 has been suggested to 
promote myofibroblastic expression particularly when incorporated on stiff 
substrates [62] and calcification via an apoptosis pathway [124,146], thus suggesting 
a non-osteoblastic like state [124]. The results presented in this study show that 
PAVICs cultured in OST+TGF-β1 medium for 21 days, a relatively late time point for in 
vitro  culture [144], do not further transdifferentiate from the activated 
myofibroblastic phenotype into osteoblast-like cells or contain calcium phosphate 
deposits within the ‘calcified nodules’ as seen in MOBs and human valves. Currently it 
remains uncertain as to whether VICs must pass through an intermediate stage of 
activated VICs to become osteoblast-like VICs [146,147]. Further investigations are 
needed to establish if the OST+TGF-β1 PAVICs models have any relationship to early 
(pre-osteoblastic) stages of calcified aortic valve disease. 
 
Previously the inhibition of nodule formation in cultured VICs has been explored 
through the addition of statins, pravastatin [149], nitric oxide donors, as well as other 
cell permeate superoxide scavengers [126]. The response and transformations of VICs 
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grown in vitro to various treatments raise interesting questions regarding the 
relationship between these cells and the complex in vivo environment both in healthy 
and disease states. As investigations into the pathobiology of aortic valve calcification 
progress, characterization of both systems using a variety of techniques offers 
promise of bridging the gap between in vitro observations and in vivo processes. 
3.6 Conclusions 
This study combines gold standard biological techniques as well as advanced material 
characterization techniques including rapid, non-invasive Raman spectroscopy to 
investigate PAVICs ‘calcified’ nodules. The results show PAVICs grown in OST+TGF-β1 
media for up to 21 days express an activated myofibroblastic phenotype and produce 
a predominantly collagen ECM, however, demonstrate no evidence of further 
transdifferentiation into an osteoblastic phenotype and/or calcium phosphate 
deposition as seen in known mineralizing in vitro systems and calcified human aortic 
cusps. These findings establish a clear limitation of cultured PAVICs grown in CTL and 
OST+TGF-β1 media as they do not appear to transdifferentiate into osteoblastic-like 
cells nor form mineral deposits what have been found indicative of calcified aortic 
valve disease [150]. This study also provides further information on the collagen-rich 
ECM produced within PAVICs nodules grown in OST+TGF-β1 medium and the 
heterogeneous nature of these nodules. The presented characterisation of in vitro 
PAVICs systems is critical in further understanding PAVICs behavior in culture and for 
comparison to aortic valve calcification. 
3.7 Future Work 
This study established a clear limitation in the ability of the cultured PAVICs ‘calcified 
nodules’ in producing mineral deposits seen in calcified aortic valve cusps and MOBs 
when grown in the conditions presented. It is critical to note the relationship between 
this system and the full spectrum of aortic valve pathobiology has yet to be 
determined. Aortic valve calcification is condition which often progresses over 
decades and as mentioned previously has proteinaceous changes as well as mineral 
deposits to consider. A myriad of complications including ECM maladaptation within 
diseased human aortic tissue cusps have been implicated and suggested to occur 
before the deposition of any calcified material. Excess fibrosis and collagen 
remodeling has been related to calcified aortic valve disease [146]. Thus the 
relationship between disruption of ECM components in the pathobiology of calcific 
aortic valve disease and the ECM production in these nodules has yet to be fully 
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explored. It also should be noted that VICs in the native valves are proposed to be very 
sensitive to their local environment and in response to environmental changes in 
order to fulfill their role of replenishing the ECM as needed to maintain normal valve 
structure and function. The difference between VICs activation and matrix production 
in a disease state and in a healthy repair state must also be clearly demarcated if any 
connection between a culture system and calcified aortic valve pathology is to be 
established. 
 
Another consideration is the potential for the promotion or selection of specific cell 
types within the mixed VICs population via culture conditions such as substrate 
stiffness, medium, medium supplementation, incubator conditions  and others [74]. 
Culture conditions are known to greatly affect cells isolated and grown in vitro. 
Previously substrate mechanics has been shown to have a direct effect on PAVICs in 
culture [62]. The relatively stiff nature of the tissue culture plastic and glass slides 
used in this study may be involved in the continuous activation of the isolated PAVICs 
and their collagen production. Another factor which may have significantly affected 
the outcome of this study was the inclusion of TGF- β1 within the medium. Despite 
being found colocalised with mineralized deposit within calcified aortic valves [124] 
and know to be connected with pathological valve matrix remodeling [143], it has 
been suggested that TGF- β signaling is associated with myofibroblast differentiation, 
not associated with the osteogenic process and may inhibit osteogenic calcification in 
the valve. These statements are yet to be fully supported through publication [146]. 
 
Further studies modifying the PAVICs and human VICs culture conditions will 
undoubtedly continue and characterizations will be critical in assessing their 
relationship to the pathology of aortic valve calcification. For any model to gain 
acceptance, it is also critical to understand the target conditions of the diseased tissue 
which the model would reproduce albeit in a simplified manner. Thus a more 
thorough investigation of the material characteristics of the diseased cusps is needed 
to establish specific model targets. In parallel work, our research group exposed and 
characterized mineral depositions which may provide new information on and targets 
of the progression of cardiovascular calcification. This is more fully described in 
chapter 4 and by Bertazzo et al. [51]. These types of revelations will undoubtedly 
provide new directions for in vitro models.  
 
 89 
The focus of chapter 4 turns to characterizing diseased human aortic valve tissue (and 
surrounding diseased cardiovascular tissue) at various stages of pathology. 
Information on the proteinaceous environment developing in the ECM colocalised 
with mineral deposits are of critical and may help address some of the limitations in 
determining the relationship between simplified models and the cardiovascular 
calcification they intend to represent. 
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4 Protein Changes Colocalised with Microscopic 
Calcium Phosphate Deposition in Cardiovascular 
Tissues 
4.1 Abstract 
Cardiovascular calcification is a growing global health concern with much of the 
pathogenesis still not understood. Recently the description and characterisation of 
microscopic spherical mineral particles (50nm-200µm) found in vasculature and 
heart valves in visually undisrupted tissue and at various stages of cardiovascular 
calcification evolution raised interesting questions regarding the introduction and role 
of microscopic mineral deposits in the cardiovascular system. Raman micro-
spectroscopy was combined with scanning electron microscopy to provide 
information on the biomolecular environments surrounding these microscopic, 
spherical mineral deposits in human aortic and aortic valve tissue ranging from 
healthy, healthy and adjacent to disturbed tissue, plaque and calcified tissue. The 
protein environments surrounding the microscopic spherical mineral particles in the 
various states were compared and analysed by comparing Raman spectra in different 
experimental groups using PLS-DA VIP score plots to highlight the significant bio-
molecular differences between them. The results demonstrated a change in the ECM 
and specifically in the collagen colocalised with the microscopic spherical mineral 
deposits found within aortic valve and aorta tissues. In both aortic and aortic valve 
tissue a specific Raman collagen peak at 874 cm-1 distinguished between tissues 
containing microscopic mineral spheres and those without. Lipid rich and protein 
differences were distinguishing factors in comparing plaque ridden tissue from 
healthy and neighbouring (samples visually undisturbed yet adjacent to disrupted 
tissue) tissue samples. This study prompts further investigations into the local 
environment surrounding the microscopic spherical mineral deposits as distinct 
protein changes were observed. Additionally this work further supports the ability of 
Raman spectroscopy to non-invasively compare the wide range of biomolecular 
environments found in cardiovascular calcification. 
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4.2 Introduction 
Cardiovascular calcification is a global concern and is project to nearly double by 2050 
as the population and life expectancy increases [49]. Cardiovascular calcification is 
currently viewed as an active process which mainly affects the aortic valve and 
arteries and is associated with an increase risk in cardiovascular and all-cause 
mortality [151-153]. Currently there are no treatment options proven to reverse 
vascular or valvular calcification and applied therapies instead often target associated 
underlying disorders such as atherosclerosis, chronic kidney disease, diabetes 
mellitus, and osteoporosis [154]. Calcified heart valves can be surgically replaced with 
mechanical or bio prosthetic implants, each with the associated advantages and 
disadvantages as reviewed in chapter 1.   
 
Aortic valve calcification was introduced extensively in chapter 1. This paragraph and 
following figure are a brief introduction into vascular calcification. A large artery 
consists of three morphologically distinct layers: the intima, media and adventitia 
(Figure 4-1). The intima is the inner most layer consisting of extracellular connective 
tissue matrix and bonded by a monolayer of endothelial cells on the luminal side and a 
sheet of elastic fibres, the internal elastic lamina, on the peripheral side. The media is 
the middle layer consisting of smooth muscles cells. The adventia is the outer most 
layer consisting of connective tissues with interspersed fibroblasts and smooth 
muscle cells [155]. Vascular calcification can be categorized by its location found 
within an atherosclerotic plaque (in the neointima) or the medial smooth muscle layer 
(tunica media). The neointima is a new or thickened layer of the arterial intima 
formed especially on a prosthesis or during atherosclerosis by migration and 
proliferation of cells from the media. Vascular calcification in both locations may occur 
in the same patient and even the same arterial site. In cardiac valve leaflets the 
mineralisation is thought to be similar to neointimal calcification [50,66]. It is 
important to note that vascular calcification is widespread in atherosclerosis and thus 
the factors affecting atherosclerosis are also of interest [156]. 
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Figure 4-1 Structure of a healthy large artery. The intima’s size is exaggerated in 
this figure and is typically a very thin region. 
 
The extracellular matrix is known to regulate many physiological and pathological 
processes and is a critical determining factor of both healthy and diseased arteries and 
valves [156-158]. In the pathological conditions of atherosclerosis, extracellular 
matrix changes accompany the development of the atherosclerotic lesion and 
significantly impact the course of the disease[156]. Interstitial collagen types I and III 
are a critical component of atherosclerotic legions with collagen constitutes up to 60% 
of the total plaque protein contributing to plaque growth and arterial lumen 
narrowing [158]. Type I collagen is approximately two-thirds of the total collagen 
content in human atherosclerotic plaques [157]. There is an overwhelming amount of 
information regarding the vast role collagen plays in cardiovascular disease however 
for the purposes of this study, the critical applicable evidence is the disrupted, 
heterogeneous nature of type I collagen distribution in cardiovascular disease and the 
co-localisation of this collagen alteration with diseased cardiovascular environments 
[156-160]. 
 
The majority of observed vascular calcification provides evidence of a bone-like 
mineralization occurring around mineral deposits [154,161]. Cells isolated from 
arterial walls grown in culture have become osteogenic through the introduction of 
inflammatory and atherogenic stimuli. Osteoclast-like cells have been found in 
calcified atherosclerotic plaques [162].   The mineral deposits found in the 
cardiovascular system have an elemental composition similar to bone mineral and are 
reported as hydroxyapatite [121]. Calcification is a common feature of atherosclerotic 
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lesions and has been described to have histologic appearances of fully formed bone 
tissue including trabeculations suggesting active remodeling [163].    
 
It remains unclear as to whether cardiovascular calcification is a cause or 
consequence of cardiovascular disease. There is evidence of atherosclerosis inducing 
cellular osteogenic transdifferentiation suggesting calcification is a consequence . 
However, calcium deposits may affect plaque stability and introduce compliance 
mismatches and overall increase the risks of a cardiovascular event [119]. 
Additionally new insights into microscopic mineral deposits discovered to be present 
before mature osteoblasts are found again raises the question of what role, if any,  
inorganic mineral deposits play in the pathology of cardiovascular calcification [44]. 
Regardless of cardiovascular calcification being a cause or consequence, it is clear 
extra-skeletal ossification in the cardiovascular system is of extreme importance. 
 
Recently Bertazzo et al. adopted a material science approach to provide insight into 
the composition and hierarchical architecture of the mineral deposits found in 
cardiovascular calcification. The study revealed and described three distinct forms of 
calcific structures: microscopic spherical particles, fibres and a larger compact 
material.  Microscopic, spherical mineral deposits ranging in size from 100 nm to five 
µm were discovered in the heart valves, aortae and coronary arteries of patients with 
and without calcific lesions. The spherical particles are composed of highly crystalline 
hydroxyapatite that is crystallographically and structurally different from bone 
mineral. The presence of these spherical particles before any macroscopically 
observable calcific lesions suggests the spherical particles may be the first mineralised 
structure to appear and this leads to interesting questions on what role, if any, the 
particles play in disease initiation and/or progression. Additionally the presence of 
these spherical particles in both valvular and vascular tissue makes them relevant to 
the wide range of cardiovascular calcification [44]. 
 
These spherical particles are of extreme interest and often found in tissues which do 
not appear to be visually disturbed. This study aimed to determine whether the 
molecular environments surrounding these microscopic mineral deposits are altered 
at the micron scale and what those alterations may be in human aortic and aortic 
valve samples. Raman spectroscopy was applied to determine the biomolecular 
environment surrounding these microscopic mineralised deposits with a particular 
emphasis on characterising and comparing the protein environments surrounding 
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mineralised spheres. The microscopic spherical mineral particles are highly 
crystalline,  50nm-200µm in diameter, and surrounded in a protein rich organic 
matrix [51] whereas the sampling volume for the collected Raman spectra is 
predominately from a focal size of approximately 10 x 20 x 40 µm. The description 
and investigation of any protein changes colocalised with the microscopic spherical 
deposits may allude to the contribution these spherical deposits play in cardiovascular 
disease, if any. 
4.3 Methods and Materials 
4.3.1 Human Tissue Collection 
Human aortic valves and aortae tissue was collected from the Heart Valve Bank at 
John Radcliffe hospital (Oxford, U.K.). A total of 20 donors were included in this study 
with a mean age of 59 ± 5 years, nine male and eleven female. The tissue was obtained 
from patients undergoing aortic valve replacement surgery or was available for 
research purposes after being rejected for use in homografts. All samples were 
collected under approved ethical guidelines with informed consent and were 
anonymously analysed. 
 
Human bone tissue was obtained from Charing Cross Hospital (London, U.K.). Cortical 
bone samples were collected from the femurs of two patients, one male (73 years old) 
and one female (72 years old) that were undergoing hip replacements. Raman spectral 
collection was performed on these bone samples as described in chapter 2. 
4.3.2 Cardiovasular Tissue Preparation 
The collected human tissue samples were washed three times in phosphate buffered 
saline (PBS) (Sigma, U.K.) immediately on receipt and subsequently fixed in 4% (w/v) 
formaldehyde (Sigma, BioReagent, ≥ 36.0%) at 4ᵒC for a minimum of one day. 
4.3.3 Sample Dissection 
Cardiovascular tissue samples were dissected in regions of interest to isolate small 
volumes (approximately 8 mm3) using common dissection tools and were visually 
categorised into the four following tissue states: 
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Healthy – the isolated tissue and the surrounding area was visually healthy (in aortic 
valve samples, the surrounding area was the entire cusp which the isolated tissue was 
taken from) 
Neighbour – the isolated tissue appeared healthy and undisturbed however a 
neighbouring region appears disturbed (thickened, streaked, etc.) 
Plaque – the isolated tissue was visually disturbed (thickened, discoloured, etc.) 
Calcified – the isolated tissue contains calcium deposits. The tissue is thickened, 
discoloured and when isolated, mechanical differences are observed (hard, brittle, off-
white depositions found within the tissue) 
 
Each isolated sample was labelled and placed into an eppendorf filled with PBS for 
transportation to Raman imaging. 
4.3.4 Raman Imaging of Aortic Valve and Aortic Tissue 
Raman spectra were collected from the isolated tissue samples using the instrument 
described in chapter 1. Briefly, samples were illuminated with a 785 nm laser  and 
Raman spectra were collected using a modified Renishaw InVia spectrometer 
connected to a Leica microscope (Renishaw, U.K.) through a water immersion  63× 
(NA=0.9) objective (Nikon, Netherlands).  The fixed tissue samples were imaged while 
immersed in PBS at room temperature for no more than six hours. Raman spectra 
were collected from a minimum of 10 independent regions within each isolated tissue 
sample using the motorized stage coordinates to ensure no overlapping occurred. 
Each spectrum consisted of three accumulations of ten seconds over the Raman shift 
range of 400 to 3200 cm-1. 
 
The collected spectra were divided into three environments independent of their 
visual tissue state and directly related to the biomolecular signatures found within 
them namely: Protein rich, Lipid rich, and Mineral rich. 
 
Raman spectra were pre-processed for multivariate analysis including smoothing 
(order: 0, window: 9pts), background removal (baseline subtraction using weighted 
least squares and multiplicative scattering correction) and mean centring. Partial 
Least Squares – Discriminate Analysis (PLS-DA) was used for classification and the 
Variable In Projection (VIP) heat maps were used to highlight spectral bands which 
describe the molecular features that distinguish the compared experimental groups 
from each other as described in chapter 2.  The sensitivity and specificity was 
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recorded for each model used and determined by the cross validated leave out 
random subsets method. The number of latent variables selected for the model was 
also noted and reported. All data analysis was performed in MatLab R2011a (The 
Mathworks, U.S.A.) using a combination of in house written scripts, some written by 
Dr. Martin AB Hedegaard, and the PLS_toolbox 7.0 (Eigenvector Research, U.S.A.). 
 
The peak labels found in the Raman spectra presented in this chapter are 
representative of the peaks found in literature and may be slightly shifted from the 
precise peak positions found in the spectral means displayed. 
 
The following study utilized an edge filter in the Raman instrumentation replacing the 
notch filter originally described in the introduction before the study began. The 
instrumentation did not change during the course of this study. 
4.3.5 Uni-variate Statistical Analysis 
All data are presented as mean ± standard deviation.  All data were compared using 
the Kruskal-Wallis one way analysis of variance test for statistical significance.  P-
values < 0.05 were considered significant. 
4.3.6 Scanning Electron Microscopy 
Scanning Electron Microscopy (SEM) sample preparation, imagining and image 
processing was performed as previously described in Bertazzo et. al. and by Dr. Sergio 
Bertazzo. Briefly after Raman imaging each isolated tissue sample was cut in half and 
dehydrated through a graded ethanol (Sigma, ACS reagent 99.5%, U.K.) series of 20, 
30, 40, 50, 70, 80, 90, 100, and 100% (v/v) for 1 hour in each solution and air dried. 
Dehydrated samples were secured to an aluminium sample holder with carbon tape 
and silver paint was applied to the area immediately surrounding each sample which 
was then coated with 5nm carbon (Quorum Technologies Turbo-Pumped Thermal 
Evaporators model K975X) and 5nm chromium in a sputter coater (Quorum 
Technologies Sputter Coater model K575X). 
 
Following the coating procedure, samples were imaged by the SEM (Gemini 1525 
FEGSEM) operated at 10 kV. The instrument was equipped with both an inlens 
detector that recorded secondary electrons and a backscatter electron detector. 
Sample regions were imaged in inlens mode and subsequently in backscatter mode 
over the same area and the resulting images were stacked. The green channel was 
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assigned to the inlens image and red channel to the backscatter channel. Energy-
dispersive X-ray spectroscopy (EDS) spectra were obtained using point and shoot 
mode to ensure the dense regions were mineralised. 
4.4 Results 
The Raman spectra collected from the aortic valve and aortic samples displayed three 
biomolecular environments namely protein, lipid, and mineral rich as shown in Figure 
4-2.  Raman spectral peaks  
representative of and used to identify each environment are highlighted in Figure 4-2 
and listed in Table 4-1. Raman spectral features found in the 1800-2500 cm-1 were 
due to background and were not considered in any of the following analyses. 
Additionally, the collected Raman spectra were not corrected for detector or 
instrument responses therefore the CH stretches found surrounding 2940 cm-1 may 
appear relatively less intense than Raman spectra found in literature. 
 
 
Figure 4-2 Raman spectra showing the three distinct environments collected 
from the human cardiovascular samples. Red – mineral rich with the 960 cm-1 
and 1070 cm-1 peaks highlighted corresponding to PO43- and CO32- respectively. 
Blue – lipid rich spectrum with the 702 cm-1 and 1437 cm-1 peaks highlighted 
corresponding to cholesterol and CH2 (lipids) respectively. Green – protein rich 
spectrum with the 1003 cm-1 and 1595-1720 cm-1 peaks highlighted 
corresponding to phenylalanine and amide III respectively. 
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Table 4-1 Raman spectral peak assignments for peaks used to identify the 
biomolecular environments in Raman spectra collected from human aortic and 
aortic valve tissue. No shading – protein assignments, light gray – lipid 
assignments, gray – mineral assignments. 
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Protein rich environments were found in all visible tissue states (healthy, neighbour, 
plaque and calcified). Lipid Raman spectra were collected from sphere containing 
plaque and calcified tissue. Mineral spectra were only collected from calcified tissue.  
 
After Raman imaging, all samples were immediately prepared for SEM imaging where 
the samples were thoroughly scanned for any evidence of microscopic calcification. 
Figure 4-3 is a representative image of the identified mineral inclusion showing a 
spherical mineral deposit found in an aortic valve sample. Both spherical and compact 
mineral deposits were first identified by morphology and density discrepancies and 
further confirmed using EDS spectral elemental analysis [51]. 
 
 
Figure 4-3 Density-dependent colour SEM micrograph of human aortic valve 
tissue showing mineralised microscopic spheres. Scale bar = 1µm. 
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Tissue samples were then divided by their visually determined tissue states (healthy, 
neighbour, plaque, and calcified), Raman spectral environments (protein, lipid, and 
mineral rich), and any inclusion of mineral deposits (organic – no mineral inclusion, 
spherical mineral deposits, large compact mineral deposits). Table 4-2 gives the 
number of spectra collected in each sample group for the aortic valve samples tested. 
 
 
Table 4-2 Total number of Raman spectra collected from the aortic valve as 
divided into each sample group. The table shows the division of Raman spectra 
collected from human aortic valve tissue into their respective sample groups, 
columns being micro-mineral inclusion, rows being Raman spectral 
environments and the shading of the cells referring to the visual tissue state. 
Each number within the table shows the number of Raman spectra collected. 
 
 
Protein rich Raman spectral environments were found in all tissue states (healthy, 
neighbour, plaque, calcified) and in tissue with and without spheres and in compact 
calcification within aortic tissue samples. Lipid rich Raman spectra were collected 
from neighbour tissue containing spheres, plaque tissue containing spheres and 
calcified aortic tissue containing compact mineral deposits. Mineral rich Raman 
spectra were only collected from calcified tissue containing compact mineral deposits.  
A Chi-squared test resulted with a two-tailed p-value less than 0.005 when comparing 
samples in which mineral deposits were expected (calcified samples) to samples 
found to contain mineral deposits and samples not  expected to contain mineral 
inclusions (healthy, neighbour and plaque) compared to samples without found 
mineral inclusions. 
 
Table 4-3 gives the number of spectra collected in each sample group for the aortic 
samples imaged. 
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Table 4-3 Total number of Raman spectra collected from the aorta as divided 
into each sample group. The table shows the division of Raman spectra collected 
from human aortic tissue into their respective sample groups, columns being 
micro-mineral inclusion, rows being Raman spectral environments and the 
shading of the cells referring to the visual tissue state. Each number within the 
table shows the number of Raman spectra collected. 
 
 
Only protein rich spectra were included in the comparisons shown in this study as the 
proteinaceous differences (if any) were of the most interest. The unsupervised 
technique of principal component analysis (PCA) was performed and although some 
experimental grouping was observed there was not sufficient information to 
distinguish experimental groups confidently from one another. For this reason 
supervised techniques were incorporated to discriminate between the experimental 
groups. A Chi-squared test resulted with a two-tailed p-value less than 0.005 when 
comparing samples in which mineral deposits were expected (calcified samples) to 
samples found to contain mineral deposits and samples not  expected to contain 
mineral inclusions (healthy, neighbour and plaque) compared to samples without 
found mineral inclusions. PLS-DA VIP plots were constructed by first plotting the 
mean spectrum of the two experimental groups compared (with one being intensity 
shifted so the spectra were not overlapping). A VIP heat-map is then overlaid onto the 
mean spectra so that the more intensely green a Raman spectral band, the more 
significant that spectral region was in discriminating between the sample groups in 
the PLS-DA model. For each of the following PLS-DA VIP plots, the mean spectrum 
from each group is shown after the pre-processing steps used in the PLS-DA analysis 
excluding mean centring. Mean centring was withheld so the resulting mean spectra 
would show spectral features as widely recognised and comparable to literature. Each 
 101 
PLS-DA plot compares two sample groups and an independent model was constructed 
for every comparison. 
 
Three experimental groups from the aortic valve samples were compared in the 
following comparisons: 
 
healthy tissue without spheres vs. neighbour tissue containing spheres (Figure 4-4). 
neighbour tissue containing spheres vs. plaque tissue containing spheres (Figure 4-5). 
healthy tissue without spheres vs. plaque tissue containing spheres (Figure 4-6). 
 
 
Figure 4-4 PLS-DA VIP scores plot displaying Raman bands from the aortic valve 
which distinguished between healthy tissue samples without mineral inclusions 
and neighboring tissue samples with microscopic, mineral, spherical inclusions. 
The more intense the green band, the more significant the Raman shift range in 
the PLS-DA models ability to distinguish between the two groups. Selected 
band’s wavenumbers are shown at the top of the figure. 
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Figure 4-5 PLS-DA VIP scores plot displaying Raman bands which distinguished 
between aortic valve neighboring tissue samples with microscopic, mineral, 
spherical inclusions and plaque tissue with microscopic, mineral, spherical 
inclusions. The more intense the green band, the more significant the Raman 
shift range in the PLS-DA models ability to distinguish between the two groups. 
Selected band’s wavenumbers are shown at the top of the figure. 
 
 
Figure 4-6 PLS-DA VIP scores plot collected from the aortic valve displaying 
Raman bands which distinguished between healthy tissue samples without 
mineral inclusions and plaque tissue containing microscopic, mineral, spherical 
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inclusions. The more intense the green band, the more significant the Raman 
shift range in the PLS-DA models ability to distinguish between the two groups. 
Selected band’s wavenumbers are shown at the top of the figure. 
 
The PLS-DA model constructed from the comparison of healthy tissue without mineral 
inclusions vs. neighbour tissue with microscopic spherical mineral inclusions resulted 
in an 80% sensitivity and specificity using four latent variables. Raman spectral band 
assignments for the bands highlighted and labelled in the VIP heat map in Figure 4-4 
are shown in Table 4-4. The highlighted wavenumbers found in this comparison are 
all protein peaks/bands including 874 and 1043 cm-1 which are specifically collagen 
assignments. 
 
The PLS-DA model constructed from comparing neighbour tissue containing mineral 
spherical deposits vs. plaque tissue containing mineral spherical deposits resulted 
with a 74% sensitivity and specificity using three latent variables. Bands assignments 
for the Raman bands highlighted and labelled in the VIP plot shown in Figure 4-4 are 
described in Table 4-4. These highlighted wavenumbers contain protein and lipid 
peaks/bands including the collagen assignments found at  855, 934 and 1335 cm-1  
and lipid assignments at 1437 and 2849 cm-1 with 2849 cm-1 specifically indicating a 
change in the amount of lipids between the compared groups. 
 
The PLS-DA model comparing healthy tissue without mineral inclusions to plaque 
tissue containing sphere mineral inclusions resulted with an 80% sensitivity and 
specificity using four latent variables. Raman spectral bands assignments for the 
bands highlighted and labelled in the VIP heat map (Figure 4-6) are shown in Table 
4-2. The highlighted wavenumbers include protein and lipid peaks/bands. Specifically 
collagen assignments were found (855, 874 cm-1) and lipid assignments (1437 and 
2848 cm-1) with 2848 cm-1 specifically indicating a change in the amount of lipids 
between the two compared sample groups. 
 
PLS-DA VIP plots were constructed for the comparison of aortic tissue sample groups. 
Four sample groups were included in the following comparisons: 
 
healthy tissue without mineral inclusions vs. healthy tissue containing spherical 
inclusions (Figure 4-7A). 
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healthy tissue containing spherical inclusions vs. neighbour tissue containing 
spherical inclusions (Figure 4-7B). 
healthy tissue containing spherical inclusions vs. plaque tissue containing spherical 
inclusions (Figure 4-7C). 
neighbour tissue containing spherical inclusions vs. plaque tissue containing spherical 
inclusions (Figure 4-7D). 
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Figure 4-7 PLS-DA VIP heat maps highlighting spectral bands distinguishing healthy tissue without spheres (yellow mean 
spectrum), healthy tissue with spheres (white mean spectrum), neighbouring tissue with spheres (green mean spectrum) and 
plaque tissue with spheres (blue mean spectrum) from the aorta. The more intense the green band, the more significant the 
Raman shift range in the PLS-DA models ability to distinguish between the two groups. Selected band’s wavenumbers are shown 
at the top of the figure. 
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The PLS-DA model used in the comparison of healthy tissue without spheres 
to healthy tissue with spheres had a sensitivity and specificity of 81% with 
one latent variable. The labelled bands highlighted through the VIP heat 
maps (Figure 4-7A) consisted of protein assignments with 874 cm-1 being a 
collagen assignment with assignments shown in Table 4-4). 
 
Table 4-4 Band Assignments for bands highlighted in the PLS-DA VIP heatmaps 
comparing tissue groups from the aortic valve and aorta. *collagen assignment
 
1595-1720 
 
The PLS-DA model used in the comparison of healthy tissue with mineral spheres to 
neighbour tissue with mineral spheres had a sensitivity and specificity of 67% with 
three latent variables. The Raman spectral bands highlighted through the VIP 
heatmaps are protein assignments (Figure 4-7B) with assignments shown in Table 
4-4. 
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The PLS-DA model used in the comparison of healthy tissue with mineral spheres to 
plaque tissue with mineral spheres resulted in a sensitivity and specificity of 79% 
with two latent variables. The labelled bands highlighted through the VIP heat maps 
(Figure 4-7C) included protein and lipid assignments. The 2848 cm-1 highlighted peak 
indicates a change in the amount of lipids between the sample groups. Corresponding 
Raman spectral band assignments are shown in Table 4-4. 
 
The PLS-DA model used in the comparison of neighbour tissue containing mineral 
spheres to plaque tissue containing mineral spheres resulted in a sensitivity and 
specificity of 79% using three latent variables. The labelled bands highlighted through 
the VIP heat maps (Figure 4-7D) include protein and lipid assignments with the 2848 
cm-1 highlighted band indicating a change in the amount of lipids between the 
compared sample groups. Corresponding Raman spectral assignments are shown in 
Table 4-4. 
 
Spectra collected from human aortic valves calcified samples and human bone 
samples contained several identifiable mineral peaks including the 960 cm-1 apatite 
(PO4) peak and the 1070 cm-1 type B carbonate (CO3) peak.  Bone samples 
demonstrated a lower full width at half maximum of the 960 cm-1 apatite (PO4) peak 
when compared to calcified valve samples suggesting bone is more crystalline 
(p<0.05) when compared to compact calcification  (Table 4-5). 
 
Table 4-5 Raman phosphate peak area and FWHM comparison between human 
bone and mineralized aortic valve cusps. *significantly different from bone 
(p<0.005) 
 
 
4.5 Discussion 
Cardiovascular calcification is a growing global concern projected to increase with 
longer life expectancies. It is highly correlated with cardiovascular disease and is a 
significant predictor of cardiovascular events [46]. Cardiovascular calcification disease 
pathogenesis is still unclear and under intense investigation.  Microscopic mineral 
 108 
spheres found in all stages of cardiovascular calcification disease progression have 
been identified and characterised by Bertazzo et al [51]. These spherical mineral 
deposits are a common mineral inclusion in valvular and vascular calcification with 
their role, if any, in disease progression yet to be determined. Important questions 
remain on the introduction, influence and impact of such microscopic spherical 
inorganic deposits as they exist embedded in an organic matrix within cardiovascular 
tissue before macroscopic mineral deposits are observed. This study investigated the 
biomolecular environments surrounding these spherical microscopic mineral 
inclusions in the human aortae and aortic valve cusps through the use of Raman 
micro-spectroscopy aiming to expose any protein differences colocalised with these 
spherical deposits.    
 
Raman spectra were collected from microscopic regions of human aortic valves and 
aortae ranging in visual tissue states (healthy, neighbouring, plaque, or calcified) and 
microscopic mineral inclusion (no mineral, microscopic spherical, or compact 
calcification). The resulting Raman spectra were classified as protein rich, lipid rich or 
mineral rich based on their molecular signatures. Raman spectra including mineral 
signatures were only found in samples which contained compact calcification. This 
suggests only compact calcification was above the sensitivity limit of the Raman 
spectroscopy as applied in this study. Samples containing microscopic mineral 
spheres without compact calcification showed no identifiable mineral peaks in the 
resulting Raman spectra. Tissue samples without spherical mineral deposits did not 
produce any lipid or mineral rich Raman spectra. Protein rich Raman spectra were 
found in all visibly determined tissue states (healthy, neighbour, plaque, calcified) 
which contained spheres in both the aortic valve and aorta samples. Protein rich and 
lipid rich spectra were found in more visual tissue states in the aortic samples than 
the aortic valve. Difference between the Raman spectral environments collected 
between aortic and aortic valve samples may be due to their distinct structural 
difference or the possible divergence in the evolution of vascular and valvular 
calcification.  Protein rich Raman spectra were collected from healthy tissue without 
mineral inclusions, healthy tissue with microscopic spherical mineral inclusions, 
neighbouring tissue with mineral spheres and plaque tissue with mineral spheres. 
These protein rich spectra were then compared to examine any changes in the 
biomolecular environment surrounding the spherical microscopic mineral presence in 
aortae and aortic valves. 
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Aortic valve calcification disease progression includes the abnormal distribution and 
organization of extracellular matrix (ECM) proteins. Inflammation, ECM remodelling, 
and cellular transdifferentiation have all been implicated as potential precursors to 
the osteoblast like cellular mineralisation found in the late stages of the disease. 
Distinct protein differences were found when comparing healthy aortic cusp tissue 
without mineral inclusions to neighbour tissue (being visually healthy however 
adjacent to diseased tissue) with microscopic spherical mineral inclusions. The Raman 
spectral bands distinguishing between these experimental groups include collagen 
specific assignments (874 and 1043 cm-1) implying collagen alterations between the 
two groups. The fibrosa is the tissue layer of the aortic valve in which aortic valve 
calcification is thought to initiate. It is a collagen rich layer closest to the aorta and 
early stages of aortic valve calcification have been reported to include a collagen 
disruption in valvular tissue undergoing microscopic abnormal processes. Fibrosis is 
increasingly implicated as a possible contributor to pathogenesis of calcified aortic 
valve disease [147]. The results here suggest a possible ECM modification and 
specifically collagen differences between healthy aortic cusp tissue without mineral 
inclusions and visually healthy tissue with microscopic spherical mineral inclusions.  
 
Healthy aortic valve tissue without mineral inclusions and neighbour tissue containing 
mineral spheres displayed proteinaceous and lipid differences when compared to 
plaque tissue containing the mineral spherical deposits. Analysis comparing healthy 
aortic cusp tissue to plaque tissue highlighted collagen alterations in bands 855, 934 
and 1335 cm-1. Interestingly, these bands differ from the bands highlighted in 
comparing healthy (without mineral inclusions) and neighbouring tissue (with 
mineral spheres) suggesting perhaps a molecularly different type of collagen 
alteration and or collagen environmental alteration. Lipid differences were found to 
be significant in discriminating between the healthy and neighbour tissue from plaque 
tissue. The introduction of lipid differences is likely due to the known lipid inclusions 
found in plaques formed in cardiovascular disease and are heavily associated with 
fatty streaks and plaque architecture. Spectral band differences found to distinguish 
plaque tissue from healthy and neighbouring tissue also included the 2848 and 2849 
cm-1 peaks signifying a change in the amount of lipids. These differences echo the 
widely reported environmental lipid constituents of plaques found in cardiovascular 
tissues.  
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Protein differences were found surrounding the microscopic spherical mineral 
deposits within visually undisturbed tissue when compared to tissue without mineral 
deposits proposing a colocalised change in the ECM around these microscopic 
spherical mineral deposits. However, this does not implicate any causality or 
relationship between mineral sphere inclusion and early fibrotic stages of 
cardiovascular calcification. In the aortic cusp, microscopic mineral spheres were 
found in almost all samples as the donors for this particular study consisted of many 
individuals past their fourth decade of life and thus mostly with some form of 
cardiovascular disruption (thickened aortic valve cusps, fatty streaks in vasculature, 
etc.). It is important to note however, although there is an increase in cardiovascular 
events with age, cardiovascular calcification is an active regulated process cannot be 
considered an inevitable, irreversible senile disorder. With larger scale (compact) 
calcification being a known implication of higher risks of a cardiovascular events 
[153], it remains to be determined if microscopic mineral deposits play a role in or are 
could be an early sign of a disruption in cardiovascular tissue. The results of this study 
suggest a change in proteins and specifically collagen in the aortic cusp accompanying 
the mineral deposits. Further investigations should be performed to determine if a 
relationship exists between a deviation from ‘healthy’ ECM production and 
maintenance and the mineral spheres inclusion surrounding protein changes 
described here. 
 
The aortic tissue micro-mineral environment characterisation exposed many tissue 
areas which were healthy in appearance, not adjacent to any regions visually 
disturbed and contained microscopic mineral sphere inclusions. The comparison of 
healthy aortic tissue with and without spheres suggests protein changes with the 874 
cm-1 band specifically identifying a collagen change. This is same Raman band and 
thus type of collagen bond change seen to distinguish healthy aortic cusp tissue 
without mineral inclusions and neighbouring tissue containing mineral spheres. This 
suggests the mineral spheres may be colocalised with a protein and particularly a 
specific type of collagen change in both tissues types. Protein changes were observed 
between healthy aortic tissue with mineral spheres and neighbouring tissue with 
mineral spheres. The protein differences found between these two groups showed 
with a distinct lack of collagen assignment specific changes. This lack of collagen 
assignment differences leads to an interesting observation of collagen specific changes 
being identified between tissues without sphere and tissue with spheres, however 
when the spheres are present, there appears to be protein changes which are not 
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specifically collagen induced. With the known role of collagen disruption in 
atherosclerosis and cardiovascular calcification [146,157-159], the possible 
distinction of collagen changes accompanying these microscopic mineral spherical 
deposits is critical as this suggests an alteration from the normal healthy state.  
 
Aortic plaque tissue with mineral spheres compared to both healthy tissues and 
neighbouring tissue with mineral spheres exposed changes in protein, lipid, and the 
amount of lipids as expected with the known lipid inclusions in vascular 
plaques[154,157].  
 
Previously Bertazzo et al. applied immunogold-labelling of cardiovascular tissue for 
early and late stage osteoblastic transcription factors in cardiovascular tissues 
containing these microscopic mineral spherical inclusions. The results suggested the 
presence of spherical particles may precede the appearance of mature osteoblastic 
cells and the localization of spherical particles may contribute to early osteoblastic 
transdifferentiation or alternatively, the expression of early osteoblastic markers may 
lead to the localization of these spherical particles. The protein and specifically 
collagen changes observed in this study are local to the spheres in an environment 
shown to contain cells with early osteoblastic markers. It is well reported that 
collagen alteration is associated with initial stages of bone mineralisation [164]. 
Compact calcified deposits are found colocalised with mature osteoblasts and display 
mineral Raman peaks. Raman spectroscopic identification of mineral produced by 
mature osteoblasts is has been previously demonstrated and even seen in mineralized 
nodules formed from osteoblasts in culture [12,30,165]. 
 
Not all Raman spectral bands highlighted in the PLS-DA VIP score plots were 
highlighted and extracted for classification and comparison between the sample 
groups. Often these spectral bands highlighted did not correspond to Raman peaks or 
bands found in the collected spectra. Bands highlighted in regions where a strong 
signal was not present may be exposing differences in background and more 
susceptible to noise. Although pre-processing techniques were applied to reduce the 
influence of background signals in the spectral analysis some fluorescence from the 
tissue remains. Raman peaks/bands highlighted in the PLS-DA VIP score plots which 
were not well described or observed in biological tissue Raman spectra literature 
were not included in the discussed comparisons between groups. The biological finger 
print region of Raman spectra is very well described and reported on and therefore 
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more confidence was placed into peaks and bands which are well supported in 
literature. The multitude of bonds, molecular environments and various vibrational 
frequencies associated with those molecular bonds can hinder analysis due to 
overlaps, multiple bond assignments and peak shifting. The selected VIP highlighted 
bands discussed in this study were well reported in literature, components found in 
cardiovascular tissue, and displayed a peak/band intensity suggesting the signal was 
from the excited sample. 
 
The SEM micrographs collected in this investigation from the aortic valve and aorta 
further echo the discoveries stated in Bertazzo et al.’s paper regarding the presence of 
these spheres in unremarkable cardiovascular tissue [51]. The application of Raman 
spectroscopy here further supports the initiative to apply materials science 
techniques to provide insight into the calcified environments in cardiovascular 
disease. Raman spectroscopy has been extensively used in bone mineralisation studies 
and is a useful tool for the rapid and non-invasive characterisation and comparison of 
mineralised tissues.  As applied here the sensitivity of Raman spectroscopy may be 
exploited to give a biomolecular fingerprint of tissue regions of interest surrounding 
the microscopic mineral sphere inclusions without being overrun by the sharp 
mineral peaks found in compact calcification. 
 
Raman spectroscopy confirms a mineral presence in the aortic valve cusps with 
inorganic mineral peaks clearly present in compact calcification.  Human aortic cusp 
mineralization does however vary from human bone as shown by a significant 
difference in their crystallinity.  Calcified aortic valve spectra showed a greater 
variation in the apatite peak area and shape in comparison to bone, suggesting a 
heterogeneous mineral environment is present.  Comparison of the mineral 
environment detected by Raman spectroscopy and that observed by electron 
microscopy confirm only ‘compact’ mineralisation is within the sensitivity limits of 
Raman spectroscopy as applied here. The spheres are below the sensitivity limit of the 
Raman spectroscopy in this study and therefore the Raman spectra show their 
encapsulation in fibrous and or lipid rich tissue.  The mineralised Raman spectra 
therefore do not reflect the highly crystalline nature of the spheres but instead 
demonstrate that compact calcification is more amorphous than human bone. This is 
may be a result of the difference between ectopic cellular mineralisation in 
cardiovascular calcification and the highly regulated and organised bone matrix 
mineralisation.  
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4.6 Conclusions 
Raman spectroscopy was combined with SEM to provide information on the 
biomolecular environment surrounding microscopic, spherical mineral deposits found 
within aortic valve and aortic tissue. The protein environments surrounding 
microscopic spherical mineral particles were compared and analysed using PLS-DA 
VIP score plots. The results demonstrated a change in the ECM and particularly in the 
collagen colocalised with the tissue containing microscopic spherical mineral deposits. 
A specific collagen alteration highlighted at 874 cm-1 was found in both aortic and 
aortic valve tissue to distinguish between tissues containing microscopic mineral 
spheres and those without. Lipid rich and protein differences were observed as 
distinguishing factors in comparing plaques tissue from healthy and neighbor tissue 
samples. This study warrants further investigations into the local environment 
surrounding these microscopic mineral deposits and the inclusion of Raman 
spectroscopy to better identify and compare the wide range of biomolecular 
environments found in cardiovascular calcification. 
4.7 Future Work 
The donor population presented in this study included a range of ages and both sexes 
however, the population distribution included in these studies needs to be expanded 
to fully understand the range of environments which may exist colocalised with the 
spherical mineral deposits of interest. The patients included in this study were all 
from a relatively small geographical area and thus a myriad of associated confounders 
such as culture, diet, access to healthcare, etc. could affect a study like the one present 
here comparing broad spectrum diseases like cardiovascular calcification. Strict 
access to tissue further limits the populations available for study. An initial step in any 
further studies should attempt to secure tissue donors from a wider array of locations, 
ages and conditions.  
 
This study suggests the spherical mineralised particles may be colocalised with 
collagen and protein changes deviating from healthy tissue without these mineral 
inclusions. This does somewhat assume cardiovascular tissue containing these 
mineral spheres are not ‘healthy’. Additionally neighbour tissue may be assumed to be 
more susceptible to alteration due to its proximity to disturbed lesions however this is 
not always the case. If the completely healthy tissue contains spheres which are not 
associated with any disruptive or pathological processes,  the comparisons found here 
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may allude to variations in healthy protein environments.  There remains intensive 
literature support suggesting fibrosis, changes in the ECM, and collagen environments 
specifically occur at early stages of the cardiovascular disease leading to calcification 
[157-159]. At a minimum the results shown in this study call for further investigation 
as to the significance of these protein changes and any relationships they may have 
with pathological protein changes. 
 
In future studies it would be interesting to investigate the presence of these 
microscopic spherical mineral inclusions in cellular or animal models associated with 
cardiovascular calcification. Chapter 3 investigated a PAVICs ‘calcified’ model and 
found no mineralisation present within the cultured nodules. The TEM applied in the 
PAVICs study found no spherical mineral inclusions however there were distinctly less 
images taken than in this study and by Bertazzo et al. in which entire tissue areas 
were scanned. Ultimately animal models showing vascular and valvular disruption 
could also be analysed using the material science techniques described in these 
studies to learn more about the microscopic mineral inclusions and their associated 
consequences. 
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5 Raman Spectroscopic Evidence of Tissue 
Restructuring in Heat-Induced Tissue Fusion 
5.1 Abstract 
Heat-induced tissue fusion via radio-frequency (RF) energy has gained wide 
acceptance clinically for blood vessel fusion and is being considered for bowel 
anastomosis. This is the first optical-Raman-spectroscopy study on tissue fusion 
samples in vitro. This study provides direct insights into tissue constituent and 
structural changes on the molecular level, exposing spectroscopic evidence for the loss 
of distinct collagen fibres rich tissue layers as well as the denaturing and restructuring 
of collagen crosslinks due to RF fusion. Raman spectroscopic maps of the cross section 
tissue of RF fused tissue is compared to adjacent histological sections and gives 
further insight into the distinct collagen environment changes between health and 
fused tissue within the same sample. Multivariate analytical methods were used to 
determine the collagen spectral fingerprint in each reason to allow for direct 
comparison of the collagen in each mapped region. Raman spectral changes indicative 
of collagen thermal denaturing were observed in RF fused tissues including the shift of 
the 1252-1261 cm-1 peak to lower frequencies in RF fused tissues demonstrated a 
collagen crosslink disruptions and the significant shift of the amide I, 1660cm-1 band 
to higher wavenumbers in RF fused tissues indicative of the increase in reducible 
crosslinks and a decrease in non-reducible crosslinks within collagen. These findings 
additionally open the door for more advanced optical feedback-control methods and 
characterization during heat-induced tissue fusion, which may lead to new clinical 
applications of this promising technology. 
5.2 Introduction 
Tissue sealing and reconnection are routine surgical procedures. Among other 
technologies, heat-induced tissue fusion using radio-frequency (RF) energy has 
attained wide acceptance. In surgery, RF based blood vessel sealing has been clinically 
approved [166,167], e.g., the RF bipolar vessel sealer (LigaSureTM, Covidien, USA). 
More recently, significant research efforts have been made to develop new fusion 
instruments for other tissue types, e.g. intestinal tissues during bowel anastomosis to 
replace traditional hand suturing or stapling [168-170]. This technology exploits the 
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heat-induced fusion of native tissues to achieve high-quality rapid tissue sealing 
without introducing foreign materials (i.e., sutures, staples, clips, or glue) and is 
expected to greatly reduce morbidity, mortality and cost. 
  
Anastomotic leaks are some of the most dreaded complication after colorectal surgery. 
Consequences for patients include agonizing abdominal pain, tachycardia, high fevers 
and a rigid abdomen often accompanying hemodynamic instability. In these cases the 
patent is urgently returned to the operation theatre for peritoneal washout and faecal 
diversion with prolonged stays in the intensive care unit. Additionally these 
complications are not always found early in the postoperative period and can be 
diagnosed late in the postoperative period [171]. Considering these concerns, RF 
fusion technology provides the advantage of a fast, technically undemanding, 
haemostatic procedure which could dramatically reduce the resulting trauma and 
complications for the patient [169]. 
 
The mechanism for heat-induced tissue fusion, particularly for blood vessel sealing, 
has been discussed in many studies [167,169,170,172]. The RF tissue fusion here 
consists of clamping tissue ends between two electrodes while holding the opposing 
faces under a compression pressure (CP). A controlled RF voltage is then applied so an 
induced current generates heat via the Joule effect. Heat-induced tissue fusion is 
believed to be the result of the simultaneously applied heat and CP. Changes in 
collagen bonds within the fused tissue are thought to be pivotal to the strength of the 
resulting fusion. It is widely accepted that heat denatures collagen to a gel-like 
amalgam, which then forms strong bonds between neighbouring tissues[167,172]. 
The existing characterization and analysis, however, have been mainly made on either 
direct microscopic observation or mechanical strength testing. The lack of 
understanding at the molecular and cellular levels has left several important questions 
in this field unresolved. Critically it is still unclear as how the collagen changes within 
the fused tissue during heat-induced RF tissue fusion and the precise mechanism for 
the formation of the strong seal. Answering these questions will provide a better 
understanding and knowledge of the intrinsic mechanisms for RF tissue fusion and 
also help to develop more effective control methods for RF fusion procedures. 
Furthermore, the main challenge in intestinal tissue anastomosis is achieving effective 
control over the delivered energy to form a successful fusion without causing 
excessive thermal tissue damage. This requires a better understanding of the fusion 
mechanism and more importantly, the development of effective feedback technologies 
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to control the fusion procedure. Therefore, more advanced techniques are in great 
demand to study RF tissue fusion on the cellular and molecular levels. 
 
Raman spectroscopy provides an attractive way of rapidly capturing the molecular 
environment of tissues without destroying or altering the samples [173-176]. Raman 
micro-spectroscopy generates information-rich spectra which, when combined with 
chemometrics, provides powerful insight into the molecular diversity within 
heterogeneous biological samples [87,177]. Proteins have been studied extensively 
using Raman spectroscopy as information regarding the amino acids, amide bonds 
between them and their tertiary structure can be extracted and analysed [178,179].  
In particular, Raman spectroscopy has been used to identify changes within isolated 
animal collagen during thermal and chemical denaturing [180,181].  These studies 
provide a molecular fingerprint to identify collagen and demonstrate the powerful 
ability of Raman spectroscopy to expose specific molecular changes within collagen.  
Additionally, it is possible to deconstruct individual contributors, such as collagen, 
from an overall tissue sample for characterisation and comparison [182]. By scanning 
across an area of interest, the individual Raman spectrum at each acquisition point 
can be combined to form a Raman map, which is similar to a microscopic image but 
with the ability to focus on certain chemical markers within the imaged area. The 
Raman map provides a direct observation of molecular distributions, such as that of 
collagen fibres, within a sampled area. 
 
In this current study, for the first time, is demonstrated the use of Raman 
spectroscopy to characterize RF tissue fusion in vitro. Tissue fusion was performed 
with two tissue types, namely porcine blood vessels and small intestines, and assessed 
the seal quality based on the mechanical strength of the seal given by burst pressure 
(BP) testing. Porcine blood vessels were used as RF tissue fusion of blood vessels is 
established and clinically approved. The Raman spectra were acquired from fusion 
samples characterized as either having a strong seals or weak seals, and conducted 
Raman mapping across fusion regions. Correlation between the Raman results and the 
mechanical strength of the seals was investigated, and the differences at the molecular 
level examined. The Raman maps were compared with conventional histopathology 
microscopic results to assess whether they were superior in characterizing RF tissue 
fusion due to the rich molecular information contained in fused tissue Raman spectra. 
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5.3 Materials and Methods 
5.3.1 Animal Tissue Preparation 
Fresh porcine small bowels were obtained from a local abattoir, cut into 20-30 cm 
long segments, moistened with physiological saline and refrigerated at 4ᵒC for up to 
30 hours (from the time of slaughter) until needed for fusion experiments. Prior to the 
fusion experiment, sufficiently long tissue samples were selected and immediately 
dissected into 5 cm long pieces for tissue fusion experiment. Prepared 5 cm samples 
were kept hydrated in sealed plastic sample bags with saline and used within 30 
minutes. Porcine blood vessels were cleaned, cut into 6 cm long pieces, and then 
immediately frozen in liquid nitrogen within 4 hours from the time the animal was 
slaughtered. The frozen tissues were kept at -70ᵒC. Frozen blood vessel samples were 
only thawed at room temperature immediately before the tissue fusion experiment. 
Sample preparation was carried out by Dr. Lei Su. 
5.3.2 Radio Frequency Tissue Fusion 
RF energy was used as the source for tissue heating in this study. The RF generator 
was an energy research tool prototype developed by Covidien (Boulder, Colorado), 
capable of delivering a programmable sinusoidal current from 0-7 A and a power from 
0-350 W. An operating RF frequency of 472 kHz was chosen to avoid neuromuscular 
stimulation and electrocution. Two tissue sealing devices were used: a commercially 
available LigaSure™ Impact (Covidien) for blood vessel sealing and an anastomosis 
prototype for small bowel sealing (Figure 5-1). Pre-written RF energy control 
algorithms were loaded into the RF generator using fusion software written in 
LabVIEW (National Instruments) so that the entire procedure could be automated. 
The algorithm was designed to control RF energy delivery to achieve tissue heating 
and the applied energy was controlled using feedback from the measured tissue 
impedance to maintain a specific variation in impedance with time. RF fusion device 
modification and tissue fusion was performed by Dr. Lei Su. 
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Figure 5-1 Radio frequency tissue fusion prototype. (a) LigaSure™ Impact fusion 
device for blood vessel sealing, (b) anastomosis prototype fusion device for 
small bowel sealing, and (c) RF tissue fusion setup. 
During fusion, the tissue samples were clamped between the jaws of the fusion device. 
RF energy was supplied by the RF generator and applied to tissue samples via 
electrodes in jaws. The RF generator also continuously monitored both voltage and 
current delivered to the tissue. The varying tissue impedance was then obtained by 
using real-time voltage and current readouts. A compression spring in the handle of 
the LigaSureTM Impact device provided a constant pressure of ~0.3 MPa, and an air 
compressor was connected to the prototype, supplying a variable CP from 0–0.5 MPa. 
More than 200 tissue fusions were performed in the experiment. 
5.3.3 Temperature Measurements 
Tissue temperature was measured using a fine (0.005 inch) tip Teflon-insulated J-type 
thermocouple (5TC-TT-J-36-36, Omega Engineering, Bridgeport, New Jersey). The 
thermocouple was inserted through slits present on the sealing device jaws and glued 
in place so that its tip protruded 0.25 mm above the electrode surface. In this way the 
thermocouple was in contact with the tissue surface without piercing it whilst 
remaining insulated from the electrode. The communication between the 
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thermocouple and the computer was achieved through a National Instruments (NI) 
PXI-6289 DAQ board and a NI SCC-68 terminal block. The latter hosted four NI SCC-
TC02 Thermocouple Signal Conditioning Modules. Each SCC-TC02 could drive one 
thermocouple and had individual signal conditioning modules with a 2 Hz low-pass 
filter, which filtered out the RF signal and eliminated the RF interference from the 
thermocouple readout. 
 
There were in total more than 200 porcine small-bowel fusion temperature profiles 
recorded and only a few of these samples were provided for the investigation 
described here. The embedded thermocouple recorded a two stage evolution in tissue 
temperature evolution during fusion: a rapid increase in tissue temperature within a 
few seconds followed by a relatively stable plateau where the tissue temperature 
variation was within the range of ± 5°C. The tissue temperature was determined by 
the impedance control algorithm. A steep rising slope significantly reduces the 
duration of the whole procedure and a higher plateau temperature in the range 
between 60°C to 90°C ensures the necessary collagen denaturation in the tissue 
[167,172], which is believed to be essential for a strong fusion. Plateau temperatures 
below 60°C may not lead to the denaturation of collagens, while excessive 
temperatures need to be avoided as they lead to permanent damage of the tissue or 
necrosis. Temperature measurements were performed by Dr. Lei Su. 
5.3.4 Sample Preparation and Imaging 
Tissue samples were stored at -80°C, following fusion. Thawed samples were trimmed 
and embedded in optimal cutting temperature medium (OCT, Tissue-Tek, Sakura, 
Torrance, California) by flash freezing in isopentane at -160°C. The OCT blocks were 
sectioned on a cryostat at -20°C, cutting 15 µm sections for histology and Raman 
spectroscopy. Sections for histology were mounted on glass, washed with water to 
remove the OCT, and stained with haematoxylin and eosin (H&E). Sections for Raman 
analysis were mounted on MgF2 slides, stored at 4°C, and imaged without further 
processing. Visualisation of the H&E-stained sections was performed under 4x 
magnification on an Olympus IX51 inverted light microscope, captured digitally and 
spliced together to allow visualisation of the entire field. Sample preparation for 
imaging was performed by Joseph Steele. 
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5.3.5 Raman Micro-spectroscopy 
Tissue Raman maps were collected with a 785 nm laser, using a Renishaw InVia 
spectrometer connected to a Leica microscope as previously described [183]. A 100x 
(NA = 0.9) objective (Leica, U.K.) was used. Raman maps were collected over selected 
regions of interest with a step size of 75 µm in the x and y direction. At each point a 
spectrum was collected using five accumulations of five second scans covering the 
Raman shifts range of 620-1700 cm-1. Samples were tested for no longer than 1 hour 
at room temperature and kept hydrated using saline. 
 
Raman spectra were pre-processed for background removal (baseline subtraction 
using weighted least squares) [184] and multiplicative scattering correction 
[185,186]. The N-FINDR spectral unmixing algorithm was used as it searches the 
original input spectra, from the non-dimension reduced input matrix, for the most 
extreme spectra present and exposes these as endmembers. These endmembers were 
then identified based on their spectral features as pure contributing component of the 
tissue (in this study, the endmember corresponding to the collagen within the tissue 
was of interest). After the identification of each relevant endmember a Raman map 
was constructed with each pixel represented as a linear combination of the 
endmembers as previously described [44]. Each pixel thus contains an abundance 
value between 0 and 1 for the presence of each endmember within the pixel’s 
spectrum [44].  
 
Raman peak shift univariate comparisons are shown as mean ± standard deviation. A 
two-sided Wilcoxon rank sum test with a p-value < 0.05 was used to determine 
statistical significance. 
 
The peak labels found in the Raman spectra presented in this chapter are 
representative of the peaks found in literature and may be slightly shifted from the 
precise peak positions found in the spectral means displayed. The following study 
utilized an edge filter in the Raman instrumentation replacing the notch filter 
originally described in the introduction before the study began. The instrumentation 
did not change during the course of this study. 
5.3.6 Burst Pressure Measurements 
The mechanical strength of the fused tissue was evaluated by a burst pressure (BP) 
testing system. This system consisted of a syringe pump, a pressure gauge, a sample 
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injection needle and a surgical clamp to close the small bowel tissue. The main arm of 
a Y-splitter tubing system was connected to a water-filled syringe controlled by the 
syringe pump. The other two split arms were connected to the pressure gauge and the 
sample injection needle, respectively. The surgical clamp sealed the other end of the 
piece of fused small bowel. The sample injection needle pierced the small bowel tissue 
to allow water to be injected into the sealed bowel without damaging the seal. After 
the initiation of the BP test, the syringe pump drove the water filled syringe to provide 
a flow rate of 20 mL/min, which constantly increased the pressure in the tubing 
system as well as in the fused tissue. Eventually the fused tissue burst at the fusion 
line, and the peak pressure was recorded as the BP.  
 
More than 200 porcine small bowel segments were fused for BP testing in a parallel 
study. As reported elsewhere [187], the BP, as an indication of the fusion mechanical 
strength, varied significantly with the change of CP during fusion. Tissue samples 
fused at CPs lower than 0.10 MPa displayed an average BP of ~10 mmHg, while 
samples fused at higher CPs (>0.10 MPa) showed an average BP of more than 20 
mmHg. Increased burst pressures were observed at all CP values above 0.10 MPa. 
These BP results served as a guideline for planning the Raman experiments carried 
out in this work with samples fused at three CPs (0, 0.2 and 0.3 MPa) selected for 
analysis in order to understand the resulting differences in fusion strength. For blood 
vessel samples, a commercial LigaSureTM Impact fusion device was employed with a 
fixed value of ~0.3 MPa. The average BP for the blood vessels was above 100 mmHg, 
higher than for small bowel samples due to differences in the tissue and devices used. 
Burst pressure measurements were performed by Dr. Lei Su and colleagues. 
 
5.4 Results 
5.4.1 Raman Micro-spectroscopy Results 
RF fused blood vessels and small bowel samples fused at different CPs were imaged 
using Raman spectroscopy. Raman maps were collected from selected regions within 
the tissue cross-sections including fused areas, undisturbed and thus considered 
‘healthy’ areas, and the interface between them. Raman maps of selected regions are 
shown for a fused porcine blood vessel at 0.3 MPa compression (Figure 5-2) and 
porcine blood vessels (Figure 5-3) fused (a) without compression, (b) with 0.2 MPa 
compression and (c) with 0.3 MPa compression. A white light micrograph showing the 
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cross section of each tissue sample is shown in each figure (Figure 5-2 and Figure 5-3, 
top left of the figure) with rectangular boxes highlighting the areas that were mapped 
by Raman. The three areas which were selected for mapping included (Figure 5-2 and 
Figure 5-3A) healthy tissue, (Figure 5-2 and Figure 5-3B) the interface between 
healthy and fused tissues and (Figure 5-3 and Figure 5-3C) fused tissues. The resulting 
Raman map and the endmember spectra identified in the sample and used to 
construct the Raman map are shown in Figure 5-2 and Figure 5-3A-C. All Raman maps 
shown were reconstructed from the two endmember as shown in spectra in each 
panel. 
 
 
 
Figure 5-2 Raman spectroscopy maps collected from within a porcine blood 
vessel tissue at the locations indicated in the white light micrograph (shown in 
the top left, scale bar = 1 mm). Mapped regions included (a) healthy tissue, (b) 
interface between fused and healthy tissues and (c) fused tissue. White light 
images of each area selected for Raman mapping are shown in sections [a-c] 
(scale bar = 250 µm) together with their corresponding Raman map shown in 
the red, green and black images. The spectra included in [a-c] shows the 
collagen endmember spectrum in red with the intensity of the red colouring in 
the Raman maps corresponding to the presence of collagen within that pixel. 
The non-collagen rich tissue endmember spectrum is shown in green and the 
intensity of the colour green in the Raman map corresponds to the presence of 
non-collagen rich tissue within that pixel. 
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Figure 5-3 Raman maps collected over porcine bowel tissue selections (each 
shown in the top left white light micrograph, scale bar = 1 mm) with (a) no 
compression (b) compression at 0.2 MPa and (c) compression at 0.3 MPa. In 
each case mapped regions included [A] healthy, [B] interface between fused and 
healthy and [C] fused tissue. For each sub-region white light images of the area 
selected for Raman mapping are presented [A-C] (scale bar = 250 µm) together 
with their corresponding Raman maps shown in the red, green and black 
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images. The spectra show the collagen endmember spectrum in red  and the 
non-collagen rich endmember spectrum is shown in green, and the intensities of 
red and green within the Raman maps are proportional to these signals. 
The bottom spectrum (in red) representing the identified collagen endmember 
spectrum within the sample and the top spectrum (in green) presents the non-
collagen rich tissue constituent. The collagen endmember spectrum identified by the 
N-finder algorithm in each map includes all the characteristic features previously 
reported in Raman spectroscopy studies of collagen and collagen rich tissues [188]. 
Specifically, Raman bands corresponding to C-C stretch of proline (855 cm-1), C-C 
stretch of hydroxyproline (874 cm-1), C-N stretch of proline (919 cm-1), proline (1043 
cm-1), and Amide III (1245-1270 cm-1) are notable [188]. The hydroxyproline and two 
proline peaks identified in these spectra are specifically Raman collagen assignments 
[188] confirming a collagen presence. The endmember spectrum which was identified 
to be non-collagen rich tissue included spectral features indicative of biological tissue 
including bands corresponding to cholesterols (699 cm-1), phenylalanine (1003 cm-1), 
C-H deformation of proteins (1262 cm-1) and carbohydrates (1342 cm-1), and amide I 
(1660 cm-1) [24]. 
 
The mean of all spectra collected from the healthy and fused areas of the blood vessel 
which underwent RF fusion and the bowel tissues which underwent RF fusion at 0 
MPa, 0.2 MPa and 0.3MPa CP are shown in Figure 5-4. In both the blood vessel and the 
bowel tissues a shift in the peak maximum occurred in the 1660 cm-1 Amide I band 
and a change in band shape was observed in the 1443 cm-1 C-H2 wag band compared 
with the fused mean spectrum from the healthy mean spectrum in each sample. Many 
peaks, including the 940 cm-1 peak representing the protein alpha helix did not appear 
to change peak position or shape. Fused bowel tissue demonstrated a significant shift in 
the Amide I band to higher wavenumbers in all CPs and corresponding burst pressures as 
shown in Figure 5-5. 
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Figure 5-4 Mean Raman spectra of healthy and fused tissue areas mapped in 
porcine blood vessel and bowel tissue. Each spectrum labelled ‘healthy’ 
represents the mean of all collected spectra from an undisturbed cross section 
of the tissue. Each spectrum labelled ‘fused’ represents the mean of all collected 
spectra from the fused cross section of the tissue. Grey spectra were collected 
from porcine blood vessel tissue with and without radio frequency fusion as 
labeled. Spectra shown in black were collected from porcine bowel tissue with 
the corresponding compression pressure labelled (in the healthy spectrum, the 
pressure of the adjacent fused tissue is indicated in the label). Raman 940 cm-1, 
1443 cm-1 and 1655 cm-1 peaks are highlighted corresponding to the protein 
alpha helix, CH2 wag, and the Amide I C-N-H stretch respectively. 
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Figure 5-5 Amide I peak maximum Raman shift (cm-1) location in bowel tissue 
samples comparing healthy and fused tissue. Samples were fused with 0, 0.2, 
and 0.3 MPa compression pressure and the corresponding burst pressure is in 
parenthesis. *p-value < 0.05.   
 
Changes specifically in the collagen rich environments were investigated through a 
threshold analysis using the endmembers identified with the N-FINDR algorithm. 
Spectra showing an abundance value greater than 0.6 of the collagen rich endmember 
were selected and the means of these spectra were then calculated for each map. 
These means were then compared between healthy and fused areas to identify 
changes in the collagen environment due to fusion via a difference spectrum (Figure 
5-6). Fused porcine blood vessel tissue showed the changes in the 1252-1261 cm-1 
peaks and a shift to lower wavenumbers in the 1447 cm-1 peak. The 1600-1650 cm-1 
Amide I band showed a shift to higher wavenumbers. For the bowel tissues, different 
changes were noted corresponding to different fusion CPs, however, only the samples 
which were fused with no compression and at 0.2 MPa compression were used for 
comparison as only these sample maps included more than three spectra which met 
the threshold requirements. The changes in the collagen rich spectra between fused 
and healthy areas were less pronounced in the porcine bowel tissue samples when 
compared to fused blood vessels. Bowel tissue fused at 0.2 MPa CP demonstrated 
similar but less distinct trends in the protein band shifts to the blood vessel results, 
specifically in the three broad protein bands, 1245-1270, 1445, and 1660 cm-1 
corresponding to the Amide III, CH2 bending and Amide I bands respectively. In bowel 
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tissue fused without compression band shift trends included the 1245 and 1660 cm-1 
Amide III and Amide I band, respectively, however less dramatic shifts were seen in 
other protein bands (Figure 5-6). 
 
 
 
Figure 5-6 Difference Raman spectra of healthy - fused collagen rich tissue areas 
from (a) RF fused porcine blood vessel and (b) RF fused porcine bowel tissue 
without compression and (c) 0.20 MPa compression pressure. The red line 
indicates a zero difference. The 1313 cm-1, 1324 cm-1, 1252-1261 cm-1 and 1600-
1690 cm-1 peaks are highlighted corresponding to the CH3CH2 twisting and 
wagging mode of collagen (respectively), amide III, and amide I (non-reducible 
collagen crosslinks at lower wavenumbers and reducible collagen crosslinks at 
higher wavenumbers) respectively. 
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5.4.2 Histopathology Results 
In Figure 5-7, the histopathology results are presented for a porcine blood vessel and 
porcine small bowels fused at different CPs. A reduction in the thickness and the loss 
of distinct tissue layering is observed in the fused porcine blood vessels as expected 
(Figure 5-7 (a)). A seal appears to have formed between the upper and lower small-
bowel pieces for the porcine small bowel tissue sample fused at no compression 
pressure, as shown in Figure 5-7(b)  although the boundary between these two layers 
can still be seen. The three layers of small bowel tissue: serosa, submucosa and 
mucosa layers can be clearly identified and the delimitations between different layers 
are apparent. Although the tissue thickness was reduced at the mucosa layer, the 
tissue structure remains similar to the native tissue. Figure 5-7(c) and (d) show 
porcine small-bowel samples fused at CPs of 0.2 and 0.3 MPa. Relative to Figure 
5-7(b), Figure 5-7(c) and (d) display significant changes in the tissue structure 
resulting from the applied CP. The delimitation between submucosa and mucosa 
layers is less clear and the thickness of the mucosa layer has reduced considerably. 
Most important, a more homogeneous amalgam was formed by the upper and the 
lower mucosa layers in the centre of the fusion region, and the boundary between the 
upper and the lower mucosa layers has completely disappeared. 
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Figure 5-7 H&E staining of a fused porcine blood vessel and bowel tissues. (a) 
porcine blood vessel; (b) porcine small-bowel sample fused at 0 MPa; (c) 
porcine small-bowel sample fused at 0.2 MPa; and (d) porcine small-bowel 
sample fused at 0.3 MPa CP. 
 
5.5 Discussion 
RF tissue fusion is a mature technology for blood-vessel sealing in modern surgery 
which holds great promise to reduce some of the critical complications in existing 
bowel anastomosis procedures including post-operative bleeding and leakage. Here 
we investigated the use of Raman spectroscopy to provide biomolecular insights into 
the restructuring which occurs during tissue fusion. Raman results were linked to 
optimal fusion parameters (CP in particular) obtained by comparing to the BP test 
results and histological sections. 
 
Raman spectroscopy was conducted in order to explain the observed changes in 
mechanical strength shown in the BP measurement of fusions when CP was changed. 
Raman spectroscopy was applied to non-invasively image cross sections of healthy 
and fused tissue as shown in Figure 5-2 and Figure 5-3. Applying N-FINDR spectral 
unmixing allowed for visualisation of the various bowel tissue layers by identification 
of the endmember spectra which are defined by the most extreme spectra present 
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within the map [189]. The tissue layers identifiable through Raman spectroscopy 
correspond to those layers seen in the white light micrographs and in the histological 
sections by utilizing only two endmember spectra, one corresponding to a high 
collagen contribution and the other to non-collagen rich tissue. Raman spectroscopic 
maps were reconstructed from the two endmembers with endmember abundance 
plots overlaid and converted to red-green colour images based of the contribution of 
each endmember to each collected spectrum. The submucosal layer is clearly 
distinguished in each small intestinal cross section by its increased collagen content. 
During sectioning of the intestinal tissue, the shear force caused some separation of 
the healthy tissue sublayers (serosa, submucosa and mucosa). In Figure 5-3(a) A, the 
loss of the serosa is clearly visible in the white light micrograph and the 
corresponding Raman map. The collagen rich submucosa is located between the 
mucosa and serosa. The mucosa and serosa are shown to include many of the Raman 
spectral signatures of biological tissues including cells (DNA peaks included) and the 
extracellular matrix. Collagen Raman signature bands are found in the mucosa and 
serosa layers as well, however these layers appear to be less collagen rich with a 
greater cellular contribution corresponding to the known constituents of these tissue 
layers. 
 
Previous reports have suggested that changes in collagen were significant in RF fusion 
[190,191]. To further explore this we compared the collagen rich spectra from healthy 
and fused tissue. In order to perform this analysis the collagen rich spectra were 
identified as those having an abundance value greater than 0.6 for the collagen 
endmember spectrum found in each Raman map. The mean of all spectra which were 
identified to be predominantly collagen was then calculated and the healthy and fused 
tissue collagen was compared through the difference spectra of these collagen means 
as shown in Figure 5-6. This analysis was performed on both fused porcine blood 
vessels as well as fused porcine bowel tissue. The difference spectrum comparing 
areas of fusion to healthy tissue in blood vessels showed similar band shifts and thus 
biomolecular bond changes in two independent samples. These trends included the 
denaturing of collagen shown through the significant shift of the peak maximum in the 
1655 cm-1 Amide I band to higher wavenumbers in the fused tissue area, also 
suggesting an increase in reducible crosslinks and a decrease of non-reducible cross 
links within the collagen [192]. Additionally a shift in the 1302 cm-1 peak to higher 
wavenumbers has been previously reported in collagen thermal denaturing [181]. 
Changes in the 1313 cm-1 and 1324 cm-1 peaks signifying changes in the CH3CH2 
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twisting and wagging modes of collagen also demonstrated a disruption to the native 
collagen [193,194]. Lastly the apparent shift of the 1252-1261 cm-1 peaks to lower 
frequencies also implicate that crosslinks may have been reduced or broken [165]. RF 
fusion of the porcine bowel tissue demonstrated less pronounced differences however 
fusion performed at 0.2 MPa compression pressure demonstrated many of the same 
changes, including shifts in the 1252-1261, 1313, 1324, 1443, and 1655 cm-1 bands, as 
seen in the fused blood vessels, again indicating a denaturing of collagen and more 
specifically a decrease in non-reducible cross links and an increase in reducible cross 
links as seen in Figure 5-6(c). 
 
Histopathology results show the fused tissue area to be thinner and lacking the tissue 
layers visible in healthy tissue. The merging and restructuring of the biochemical 
constituents of the tissue layers in the bowel tissue during RF tissue fusion with CP is 
also demonstrated in the Raman maps. At 0 MPa CP, the fused area is visibly thicker, 
and the tissue layers are still distinct as shown with the white light images and 
histology. The Raman map shows this again with the collagen rich layers remaining 
very distinct and encased by non-collagen rich layers as seen in Figure 5-3(b and c). As 
the CP was increased to 0.2 MPa, the greatly reduced thickness of the fused area made 
it hard to visually distinguish whether the native tissue layers were still preserved 
post RF fusion. The Raman map indicated a collagen rich upper and lower layer in 
some areas of the fused region and less distinguishable collagen layering in other 
areas (Figure 5-3(b)). Furthermore at 0.3 MPa CP there was no distinct layering of 
collagen rich and non-collagen rich regions within the fused tissue and collagen rich 
areas are found throughout the thin fused area. The collagen within the fused region 
of samples which underwent compression also demonstrated collagen cross linking 
modification and collagen amide bond modification which were not detected in tissue 
fused without compression as seen in the Raman results. When comparing these 
results to the burst pressure measurements, it is notable that both the 0.2 MPa and 0.3 
MPa CP fused tissues showed median burst pressures of more than 20 mmHg. The 
correlation of higher burst pressures in the compressed fused tissue samples with less 
distinct tissue layering and a change in collagen crosslinking supports the hypothesis 
that collagen crosslinking modification via RF fusion plays an important role in the 
overall quality of the tissue fusion. 
 
H&E histological stains of the porcine small intestinal tissue showed that fusion 
without compression produced a decrease in the tissue cross sectional thickness 
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however the tissue layers and band structures appeared to remain much like that of 
the native state and produced a median burst pressure of less than 10 mmHg. RF 
fusion performed with accompanying compression showed a dramatic reduction in 
fused tissue thickness and significant changes in the tissue layers with the 
delimitation between the submucosa and mucosa layers becoming less distinguishable 
as seen in Figure 5-3 and Figure 5-7. Additionally, the upper and lower mucosa of the 
fused tissue became indistinguishable from one another in the histological sections, 
white light micrographs and Raman maps. Fusion is therefore demonstrated by the 
unification of the mucosa during fusion along with the increase in burst pressure. 
 
Tissue fused without compression appears to undergo some molecular restructuring 
as indicated in the mean plots (Figure 5-4) and shown in the Amide I maximum peak 
shift in Figure 5-5 may be expected due to exposure to higher temperatures. This 
molecular restructuring appears to be less collagen dependent as shown in the Raman 
difference plots in Figure 5-6(b) with the collagen difference spectrum highlighting 
fewer distinct band shifts in compressed tissue versus non-compressed tissue. This 
may be attributed to more collagen bond restructuring with the additional mechanical 
pressure during fusion introduced with tissue compression.  
 
Particular consideration to Raman spectral background changes was taken during the 
analysis of the Raman tissue maps as fibre and water content may alter the Raman 
background signal. A polynomial fit was used to remove the background and spectra 
were normalised before comparing means directly or through difference spectra. 
Changes within the Raman spectral backgrounds were in line with expectations with 
the fused regions being denser, less hydrated and less organised into distinct tissue 
layers. Some of the difference spectra were not considered (namely 0.3 MPa CP) as 
those tissue areas showed less than three spectra with an abundance value greater 
than 0.6 for the collagen rich endmembers. When comparing difference spectra it is 
also important to note that the collected Raman spectra are semi-quantitative thus 
general trends (peak shifts and shape changes) are important rather than absolute 
intensity differences. Future studies using a smaller mapping step sizes and/or a 
larger tissue section may be considered to improve upon these challenges. 
5.6 Conclusions 
For the first time the use of Raman spectroscopy to characterize fused tissues in RF 
heat-induced tissue fusion was proposed and demonstrated. It was discovered that 
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tissue restructuring, or more specifically tissue layer and collagen molecular 
restructuring in the fusion areas, seems to be a contributing mechanism for a strong 
fusion. These results suggest a decrease in non-reducible collagen crosslinks and an 
increase in reducible collagen crosslinks occur during fusion. These changes are 
associated with collagen undergoing heat treatment and this restructuring provides 
new insight into the effects of RF fusion on the biochemical changes in the native 
collagen. Additionally, the presence of compression pressure during fusion produced a 
difference in collagen restructuring. Tissues fused with compression showed an 
increase in collagen transformation while tissues fused without compression showed 
collagen changes associated with a heat treatment.  
 
The correlation between the Raman maps and the histological maps supports the 
utilisation of Raman spectroscopy in the investigation of RF fusion quality and tissue 
restructuring. Raman spectroscopy allowed for highly spatially resolved mapping 
which provided biochemical information without suffering from hydration and tissue 
density changes between the healthy and fused tissue. The information rich nature of 
the collected Raman spectra combined with multivariate statistical analysis allowed 
the selection and comparison of the collagen content between tissue sections of 
interest. These high resolution maps were collected from four independent samples 
and further studies are required to fully describe the molecular changes occurring 
during fusion. The abilities of Raman mapping are of further interest when 
investigations of RF fusion and comparable techniques are compared in situ and in 
vivo. Raman microscopy has been demonstrated to be translatable into the clinical 
setting [195-197]. Thus the rapid, non-destructive, hydration and dehydration-
compatible technique utilised in this study holds promise to further elicit information 
in the translation of the technique to bowel anastomoses. 
 
Overall these insights are the first to demonstrate the previously suspected 
involvement of collagen in RF tissue fusion, both with and without concurrent 
compression, using Raman spectroscopy. These molecular insights help provide 
information on the transformation occurring due to RF fusion as well as inspiration 
for future investigations into optical feedback methods. 
5.7 Future Works 
The work presented in this study demonstrates the ability of Raman spectroscopy to 
be non-invasively applied to tissues of interest and deliver biomolecular insights 
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through multivariate analysis. The potential of the regular use of Raman spectroscopy 
in a clinical and more specifically surgical setting increases with technological 
advancements serving to improve the collection and analytical power of Raman 
spectroscopy. There are many factors to consider when applying this technology to 
the clinical arena including the confidence of the results and the ease in translation of 
the high dimensional datasets into medically relevant information. Raman 
spectroscopic probes have already shown demonstrated ability to collect information 
in vivo in studies including intravascular atherosclerosis testing  [16], gastrointestinal 
tissues during routine clinical endoscopy [17], cervical normal and abnormal cells 
[18], and intraoperative margin assessment of breast tissue during partial 
mastectomy procedures [198] to highlight a few. 
 
Transferring Raman spectroscopy from a microscopic in vitro environment to in vivo 
real time diagnostics takes advantage of ability to deliver and collect light via optical 
fibres which can be incorporated into catheters, endoscopes, cannulas, needles, and in 
this previous study, the RF fusion device. Raman spectroscopy has a demonstrated 
ability to image chemical changes in tissues which may be useful in cases where a 
biopsy cannot be readily performed, such as in coronary artery disease and 
Alzheimer’s. The option of a non-invasive follow up or confirmation technique may 
reduce the incident of false positive screenings leading to unnecessary medical 
procedures. Utilizing Raman spectroscopy to analyse tissue during the development 
and confirmation of this RF tissue fusion device also serves the purpose of building up 
a dataset, confirming the ability of Raman to analyse fused and healthy tissue, and 
allows for the consideration of Raman probe in the next generation to device designs.  
 
The Raman spectra in this study were collected over carefully prepared sections of 
tissue allowing for a microscopic inspection. This aided in the analysis and allowed for 
a direct comparison to histology. Even with this preparation, each mapped area 
underwent independent analysis so as to alleviate the potential background influence 
which may be introduced due to sample thickness variation, focal depth and 
differences arising from sample preparation and sectioning. The continuation of using 
Raman spectroscopy on samples undergoing RF fusion would allow for the 
establishment of a spectral database and the determination of more robust analytical 
techniques which would help select potential methods for moving forward into in vivo 
imaging. 
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6 Conclusions and Future Work 
Raman micro-spectroscopy is continuing to prove to be a powerful technique in 
providing molecular insight into biological studies. Throughout this thesis Raman 
micro-spectroscopy has demonstrated the ability to further expose chemical 
differences or similarities between experimental groups of interest.  
 
Analytical tools which help researchers visualize critical differences between subject 
groups were explored in this thesis. Three studies demonstrated how PLS-DA VIP 
score plots can capture the changes across the entire interrogated spectral range in an 
‘easy to read’ manner. The studies supporting the incorporation of PLS-DA VIP score 
plots included examining HeLa cells in various states (live, fixed, dehydrated, and 
rehydrated), osteoportic vs. healthy bone, and human cardiovascular tissue in various 
conditions. These studies helped to establish PLS-DA VIP score plots are useful to the 
visualization of spectral ranges which distinguish between groups however these 
ranges must be further translated into molecular changes which requires a certain 
degree of interpretation. This suggests this technique may be best accompanied by 
complimentary techniques to expose which spectral ranges to prioritize for 
investigation despite the intensity found in these heatmaps. This is demonstrated in 
the HeLa cells study as spectral regions highlighted between groups included protein, 
phospholipids, lipids, and DNA changes as expected based on literature however a 
prioritization of changes beyond an increase or decrease in content were not 
achieved. When applied to human calcified cardiovascular tissue each highlighted 
region was further researched and specific (often high intensity on the PLS-DA VIP 
heatmap) spectral regions thus molecular changes where identified however not 
immediately using these ‘easy to read’ plots. 
 
A large part of the work presented here focused specifically on aortic valve 
calcification with some work on vascular calcification. A PAVICs study provided 
information on the distinct lack of calcification in a model used previously to 
represent ‘calcified’ nodules which is a critical insight for further use of these systems 
and similar model systems. Additionally this study identified the abundant production 
of type I collagen within these nodular systems. This study met the aim to characterize 
the PAVICs cellular system with respects of interrogating the mineral and organic 
content. The resulting identified components may help future studies determine the 
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appropriate place, if any, for this cellar system as a model of aortic valve disease 
progression. 
 
A calcified human cardiovascular tissue study was performed in an effort to determine 
if changes were occurring in the organic matrix surrounding microscopic mineral 
inclusions (which were recently discovered and characterized) and if so, aimed to 
identify some of these changes. Changes were identified in the Raman spectra which 
distinguished between tissues with and without these microscopic mineral inclusions. 
This helped to satisfy one objective by suggesting organic changes where occurring 
colocalised with the microscopic mineral deposits. The second objective of identifying 
these changes leaves some room for further study. Spectral features were identified 
suggesting collagen changes are occurring in tissues containing microscopic mineral 
spheres in comparison to those without. This helps to identify one potential candidate 
for further study however other candidates and the significance of this potential 
collagen change was not determined. 
 
Raman microscopic mapping was utilized in different parts of this thesis to provide a 
more granular perspective to biological systems including the previously mentioned 
PAVICs in vitro nodules and heat induced tissue fusion. In the tissue fusion study, the 
mapping allowed for the comparison of healthy independent bowel segments and 
fused tissue sections exposing the collagen restructuring occurring post tissue fusion. 
The collagen restructuring identified in this study was specifically collagen crosslink 
changes in the way of increased reducible crosslinks and decreased non-reducible 
cross links. Further study is required however to fully reach the aim of identifying if 
these changes are responsible for the integrity of the strong seal which is formed 
when tissue is fused in this manner. 
 
Some suggestions for future research from each study in this thesis are outlined at the 
end of each chapter. The following section briefly addresses some general trends and 
possible future directions for Raman micro-spectroscopy in biological and clinical 
studies. 
 138 
6.1 Using accessible tools for the analysis of Raman 
spectroscopic results 
The work presented in this thesis demonstrates the application potential of Raman 
spectroscopy as well as its ability to test live in vitro cellular models, classify human 
tissue of interest, and determine the biomolecular differences in tissue samples which 
are diseased or undergoing treatment. Additionally new ways of visualizing and 
interpreting multivariate analytical results are shown for the ease of determining the 
biomolecular features which are most important when comparing sample groups. 
There remain careful considerations when applying this powerful technique to future 
biological studies including the continuation of the works presented in this thesis. 
 
The challenges of analysing and interpreting the data rich Raman spectra collected 
from biological samples have been highlighted extensively in this thesis. The 
techniques and tools used to overcome these challenges differ between researchers. 
There is an extensive range in the tools used for preprocessing and modelling which 
often are tailored for the study of interest but also vary for the personal preference 
and familiarity of the research group. In chapter 2 of this thesis there is a discussion 
on the way to portray the VIP scores and the heat maps were one of several options 
including a simple 2D plot alongside the mean spectra or as demonstrated in the Xia 
and Wishart’s paper, a list of spectral component highlighted on the y-axis and the VIP 
scored on the X-axis [101]. The flexibility in the analysis allows for tailoring to the 
great range of biological samples however does have drawbacks in the ability to 
compare, fairly, various studies of similar materials.  
 
The work in this thesis often used commercially available software such as the 
PLS_toolbox from Eigenvector research. Although at times it was determined 
necessary to use in-house written scripts and sometimes a hybrid between in house 
written scripts and commercial toolboxes, there are distinct advantages to using the 
commercial software. The use of commercial software allows for more ready 
reproducibility by other research groups interested in a similar type of analysis and 
also allows for a better discussion on the results with such groups. Additionally the 
toolboxes used are not used solely for Raman spectral analysis and thus the 
advancements made in other research arenas can more easily be translated into 
Raman spectral analysis if incorporating the same platforms. Finally if and when 
Raman systems are incorporated into surgical or cell culture environments there are 
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advantages to using commercial software as it has already been applied to studies 
establishing Raman spectroscopic imaging of tissues as seen in this thesis and other 
studies using Raman spectroscopic systems in vivo [14,17]. 
   
6.2  Raman micro-spectroscopy in monitoring live cells in 
culture 
The advantages of utilizing Raman spectroscopy in biological application include its 
ability to rapidly, non-invasively collect a wealth of chemical data from hydrated 
samples. In the studies provided in this thesis Raman spectroscopy was performed 
before the samples were then taken for further complimentary testing with labelling, 
altering, or destructive techniques (staining, SEM imaging, FIB, etc.). The advantages 
to subsequent testing are it offers complimentary information on the same sample and 
further validation of points of interest.  This does however leave time course studies 
to be performed on independent samples as ultimately Raman testing was conducted 
in a non-sterile environment leaving the samples exposed to contaminates which 
disallows for further culture. Additionally there is a substrate consideration as the 
substrates best used for Raman are less cell compatible as tissue culture plastic and 
more expensive.  
 
In future studies with various time points or continuous monitoring is necessary, 
Raman spectroscopy can still be used independently to provide biomolecular feedback 
in-vitro and in-vivo without a need to sacrifice those samples. A study by Pascut et al. 
recently demonstrated this by monitoring the cardiac differentiation of human 
embryonic stem cells in-vitro in purpose-built micro-bioreactors used on the Raman 
microscope for five days [10]. This study also included time-course mapping of 
embryoid bodies and ultimately demonstrated the ability of in-situ non-invasive 
monitoring of cells cultured in vitro. Many researchers from this study also reported 
dramatically reducing the time it takes to phenotypically identify human embryonic 
stems cells which would also may aid in the quest for utilizing Raman spectroscopy in 
cell sorting application [199]. Taken together these studies and others are showcasing 
another dimension in utilizing Raman spectroscopy as a powerful tool in cell culture 
[200-202]. Many challenges of robustly incorporating this technology in cell culture 
environments include maintaining sterile conditions so multiple cultures could be 
imaged using the same instrument, producing easy-to-read results and the seamless 
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integration of the Raman system with equipment already used in the lab 
(microscopes, cell culture hoods, etc.). 
6.3 Raman spectroscopic imaging of Rheumatic fever 
cardiac valves 
An opportunity to collaborate with a hospital in Aswan, Egypt to investigate 
Rheumatic fever samples which would be placed in 4% PFA and transferred to the 
London, U.K. arose and a few samples were transferred across for initial testing. 
Within the tissue of these samples a form of precipitation occurred which is still 
unidentifiable. This precipitation showed distinct peaks in the collected Raman 
spectra and distinct features in SEM micrographs. There were many factors which 
could have contributed to such a sample distortion, namely the lack of temperature 
controlled storage and transportation of both the solutions for fixation and of the 
samples within the fixative. The potential extreme heat cycling and the transportation 
delays lead to many possibilities for alteration to occur. The Raman spectral peaks of 
the unidentified precipitates are shown in Appendix B along with SEM micrographs of 
those regions as collected by Dr. Sergio Bertazzo. This preliminary investigation 
served to identify potential conflicts and also served to demonstrate the ability of 
Raman spectroscopy to expose the content diversity in samples which are not visually 
detectable. 
6.4 Caveat regarding cardiovascular calcification and 
mechanics 
An important caveat within the investigations of cardiovascular calcification 
presented in this thesis is the absence of monitoring of the biomechanical 
contributions to disease and model progression. The biomechanical factors including 
shear stress due to blood flow, radial vessel pressure, alterations due to ECM 
modifications and mineral deposits, and many more were excluded as they are  
independently widely studies areas. Although they are not thoroughly mentioned, it is 
important to make clear their undeniable influence in cardiovascular pathology and 
almost certain relationship to the diseased processes and possibly specific 
mechanisms discussed in this thesis. Ultimately the molecular level insight provided 
within this thesis may help describe and be described by the contributing mechanical 
factors which are known accompanying players in cardiovascular disease. 
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6.5 Selection of Raman instrumentation based on 
application and interest 
The microscopic mineral inclusions found within cardiovascular tissues, diseased and 
visually undisrupted ranged in size from 100nm to 5µm in diameter and were found 
to be surrounded in a protein rich matrix in visually unperturbed tissues. Using the 
Raman spectroscopic system described and applied here, the microscopic mineral 
inclusions were often below the detection limit and sensitivity threshold of the 
instrumentation. This ‘invisibility’ was utilised to study the protein rich environment 
surrounding these mineral deposits and exposed protein changes, and specifically 
collagen alterations occurring around them. Alternative Raman instrumentation is 
able to detect such microscopic mineral inclusions as recently reported by Pilarczyk et 
al. [203].  Pilarczyk et al. utilised a high spatial resolution Raman spectroscopic system 
with confocal depth proﬁling for the direct imaging of these microscopic mineral 
deposits. The collected Raman spectroscopic information was used to identify and 
classify the mineral deposits found within human aortic valve tissues focusing on the 
inorganic rather than the organic. Interestingly their study echoed the suggestion of 
these microscopic spherical mineral inclusions occurring at very early stages of aortic 
valve calcification.  Alternative Raman systems and types of Raman spectroscopy were 
not described in depth in this text however, it is important to note the application of 
various systems and adaptations of Raman spectroscopy can provide complimentary 
molecular level information.  
6.6 Applying Raman spectroscopy to Biological Studies 
Raman spectroscopy was applied to the imaging of live Hela cells in vitro, human bone 
tissue, PAVICs nodules in vitro, human aortic valve and aortic tissue, and porcine 
blood vessel and bowel tissue. The results demonstrated the rapid, non-invasive, 
biocompatible nature of Raman spectroscopy, the information rich spectra which are 
collected, and the sophisticated analysis techniques which are applied to translate 
those spectral datasets into biologically meaningful information. The inclusion of 
Raman spectroscopy within each study added a dimension of visualisation exposing 
protein changes, mineral differences, lipid differences, and distinguishing molecular 
alterations between seemingly very similar experimental groups. Looking forward, 
the diversity and range of Raman spectroscopy will undoubtedly expand to meet the 
many needs of biological research.  
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Appendix 2 
 
Rheumatic Fever Heart Disease, Calcified Valve Artefacts 
 
Rheumatic fever (RFev) is an inflammatory disease which develops as a complication of 
inadequately treated infections. RFev can cause permanent damage to heart including 
damaged heart valves and heart failure.  Incidences of RFev have dramatically declined in the 
developed world partially due accessible medical facilities and anti-biotic treatments. In the 
developing world RFev remains a major medical and social problem including the complication 
of heart valve sclerosis and stenosis. The scientific interest on RFev has notably diminished 
despite its continued prevalence in the developing world [204]. A potential collaboration with 
an Egyptian hospital was explored to see the feasibility in transporting calcified valves to 
London for Raman spectroscopic testing. The following information is a brief account of one 
major consideration of possible precipitates or artefact introduction in such a study and 
demonstrated the ability of Raman spectroscopy to detect material differences in tissue 
samples. 
 
Samples preparation: 
Human aortic valves surgically removed for replacement were collected for research. Samples 
were stored in Formalin (time stored uncertain), dehydrated through a graded ethanol series, 
and lastly stored in desiccators until imaging. 
 
Raman Spectral measurement: 
Raman spectra were collected using the Raman system as described in the introduction. Briefly 
a modified Renishaw InVia Raman dispersive spectrometer system (Renishaw, Wotton-under-
Edge, Gloucestershire, UK) connected to a Leica microscope with a 50x objective.  The 
excitation source was a 785 nm diode line focus laser with ~300 mW at source, ~120mW 
before objective and ~100mW at sample.   The sample volume illuminated at the focal plane is 
roughly elliptical in shape with a minor axis of x≈10 µm, major axis of y≈20 µm and axial 
resolution of z≈30 µm.   
 
Point Spectral collection: 
Each spectrum was collected using 10% laser power, 5 second exposure, 5 accumulations per 
measurement.  Analysis was performed using Matlab R2010b (Mathworks).  Spectra were 
normalized, background subtracted, smoothed and baseline removed.   
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Results: 
Samples from 11 patients were selected for analysis.  From visible inspection these ranged in 
degrees of calcification with many showing no visible calcification.  A total of 198 spectra were 
collected from these 11 samples for comparison.  Three spectral environments were identified 
as shown in figure 1 including protein rich (figure 1A), mineral rich (figure 1B), and a third 
unidentified material (figure 1C). SEM micrographs were collected from the same tissue 
samples post Raman imaging. The material producing the unidentified Raman spectral 
fingerprint is shown in figure 2. 
 
 
 
Figure 1: Mean spectra from three environments present in the Rheumatic fever samples received 
from Egypt.  A. Spectrum displaying typical cellular and extracellular matrix peaks.  B. Spectrum 
displaying strong sharp apatite peak at 960cm-1.  Blue arrow in B apatite PO4 peak C. Spectrum 
displaying mineral peaks, such as apatite however showing sharp peaks not displayed in A. or B. 
which corresponds to previously reported peaks found in mineral precipitates.  Red arrows in C. 
indicate peaks which expose possible precipitates. 
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Figure 2: Two SEM micrographs of inorganic crystal deposition found in calcified RF valves as 
collected and prepared from a hospital in Egypt. Scale bar = 1µm. 
 
Discussion: 
 
Raman spectra collected from the calcified RF valves presented three main 
biomolecular environments, tissue (rich in protein peaks), apatite (calcium phosphate 
and calcium phosphate peaks) and an environment not previously associated with soft 
tissues or phosphate species.  The Raman spectra collected from tissue without 
mineralisation yielded protein rich peaks associated with biological spectra including 
855, 874, 1003, 1235-1239, 1480-1575 cm-1 corresponding to proline, 
hydroxyproline, phenylalanine, amide III, and amide I respectively [24] and s seen 
previously in chapter 4. The 960 and 1070 cm-1 apatite and carbonate peaks 
respectively were found in Raman spectra collected from hard deposits within the 
tissue of the RF calcified valves and are comparable to those observed in chapter 4. In 
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contrast to those environments previously identified in cardiac valves with Raman 
spectroscopy, a third Raman spectral fingerprint appeared showing strong, sharp 
peaks in location which have been previously identified with calcium carbonates 
however not collectively with the relative intensities shown [205]. A sharp peak at 
1065 cm-1 appears which is in range of a peak previously identified as amorphous 
calcium carbonate [206,207]. The peaks shown in the unidentified material do no 
correspond to any found PFA peaks. 
 
Conclusions: 
 
The undefined material found in the calcified RF valves compromised all spectra 
collected from this collection of cardiac valves. Further study using these valves would 
have to undergo strict chemical, temporal, and temperature controls in order to avoid 
further artefact introduction. Raman spectra were very useful to determine alterations 
in the cardiac valve material suggesting it is a useful too not only in the 
characterisation of material environments but also for the detection of contaminates 
within biological tissues. 
 148 
References 
1. Raman CV (1928) A new type of secondary radiation. Nature 121: 501. 
2. (2013) Nobel Prize in Physics 1930 - Presentation Speech. 
3. Notingher I, Jell G, Lohbauer U, Salih V, Hench LL (2004) In situ non‐invasive spectral 
discrimination between bone cell phenotypes used in tissue engineering. Journal 
of cellular biochemistry 92: 1180-1192. 
4. Notingher I, Verrier S, Romanska H, Bishop A, Polak J, et al. (2002) In situ 
characterisation of living cells by Raman spectroscopy. Spectroscopy: An 
International Journal 16: 43-51. 
5. Campion A, Kambhampati P (1998) Surface-enhanced Raman scattering. Chemical 
Society Reviews 27: 241-250. 
6. Otto A, Mrozek I, Grabhorn H, Akemann W (1992) Surface-enhanced Raman scattering. 
Journal of Physics: Condensed Matter 4: 1143. 
7. Tolles WM, Nibler J, McDonald J, Harvey A (1977) A review of the theory and application 
of coherent anti-Stokes Raman spectroscopy (CARS). Applied spectroscopy 31: 
253-271. 
8. Yuratich M, Hanna D (1977) Coherent anti-Stokes Raman spectroscopy (CARS) Selection 
rules, depolarization ratios and rotational structure. Molecular Physics 33: 671-
682. 
9. Cloyd KL, El-Hamamsy I, Boonrungsiman S, Hedegaard M, Gentleman E, et al. (2012) 
Characterization of Porcine Aortic Valvular Interstitial Cell ‘Calcified’ Nodules. PLoS 
ONE 7: e48154. 
10. Pascut FC, Kalra S, George V, Welch N, Denning C, et al. (2013) Non-invasive label-free 
monitoring the cardiac differentiation of human embryonic stem cells in-vitro by 
Raman spectroscopy. Biochimica et Biophysica Acta (BBA) - General Subjects 1830: 
3517-3524. 
11. Notingher I, Bisson I, Bishop AE, Randle WL, Polak JMP, et al. (2004) In Situ Spectral 
Monitoring of mRNA Translation in Embryonic Stem Cells during Differentiation in 
Vitro. Analytical Chemistry 76: 3185-3193. 
12. Gentleman E, Swain RJ, Evans ND, Boonrungsiman S, Jell G, et al. (2009) Comparative 
materials differences revealed in engineered bone as a function of cell-specific 
differentiation. Nat Mater 8: 763-770. 
 149 
13. Shetty G, Kendall C, Shepherd N, Stone N, Barr H (2006) Raman spectroscopy: 
elucidation of biochemical changes in carcinogenesis of oesophagus. British 
journal of cancer 94: 1460-1464. 
14. Molckovsky A, Song L-MWK, Shim MG, Marcon NE, Wilson BC (2003) Diagnostic 
potential of near-infrared Raman spectroscopy in the colon: Differentiating 
adenomatous from hyperplastic polyps. Gastrointestinal Endoscopy 57: 396-402. 
15. Shim MG, Wilson BC, Marple E, Wach M (1999) Study of Fiber-Optic Probes for in Vivo 
Medical Raman Spectroscopy. Appl Spectrosc 53: 619-627. 
16. Buschman HP, Marple ET, Wach ML, Bennett B, Bakker Schut TC, et al. (2000) In Vivo 
Determination of the Molecular Composition of Artery Wall by Intravascular 
Raman Spectroscopy. Analytical Chemistry 72: 3771-3775. 
17. Shim MG, Wong Kee Song L-M, Marcon NE, Wilson BC (2000) In vivo Near-infrared 
Raman Spectroscopy: Demonstration of Feasibility During Clinical Gastrointestinal 
Endoscopy Photochemistry and Photobiology 72: 146-150. 
18. Utzinger U, Heintzelman DL, Mahadevan-Jansen A, Malpica A, Follen M, et al. (2001) 
Near-Infrared Raman Spectroscopy for in Vivo Detection of Cervical Precancers. 
Appl Spectrosc 55: 955-959. 
19. Hanlon EB, Manoharan R, Koo TW, Shafer KE, Motz JT, et al. (2000) Prospects for in 
vivo Raman spectroscopy. Physics in Medicine and Biology 45: R1. 
20. Manoharan R, Wang Y, Feld MS (1996) Histochemical analysis of biological tissues 
using Raman spectroscopy. Spectrochimica Acta Part A: Molecular and 
Biomolecular Spectroscopy 52: 215-249. 
21. Lord RC, Yu N-t (1970) Laser-excited Raman spectroscopy of biomolecules: I. Native 
lysozyme and its constituent amino acids. Journal of Molecular Biology 50: 509-
524. 
22. Rothschild KJ, Andrew JR, De Grip WJ, Stanley HE (1976) Opsin structure probed by 
Raman spectroscopy of photoreceptor membranes. Science 191: 1176-1178. 
23. Prescott B, Steinmetz W, Thomas GJ (1984) Characterization of DNA structures by laser 
Raman spectroscopy. Biopolymers 23: 235-256. 
24. Movasaghi Z, Rehman S, Rehman IU (2007) Raman Spectroscopy of Biological Tissues. 
Applied Spectroscopy Reviews 42: 493-541. 
25. Tarnowski CP, Ignelzi MA, Morris MD (2002) Mineralization of developing mouse 
calvaria as revealed by Raman microspectroscopy. Journal of Bone and Mineral 
Research 17: 1118-1126. 
 150 
26. Gough J, Notingher I, Hench L (2004) Osteoblast attachment and mineralized nodule 
formation on rough and smooth 45S5 bioactive glass monoliths. Journal of 
Biomedical Materials Research Part A 68: 640-650. 
27. Boskey AL, Mendelsohn R (2005) Infrared spectroscopic characterization of 
mineralized tissues. Vibrational spectroscopy 38: 107-114. 
28. Penel G, Leroy G, Rey C, Bres E (1998) MicroRaman spectral study of the PO4 and CO3 
vibrational modes in synthetic and biological apatites. Calcified tissue 
international 63: 475-481. 
29. Swain RJ (2008) Non-invasive biochemical analysis of cells, tissues and tissue 
constructs with Raman micro-spectroscopy [Ph.D.]. London, U.K.: Imperial College 
London. 
30. Carden A, Morris MD (2000) Application of vibrational spectroscopy to the study of 
mineralized tissues (review). Journal of Biomedical Optics 5: 259-268. 
31. Akkus O, Adar F, Schaffler MB (2004) Age-related changes in physicochemical 
properties of mineral crystals are related to impaired mechanical function of 
cortical bone. Bone 34: 443-453. 
32. Draper ER, Morris MD, Camacho NP, Matousek P, Towrie M, et al. (2005) Novel 
Assessment of Bone Using Time‐Resolved Transcutaneous Raman Spectroscopy. 
Journal of Bone and Mineral Research 20: 1968-1972. 
33. Awonusi A (2007) Carbonate assignment and calibration in the Raman spectrum of 
apatite. Calcified tissue international 81: 46. 
34. Savitzky A, Golay MJE (1964) Smoothing and Differentiation of Data by Simplified Least 
Squares Procedures. Analytical Chemistry 36: 1627-1639. 
35. Lieber CA, Mahadevan-Jansen A (2003) Automated Method for Subtraction of 
Fluorescence from Biological Raman Spectra. Appl Spectrosc 57: 1363-1367. 
36. Martens H, Nielsen JP, Engelsen SB (2003) Light Scattering and Light Absorbance 
Separated by Extended Multiplicative Signal Correction. Application to Near-
Infrared Transmission Analysis of Powder Mixtures. Analytical Chemistry 75: 394-
404. 
37. Wold S, Sjöström M, Eriksson L (2001) PLS-regression: a basic tool of chemometrics. 
Chemometrics and Intelligent Laboratory Systems 58: 109-130. 
38. Barker M, Rayens W (2003) Partial least squares for discrimination. Journal of 
Chemometrics 17: 166-173. 
 151 
39. Hedegaard M, Krafft C, Ditzel HJ, Johansen LE, Hassing S, et al. (2010) Discriminating 
isogenic cancer cells and identifying altered unsaturated fatty acid content as 
associated with metastasis status, using k-means clustering and partial least 
squares-discriminant analysis of Raman maps. Analytical Chemistry 82: 2797-2802. 
40. Heraud P, Wood BR, Beardall J, McNaughton D (2006) Effects of pre-processing of 
Raman spectra on in vivo classification of nutrient status of microalgal cells. 
Journal of Chemometrics 20: 193-197. 
41. Mello C, Ribeiro D, Novaes F, Poppi RJ (2005) Rapid differentiation among bacteria that 
cause gastroenteritis by use of low-resolution Raman spectroscopy and PLS 
discriminant analysis. Analytical and Bioanalytical Chemistry 383: 701-706. 
42. Palermo G, Piraino P, Zucht H-D (2009) Performance of PLS regression coefficients in 
selecting variables for each response of a multivariate PLS for omics-type data. 
Advances and applications in bioinformatics and chemistry: AABC 2: 57. 
43. Matthäus C, Chernenko T, Quintero L, Milan L, Kale A, et al. (2008) Raman microscopic 
imaging of cells and applications monitoring the uptake of drug delivery systems. 
699106-699106. 
44. Hedegaard M, Matthäus C, Hassing S, Krafft C, Diem M, et al. (2011) Spectral unmixing 
and clustering algorithms for assessment of single cells by Raman microscopic 
imaging. Theoretical Chemistry Accounts 130: 1249-1260. 
45. Butler D (2011) UN targets top killers. Nature 477: 260-261. 
46. Speer MY, Giachelli CM (2004) Regulation of cardiovascular calcification. 
Cardiovascular Pathology 13: 63-70. 
47. Boström K, Watson K, Horn S, Wortham C, Herman I, et al. (1993) Bone morphogenetic 
protein expression in human atherosclerotic lesions. Journal of Clinical 
Investigation 91: 1800. 
48. Mohler ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, et al. (2001) Bone 
Formation and Inflammation in Cardiac Valves. Circulation 103: 1522-1528. 
49. Miller JD (2013) Cardiovascular calcification: Orbicular origins. Nature materials 12: 
476-478. 
50. Demer LL (1995) A Skeleton in the Atherosclerosis Closet. Circulation 92: 2029-2032. 
51. Bertazzo S, Gentleman E, Cloyd KL, Chester AH, Yacoub MH, et al. (2013) Nano-
analytical electron microscopy reveals fundamental insights into human 
cardiovascular tissue calcification. Nature materials 12: 576-583. 
 152 
52. Roberts WC, Ko JM (2005) Frequency by decades of unicuspid, bicuspid, and tricuspid 
aortic valves in adults having isolated aortic valve replacement for aortic stenosis, 
with or without associated aortic regurgitation. Circulation 111: 920-925. 
53. Otto CM, Burwash IG, Legget ME, Munt BI, Fujioka M, et al. (1997) Prospective study of 
asymptomatic valvular aortic stenosis clinical, echocardiographic, and exercise 
predictors of outcome. Circulation 95: 2262-2270. 
54. Hakuno D, Fukuda K (2007) Role of anti-angiogenic factor chondromodulin-I for 
maintaining cardiac valvular function. Clin Calcium 17: 361-372. 
55. Schoen FJ, Edwards WD (2001) Cardiovascular Pathology : Valvular heart disease: 
general principles and stenosis. New York, NY: Churchill Livingtone. 
56. images ADAM (accessed : 20-09-2010) Heart Valve Surgery. In: 
http://www.medhelp.org/medical-information/show/3962/Heart-valve-surgery---
series, editor. internet: A.D.A.M. images. 
57. Sacks MS, Yoganathan AP (2007) Heart valve function: a biomechanical perspective. 
Philosophical Transactions of the Royal Society B: Biological Sciences 362: 1369-
1391. 
58. Mulholland DL, Gotlieb AI (1996) Cell biology of valvular interstitial cells. The Canadian 
journal of cardiology 12: 231-236. 
59. Marron K, Yacoub MH, Polak JM, Sheppard MN, Fagan D, et al. (1996) Innervation of 
human atrioventricular and arterial valves. Circulation 94: 368-375. 
60. Osman L, Yacoub MH, Latif N, Amrani M, Chester AH (2006) Role of Human Valve 
Interstitial Cells in Valve Calcification and Their Response to Atorvastatin. 
Circulation 114: I-547-I-552. 
61. Tanaka K, Sata M, Fukuda D, Suematsu Y, Motomura N, et al. (2005) Age-associated 
aortic stenosis in apolipoprotein E-deficient mice. Journal of the American College 
of Cardiology 46: 134-141. 
62. Yip CYY, Chen J-H, Zhao R, Simmons CA (2009) Calcification by Valve Interstitial Cells Is 
Regulated by the Stiffness of the Extracellular Matrix. Arteriosclerosis, thrombosis, 
and vascular biology 29: 936-942. 
63. El-Hamamsy I, Balachandran K, Yacoub MH, Stevens LM, Sarathchandra P, et al. (2009) 
Endothelium-dependent regulation of the mechanical properties of aortic valve 
cusps. Journal of the American College of Cardiology 53: 1448-1455. 
 153 
64. Lester WM, Damji AA, Gedeon I, Tanaka M (1993) Interstitial cells from the atrial and 
ventricular sides of the bovine mitral valve respond differently to denuding 
endocardial injury. In Vitro Cellular & Developmental Biology-Animal 29: 41-50. 
65. Otto CM (2008) Calcific Aortic Stenosis — Time to Look More Closely at the Valve. New 
England Journal of Medicine 359: 1395-1398. 
66. Demer LL, Tintut Y (2008) Vascular Calcification: Pathobiology of a Multifaceted 
Disease. Circulation 117: 2938-2948. 
67. Hoffmann G, Lutter G, Cremer J (2008) Durability of bioprosthetic cardiac valves. 
Deutsches Arzteblatt international 105: 143. 
68. Vesely I (2005) Heart valve tissue engineering. Circulation Research 97: 743-755. 
69. Taylor PM, Batten P, Brand NJ, Thomas PS, Yacoub MH (2003) The cardiac valve 
interstitial cell. The International Journal of Biochemistry & Cell Biology 35: 113-
118. 
70. Kim K. Calcification of matrix vesicles in human aortic valve and aortic media; 1976. pp. 
156-162. 
71. Walker GA, Guerrero IA, Leinwand LA (2001) Myofibroblasts: molecular crossdressers. 
Current topics in developmental biology 51: 91-107. 
72. Brand NJ, Roy A, Hoare G, Chester A, Yacoub MH (2006) Cultured interstitial cells from 
human heart valves express both specific skeletal muscle and non-muscle 
markers. The International Journal of Biochemistry & Cell Biology 38: 30-42. 
73. Dreger S, Taylor P, Allen S, Yacoub M (2002) Profile and localization of matrix 
metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart 
valves. The Journal of heart valve disease 11: 875. 
74. Liu AC, Joag VR, Gotlieb AI (2007) The Emerging Role of Valve Interstitial Cell 
Phenotypes in Regulating Heart Valve Pathobiology. The American journal of 
pathology 171: 1407-1418. 
75. Paruchuri S, Yang J-H, Aikawa E, Melero-Martin JM, Khan ZA, et al. (2006) Human 
pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in 
response to vascular endothelial growth factor-A and transforming growth factor-
β2. Circulation Research 99: 861-869. 
76. Chen J-H, Yip CYY, Sone ED, Simmons CA (2009) Identification and Characterization of 
Aortic Valve Mesenchymal Progenitor Cells with Robust Osteogenic Calcification 
Potential. The American journal of pathology 174: 1109-1119. 
 154 
77. Chalajour F, Treede H, Gehling UM, Ebrahimnejad A, Boehm DH, et al. (2007) 
Identification and characterization of cells with high angiogenic potential and 
transitional phenotype in calcific aortic valve. Experimental cell research 313: 
2326-2335. 
78. Kershaw J, Misfeld M, Sievers H-H, Yacoub MH, Chester AH (2004) Specific regional and 
directional contractile responses of aortic cusp tissue. The Journal of heart valve 
disease 13: 798-803. 
79. Filip D, Radu A, Simionescu M (1986) Interstitial cells of the heart valves possess 
characteristics similar to smooth muscle cells. Circulation Research 59: 310-320. 
80. Messier RH, Bass BL, Aly HM, Jones JL, Domkowski PW, et al. (1994) Dual structural and 
functional phenotypes of the porcine aortic valve interstitial population: 
characteristics of the leaflet myofibroblast. Journal of Surgical Research 57: 1-21. 
81. Masters KS, Shah DN, Leinwand LA, Anseth KS (2005) Crosslinked hyaluronan scaffolds 
as a biologically active carrier for valvular interstitial cells. Biomaterials 26: 2517-
2525. 
82. Johnson CM, Hanson MN, Helgeson SC (1987) Porcine cardiac valvular subendothelial 
cells in culture: Cell isolation and growth characteristics. Journal of Molecular and 
Cellular Cardiology 19: 1185-1193. 
83. Lester W, Rosenthal A, Granton B, Gotlieb A (1988) Porcine mitral valve interstitial cells 
in culture. Laboratory investigation; a journal of technical methods and pathology 
59: 710-719. 
84. Gotlieb A, Spector W (1981) Migration into an in vitro experimental wound: a 
comparison of porcine aortic endothelial and smooth muscle cells and the effect 
of culture irradiation. The American journal of pathology 103: 271. 
85. Zacks S, Rosenthal A, Granton B, Havenith M, Opas M, et al. (1991) Characterization of 
Cobblestone mitral valve interstitial cells. Archives of pathology & laboratory 
medicine 115: 774. 
86. Rajamannan NM, Subramaniam M, Caira F, Stock SR, Spelsberg TC (2005) Atorvastatin 
inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 
receptor pathway. Circulation 112: I-229-I-234. 
87. Krafft C, Dietzek B, Popp J (2009) Raman and CARS microspectroscopy of cells and 
tissues. Analyst 134: 1046-1057. 
 155 
88. Krafft C, Belay B, Bergner N, Romeike BF, Reichart R, et al. (2012) Advances in optical 
biopsy–correlation of malignancy and cell density of primary brain tumors using 
Raman microspectroscopic imaging. Analyst 137: 5533-5537. 
89. Bergholt MS, Zheng W, Huang Z (2012) Characterizing variability in in vivo Raman 
spectroscopic properties of different anatomical sites of normal tissue in the oral 
cavity. Journal of Raman spectroscopy 43: 255-262. 
90. Neugebauer U, Bocklitz T, Clement J, Krafft C, Popp J (2010) Towards detection and 
identification of circulating tumour cells using Raman spectroscopy. Analyst 135: 
3178-3182. 
91. Swain RJ, Kemp SJ, Goldstraw P, Tetley TD, Stevens MM (2008) Spectral monitoring of 
surfactant clearance during alveolar epithelial type II cell differentiation. 
Biophysical journal 95: 5978-5987. 
92. Notingher I, Jell G, Notingher PL, Bisson I, Tsigkou O, et al. (2005) Multivariate analysis 
of Raman spectra for in vitro non-invasive studies of living cells. Journal of 
Molecular Structure 744–747: 179-185. 
93. Swain R, Stevens M (2007) Raman microspectroscopy for non-invasive biochemical 
analysis of single cells. Biochemical Society Transactions 35: 544-550. 
94. Swain RJ, Kemp SJ, Goldstraw P, Tetley TD, Stevens MM (2010) Assessment of cell line 
models of primary human cells by Raman spectral phenotyping. Biophysical 
journal 98: 1703-1711. 
95. Bocklitz T, Putsche M, Stüber C, Käs J, Niendorf A, et al. (2009) A comprehensive study 
of classification methods for medical diagnosis. Journal of Raman spectroscopy 40: 
1759-1765. 
96. Sattlecker M, Baker R, Stone N, Bessant C (2011) Support vector machine ensembles 
for breast cancer type prediction from mid-FTIR micro-calcification spectra. 
Chemometrics and Intelligent Laboratory Systems 107: 363-370. 
97. Sattlecker M, Stone N, Smith J, Bessant C (2011) Assessment of robustness and 
transferability of classification models built for cancer diagnostics using Raman 
spectroscopy. Journal of Raman spectroscopy 42: 897-903. 
98. Krafft C, Salzer R, Seitz S, Ern C, Schieker M (2007) Differentiation of individual human 
mesenchymal stem cells probed by FTIR microscopic imaging. Analyst 132: 647-
653. 
 156 
99. Lasch P, Haensch W, Naumann D, Diem M (2004) Imaging of colorectal 
adenocarcinoma using FT-IR microspectroscopy and cluster analysis. Biochimica et 
Biophysica Acta (BBA)-Molecular Basis of Disease 1688: 176-186. 
100. Bryan K, Brennan L, Cunningham P (2008) MetaFIND: A feature analysis tool for 
metabolomics data. BMC Bioinformatics 9: 470. 
101. Xia J, Wishart DS (2011) Web-based inference of biological patterns, functions and 
pathways from metabolomic data using MetaboAnalyst. Nature Protocols 6: 743-
760. 
102. Kohler A, Kirschner C, Oust A, Martens H (2005) Extended multiplicative signal 
correction as a tool for separation and characterization of physical and chemical 
information in Fourier transform infrared microscopy images of cryo-sections of 
beef loin. Applied spectroscopy 59: 707-716. 
103. Chong I-G, Jun C-H (2005) Performance of some variable selection methods when 
multicollinearity is present. Chemometrics and Intelligent Laboratory Systems 78: 
103-112. 
104. Kvalheim OM (2010) Interpretation of partial least squares regression models by 
means of target projection and selectivity ratio plots. Journal of Chemometrics 24: 
496-504. 
105. Rajalahti T, Arneberg R, Berven FS, Myhr K-M, Ulvik RJ, et al. (2009) Biomarker 
discovery in mass spectral profiles by means of selectivity ratio plot. 
Chemometrics and Intelligent Laboratory Systems 95: 35-48. 
106. Wold S, Johansson E, Cocchi M (1993) PLS—partial least squares projections to latent 
structures. 3D QSAR in drug design 1: 523-550. 
107. Meade AD, Clarke C, Draux F, Sockalingum GD, Manfait M, et al. (2010) Studies of 
chemical fixation effects in human cell lines using Raman microspectroscopy. 
Analytical and Bioanalytical Chemistry 396: 1781-1791. 
108. Mariani MM, Lampen P, Popp J, Wood BR, Deckert V (2009) Impact of fixation on in 
vitro cell culture lines monitored with Raman spectroscopy. Analyst 134: 1154-
1161. 
109. Oxlund H, Sekilde L, Ørtoft G (1996) Reduced concentration of collagen reducible 
cross links in human trabecular bone with respect to age and osteoporosis. Bone 
19: 479-484. 
110. Khosla S, Melton LJ, Atkinson EJ, O’fallon W, Klee GG, et al. (1998) Relationship of 
serum sex steroid levels and bone turnover markers with bone mineral density in 
 157 
men and women: a key role for bioavailable estrogen. Journal of Clinical 
Endocrinology & Metabolism 83: 2266-2274. 
111. Beck TJ, Ruff CB, Scott Jr WW, Plato CC, Tobin JD, et al. (1992) Sex differences in 
geometry of the femoral neck with aging: a structural analysis of bone mineral 
data. Calcified tissue international 50: 24-29. 
112. Yacoub MH, Kilner PJ, Birks EJ, Misfeld M (1999) The aortic outflow and root: a tale of 
dynamism and crosstalk. The Annals of Thoracic Surgery 68: S37-S43. 
113. El Hamamsy I (2010) Long-term outcomes after autograft versus homograft aortic 
root replacement in adults with aortic valve disease: a randomised controlled trial. 
Lancet 376: 524-531. 
114. Chester AH (2011) Molecular and cellular mechanisms of valve calcification. Aswan 
Heart Centre Science & Practice Series 2011: 4. 
115. Frederick J S Cardiac valves and valvular pathology: Update on function, disease, 
repair, and replacement. Cardiovascular Pathology 14: 189-194. 
116. Yacoub MH, Takkenberg JJM (2005) Will heart valve tissue engineering change the 
world? Nature clinical practice cardiovascular medicine 2: 60-61. 
117. Freeman RV, Otto CM (2005) Spectrum of Calcific Aortic Valve Disease. Circulation 
111: 3316-3326. 
118. O’Brien KD (2006) Pathogenesis of Calcific Aortic Valve Disease. Arteriosclerosis, 
thrombosis, and vascular biology 26: 1721-1728. 
119. Schoen FJ (2008) Evolving Concepts of Cardiac Valve Dynamics. Circulation 118: 1864-
1880. 
120. Cawley PJ (2009) Prevention of calcific aortic valve stenosis-fact or fiction? Annals of 
medicine (Helsinki) 41: 100-108. 
121. Elmariah S (2010) The Pathogenesis and treatment of the valvulopathy of aortic 
stenosis: Beyond the SEAS. Current Cardiology Reports 12: 125-132. 
122. Durbin AD, Gotlieb AI Advances towards understanding heart valve response to 
injury. Cardiovascular Pathology 11: 69-77. 
123. Rajamannan NM (2003) Human aortic valve calcification is associated with an 
osteoblast phenotype. Circulation 107: 2181-2184. 
124. Jian B, Narula N, Li Q-y, Mohler ER, III, Levy RJ (2003) Progression of aortic valve 
stenosis: TGF-{beta}1 is present in calcified aortic valve cusps and promotes aortic 
valve interstitial cell calcification via apoptosis. Ann Thorac Surg 75: 457-465. 
 158 
125. Clark-Greuel JN, Connolly JM, Sorichillo E, Narula NR, Rapoport HS, et al. (2007) 
Transforming Growth Factor-{beta}1 Mechanisms in Aortic Valve Calcification: 
Increased Alkaline Phosphatase and Related Events. Ann Thorac Surg 83: 946-953. 
126. Kennedy JA, Hua X, Mishra K, Murphy GA, Rosenkranz AC, et al. (2009) Inhibition of 
calcifying nodule formation in cultured porcine aortic valve cells by nitric oxide 
donors. European Journal of Pharmacology 602: 28-35. 
127. Mikroulis D (2002) Physicochemical and microscopical study of calcific deposits from 
natural and bioprosthetic heart valves. Comparison and implications for 
mineralization mechanism. Journal of materials science Materials in medicine 13: 
885-889. 
128. Dorfmuller P, Bazin D, Aubert S, Weil R, Brisset F, et al. (2010) Crystalline 
Ultrastructures, Inflammatory Elements, and Neoangiogenesis Are Present in 
Inconspicuous Aortic Valve Tissue. Cardiology Research and Practice 2010. 
129. Weska RF, Aimoli CG, Nogueira GM, Leirner AA, Maizato MJS, et al. (2010) Natural 
and Prosthetic Heart Valve Calcification: Morphology and Chemical Composition 
Characterization. Artificial Organs 34: 311-318. 
130. Delogne C, Lawford PV, Habesch SM, Carolan VA (2007) Characterization of the 
calcification of cardiac valve bioprostheses by environmental scanning electron 
microscopy and vibrational spectroscopy. Journal of Microscopy 228: 62-77. 
131. Cheng W-T, Liu M-T, Liu H-N, Lin S-Y (2005) Micro-Raman spectroscopy used to 
identify and grade human skin pilomatrixoma. Microscopy Research and 
Technique 68: 75-79. 
132. Wong GL (1975) Target cells in bone for parathormone and calcitonin are different: 
enrichment for each cell type by sequential digestion of mouse calvaria and 
selective adhesion to polymeric surfaces. Proceedings of the National Academy of 
Sciences of the United States of America 72: 3167-3171. 
133. Gruber HE, Ingram J, Zinchenko N, Hanley EN (2010) Practical histological methods for 
use with cultured cells  Biotechnic & Histochemistry 84: 283-286. 
134. Geladi P (1985) Linearization and scatter-correction for near-infrared reflectance 
spectra of meat. Applied spectroscopy 39: 491-500. 
135. Hancewicz TM, Petty C (1995) Quantitative analysis of vitamin A using Fourier 
transform Raman spectroscopy. Spectrochimica Acta Part A: Molecular and 
Biomolecular Spectroscopy 51: 2193-2198. 
 159 
136. Norgaard L, Saudland A, Wagner J, Nielsen JP, Munck L, et al. (2000) Interval Partial 
Least-Squares Regression (iPLS): A Comparative Chemometric Study with an 
Example from Near-Infrared Spectroscopy. Appl Spectrosc 54: 413-419. 
137. Barragan Adjemian C (2006) Mechanism by which MLO-A5 Late Osteoblasts/Early 
Osteocytes Mineralize in Culture: Similarities with Mineralization of Lamellar 
Bone. Calcified tissue international 79: 340-353. 
138. Starborg T (2008) Electron microscopy in cell-matrix research. Methods 45: 53-64. 
139. Hodge AJ, Petruska JA (1963) Aspect of Protein Structure; Ramachandran GN, editor. 
New York: Academic Press. 
140. Frushour BG, Koenig JL (1975) Raman scattering of collagen, gelatin, and elastin. 
Biopolymers 14: 379-391. 
141. Rajamannan NM (2009) Calcific aortic stenosis: lessons learned from experimental 
and clinical studies. Arteriosclerosis, thrombosis, and vascular biology 29: 162-168. 
142. Rodriguez KJ, Masters KS (2009) Regulation of valvular interstitial cell calcification by 
components of the extracellular matrix. Journal of Biomedical Materials Research 
Part A 90A: 1043-1053. 
143. Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA (2004) Valvular 
Myofibroblast Activation by Transforming Growth Factor-β. Circulation Research 
95: 253-260. 
144. Monzack EL, Masters KS (2011) Can Valvular Interstitial Cells Become True 
Osteoblasts? A Side-by-Side Comparison. The Journal of Heart Valve Disease 20: 
449-463. 
145. Aikawa E, Nahrendorf M, Sosnovik D, Lok VM, Jaffer FA, et al. (2007) Multimodality 
Molecular Imaging Identifies Proteolytic and Osteogenic Activities in Early Aortic 
Valve Disease. Circulation 115: 377-386. 
146. Chen J-H, Simmons CA (2011) Cell–Matrix Interactions in the Pathobiology of Calcific 
Aortic Valve Disease. Circulation Research 108: 1510-1524. 
147. Miller JD, Weiss RM, Heistad DD (2011) Calcific Aortic Valve Stenosis: Methods, 
Models, and Mechanisms. Circulation Research 108: 1392-1412. 
148. Sappino AP (1990) Differentiation repertoire of fibroblastic cells: expression of 
cytoskeletal proteins as marker of phenotypic modulations. Laboratory 
Investigation 63: 144. 
 160 
149. Monzack EL, Gu X, Masters KS (2009) Efficacy of simvastatin treatment of valvular 
interstitial cells varies with the extracellular environment. Arteriosclerosis, 
thrombosis, and vascular biology 29: 246-253. 
150. Rocha R (2007) Identification of calcifications in cardiac valves by near infrared 
Raman spectroscopy. Photomedicine and laser surgery 25: 287-290. 
151. Keelan PC, Bielak LF, Ashai K, Jamjoum LS, Denktas AE, et al. (2001) Long-term 
prognostic value of coronary calcification detected by electron-beam computed 
tomography in patients undergoing coronary angiography. Circulation 104: 412-
417. 
152. Hjortnaes J, New SEP, Aikawa E (2013) Visualizing novel concepts of cardiovascular 
calcification. Trends in Cardiovascular Medicine 23: 71-79. 
153. Rennenberg R, Kessels A, Schurgers L, Van Engelshoven J, De Leeuw P, et al. (2009) 
Vascular calcifications as a marker of increased cardiovascular risk: a meta-
analysis. Vascular health and risk management 5: 185. 
154. Sage AP, Tintut Y, Demer LL (2010) Regulatory mechanisms in vascular calcification. 
Nature Reviews Cardiology 7: 528-536. 
155. Lusis AJ (2000) Atherosclerosis. Nature 407: 233-241. 
156. Watson KE, Parhami F, Shin V, Demer LL (1998) Fibronectin and Collagen I Matrixes 
Promote Calcification of Vascular Cells in Vitro, Whereas Collagen IV Matrix Is 
Inhibitory. Arteriosclerosis, thrombosis, and vascular biology 18: 1964-1971. 
157. Rekhter MD (1999) Collagen synthesis in atherosclerosis: too much and not enough. 
Cardiovascular Research 41: 376-384. 
158. Rekhter M, Zhang K, Narayanan A, Phan S, Schork M, et al. (1993) Type I collagen 
gene expression in human atherosclerosis. Localization to specific plaque regions. 
The American journal of pathology 143: 1634. 
159. Adiguzel E, Ahmad PJ, Franco C, Bendeck MP (2009) Collagens in the progression and 
complications of atherosclerosis. Vascular Medicine 14: 73-89. 
160. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, et al. (1995) A definition of 
advanced types of atherosclerotic lesions and a histological classification of 
atherosclerosis A report from the Committee on Vascular Lesions of the Council 
on Arteriosclerosis, American Heart Association. Arteriosclerosis, thrombosis, and 
vascular biology 15: 1512-1531. 
 161 
161. Vattikuti R, Towler DA (2004) Osteogenic regulation of vascular calcification: an early 
perspective. American Journal of Physiology - Endocrinology And Metabolism 286: 
E686-E696. 
162. Jeziorska M, McCollum C, Woolley D (1998) Observations on bone formation and 
remodelling in advanced atherosclerotic lesions of human carotid arteries. 
Virchows Archiv 433: 559-565. 
163. Hunt JL, Fairman R, Mitchell ME, Carpenter JP, Golden M, et al. (2002) Bone 
formation in carotid plaques a clinicopathological study. stroke 33: 1214-1219. 
164. Cowles E, DeRome M, Pastizzo G, Brailey L, Gronowicz G (1998) Mineralization and 
the expression of matrix proteins during in vivo bone development. Calcified 
tissue international 62: 74-82. 
165. Carden A, Rajachar RM, Morris MD, Kohn DH (2003) Ultrastructural Changes 
Accompanying the Mechanical Deformation of Bone Tissue: A Raman Imaging 
Study. Calcified tissue international 72: 166-175. 
166. Newcomb WL, Hope WW, Schmelzer TM, Heath JJ, Norton HJ, et al. (2009) 
Comparison of blood vessel sealing among new electrosurgical and ultrasonic 
devices. Surgical Endoscopy and Other Interventional Techniques 23: 90-96. 
167. Sigel B, Dunn MR (1965) MECHANISM OF BLOOD VESSEL CLOSURE BY HIGH 
FREQUENCY ELECTROCOAGULATION. Surgery Gynecology and Obstetrics with 
International Abstracts of Surgery 121: 823-&. 
168. Winter H, Holmer C, Buhr HJ, Lindner G, Lauster R, et al. (2010) Pilot study of bipolar 
radiofrequency-induced anastomotic thermofusion-exploration of therapy 
parameters ex vivo. Int J Colorectal Dis 25: 129-133. 
169. Floume T, Syms RR, Darzi AW, Hanna GB (2008) Real-time optical monitoring of radio-
frequency tissue fusion by continuous wave transmission spectroscopy. J Biomed 
Opt 13: 064006. 
170. Floume T, Syms RR, Darzi AW, Hanna GB (2010) Optical, thermal, and electrical 
monitoring of radio-frequency tissue modification. J Biomed Opt 15: 018003. 
171. Hyman N (2007) Anastomotic leaks after intestinal anastomosis: it's later than you 
think. Annals of surgery 245: 254. 
172. Foschi D, Cellerino P, Corsi F, Taidelli T, Morandi E, et al. (2002) The mechanisms of 
blood vessel closure in humans by the application of ultrasonic energy. Surgical 
Endoscopy and Other Interventional Techniques 16: 814-819. 
 162 
173. Lieber CA, Mahadevan-Jansen A (2007) Development of a handheld Raman 
microspectrometer for clinical dermatologic applications. Optics Express 15: 
11874-11882. 
174. Patil CA, Bosschaart N, Keller MD, van Leeuwen TG, Mahadevan-Jansen A (2008) 
Combined Raman spectroscopy and optical coherence tomography device for 
tissue characterization. Optics Letters 33: 1135-1137. 
175. Jhan J-W, Chang W-T, Chen H-C, Lee Y-T, Wu M-F, et al. (2008) Integrated multiple 
multi-photon imaging and Raman spectroscopy for characterizing structure-
constituent correlation of tissues. Optics Express 16: 16431-16441. 
176. Srinivasan S, Schulmerich M, Cole JH, Dooley KA, Kreider JM, et al. (2008) Image-
guided Raman spectroscopic recovery of canine cortical bone contrast in situ. 
Optics Express 16: 12190-12200. 
177. Moreira LM, Silveira L, Jr., Santos FV, Lyon JP, Rocha R, et al. (2008) Raman 
spectroscopy: A powerful technique for biochemical analysis and diagnosis. 
Spectroscopy-an International Journal 22: 1-19. 
178. Thomas GJ (1999) Raman spectroscopy of protein and nucleic acid assemblies. Annual 
Review of Biophysics and Biomolecular Structure 28: 1-+. 
179. Lippert JL, Tyminski D, Desmeules PJ (1976) DETERMINATION OF SECONDARY 
STRUCTURE OF PROTEINS BY LASER RAMAN-SPECTROSCOPY. Journal of the 
American Chemical Society 98: 7075-7080. 
180. Alimova A, Chakraverty R, Muthukattil R, Elder S, Katz A, et al. (2009) In vivo 
molecular evaluation of guinea pig skin incisions healing after surgical suture and 
laser tissue welding using Raman spectroscopy. Journal of Photochemistry and 
Photobiology B-Biology 96: 178-183. 
181. Dong RX, Yan XL, Pang XF, Liu SG (2004) Temperature-dependent Raman spectra of 
collagen and DNA. Spectrochimica Acta Part a-Molecular and Biomolecular 
Spectroscopy 60: 557-561. 
182. Bergner N, Krafft C, Geiger KD, Kirsch M, Schackert G, et al. (2012) Unsupervised 
unmixing of Raman microspectroscopic images for morphochemical analysis of 
non-dried brain tumor specimens. Analytical and Bioanalytical Chemistry 403: 719-
725. 
183. Gentleman E, Swain RJ, Evans ND, Boonrungsiman S, Jell G, et al. (2009) Comparative 
materials differences revealed in engineered bone as a function of cell-specific 
differentiation. Nature Materials 8: 763-770. 
 163 
184. Lieber CA, Mahadevan-Jansen A (2003) Automated method for subtraction of 
fluorescence from biological Raman spectra. Applied Spectroscopy 57: 1363-1367. 
185. Geladi P, Macdougall D, Martens H (1985) LINEARIZATION AND SCATTER-
CORRECTION FOR NEAR-INFRARED REFLECTANCE SPECTRA OF MEAT. Applied 
Spectroscopy 39: 491-500. 
186. Hancewicz TM, Petty C (1995) Quantitative analysis of vitamin A using Fourier 
transform Raman spectroscopy. Spectrochimica Acta Part a-Molecular and 
Biomolecular Spectroscopy 51: 2193-2198. 
187. Shobhit A, Hadjievangelou N, Su L, Kudo H, Goldin RD, et al. (2013) Radiofrequency 
induced small bowel thermofusion: An ex vivo study of intestinal seal adequacy 
using mechanical and imaging modalities. Surg Endosc Accepted. 
188. Frushour BG, Koenig JL (1975) RAMAN-SCATTERING OF COLLAGEN, GELATIN, AND 
ELASTIN. Biopolymers 14: 379-391. 
189. Hedegaard M, Matthaeus C, Hassing S, Krafft C, Diem M, et al. (2011) Spectral 
unmixing and clustering algorithms for assessment of single cells by Raman 
microscopic imaging. Theoretical Chemistry Accounts 130: 1249-1260. 
190. Salameh JR, Schwartz JH, Hildebrandt DA (2006) Can LigaSure seal and divide the 
small bowel? American Journal of Surgery 191: 791-793. 
191. Shields CA, Schechter DA, Tetzlaff P, Baily AL, Dycus S, et al. (2004) Method for 
creating ideal tissue fusion in soft-tissue structures using radio frequency (RF) 
energy. Surg Technol Int 13: 49-55. 
192. Tarnowski CP, Stewart S, Holder K, Campbell-Clark L, Thoma RJ, et al. (2003) Effects of 
treatment protocols and subcutaneous implantation on bovine pericardium: a 
Raman spectroscopy study. J Biomed Opt 8: 179-184. 
193. Stone N, Kendall C, Smith J, Crow P, Barr H (2004) Raman spectroscopy for 
identification of epithelial cancers. Faraday Discussions 126: 141-157. 
194. Lau DP, Huang ZW, Lui H, Anderson DW, Berean K, et al. (2005) Raman spectroscopy 
for optical diagnosis in the larynx: Preliminary findings. Lasers Surg Med 37: 192-
200. 
195. Hanlon EB, Manoharan R, Koo TW, Shafer KE, Motz JT, et al. (2000) Prospects for in 
vivo Raman spectroscopy. Physics in Medicine and Biology 45: R1-R59. 
196. Kaminaka S, Ito T, Yamazaki H, Kohda E, Hamaguchi H (2002) Near-infrared 
multichannel Raman spectroscopy toward real-time in vivo cancer diagnosis. 
Journal of Raman Spectroscopy 33: 498-502. 
 164 
197. Shim MG, Song L, Marcon NE, Wilson BC (2000) In vivo near-infrared Raman 
spectroscopy: Demonstration of feasibility during clinical gastrointestinal 
endoscopy. Photochem Photobiol 72: 146-150. 
198. Haka AS, Volynskaya Z, Gardecki JA, Nazemi J, Lyons J, et al. (2006) In vivo Margin 
Assessment during Partial Mastectomy Breast Surgery Using Raman 
Spectroscopy[?Q1: Running head: Raman Margin Assessment at Partial 
Mastectomy. Short title OK?Q1]. Cancer Research 66: 3317-3322. 
199. Pascut FC, Goh HT, George V, Denning C, Notingher I (2011) Toward label-free 
Raman-activated cell sorting of cardiomyocytes derived from human embryonic 
stem cells. Journal of Biomedical Optics 16: 045002-045002-045004. 
200. Schulze HG, Konorov SO, Caron NJ, Piret JM, Blades MW, et al. (2010) Assessing 
differentiation status of human embryonic stem cells noninvasively using Raman 
microspectroscopy. Analytical Chemistry 82: 5020-5027. 
201. Chan JW, Lieu DK, Huser T, Li RA (2009) Label-Free Separation of Human Embryonic 
Stem Cells and Their Cardiac Derivatives Using Raman Spectroscopy. Analytical 
Chemistry 81: 1324-1331. 
202. Ramm Sander P, Hau P, Koch S, Schütze K, Bogdahn U, et al. (2013) Stem cell 
metabolic and spectroscopic profiling. Trends in Biotechnology 31: 204-213. 
203. Pilarczyk M, Czamara K, Baranska M, Natorska J, Kapusta P, et al. (2013) Calcification 
of aortic human valves studied in situ by Raman microimaging: following 
mineralization from small grains to big deposits. Journal of Raman spectroscopy 
44: 1222-1229. 
204. Azevedo P, Pereira R, Guilherme L (2012) Understanding rheumatic fever. 
Rheumatology International 32: 1113-1120. 
205. Antonakos A, Liarokapis E, Leventouri T (2007) Micro-Raman and FTIR studies of 
synthetic and natural apatites. Biomaterials 28: 3043-3054. 
206. Raz S, Testeniere O, Hecker A, Weiner S, Luquet G (2002) Stable Amorphous Calcium 
Carbonate Is the Main Component of the Calcium Storage Structures of the 
Crustacean Orchestia cavimana. The Biological Bulletin 203: 269-274. 
207. Addadi L, Raz S, Weiner S (2003) Taking Advantage of Disorder: Amorphous Calcium 
Carbonate and Its Roles in Biomineralization. Advanced Materials 15: 959-970. 
 
 
